0001021408-24-004825.txt : 20240827 0001021408-24-004825.hdr.sgml : 20240827 20240827133500 ACCESSION NUMBER: 0001021408-24-004825 CONFORMED SUBMISSION TYPE: N-PX PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240827 DATE AS OF CHANGE: 20240827 EFFECTIVENESS DATE: 20240827 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Health Sciences Trust CENTRAL INDEX KEY: 0001314966 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: N-PX SEC ACT: 1940 Act SEC FILE NUMBER: 811-21702 FILM NUMBER: 241246812 BUSINESS ADDRESS: STREET 1: 100 BELLEVUE PARKWAY CITY: WILMINGTON STATE: DE ZIP: 19809 BUSINESS PHONE: (888) 825-2257 MAIL ADDRESS: STREET 1: 100 BELLEVUE PARKWAY CITY: WILMINGTON STATE: DE ZIP: 19809 N-PX 1 primary_doc.xml N-PX RMIC LIVE 0001314966 XXXXXXXX false false N-2 06/30/2024 YEAR 2024 BlackRock Health Sciences Trust 800-882-0052

100 Bellevue Parkway Wilmington DE 19809

John Perlowski

50 Hudson Yards New York NY 10001

FUND VOTING REPORT N 811-21702 N 1 19 028-04295 000106614 801-47710 5493001LN9MRM6A35J74 BlackRock Advisors, LLC 0 BlackRock Health Sciences Trust John Perlowski John Perlowski Chief Executive Officer 08/27/2024 PROXY VOTING RECORD 2 proxyvote.xml IVERIC bio, Inc. 46583P102 US46583P1021 07/06/2023 To adopt the Agreement and Plan of Merger (the "Merger Agreement"), dated April 28, 2023, by and among IVERIC bio, Inc. ("IVERIC"), Astellas US Holding, Inc. ("Parent"), Berry Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), and Solely as provided by Section 8.10(b) of the Merger Agreement, Astellas Pharma Inc., pursuant to which Merger Sub will merge with and into IVERIC, and IVERIC will become a wholly owned subsidiary of Parent (the "Merger"). EXTRAORDINARY TRANSACTIONS ISSUER 12230.000000 0 FOR 12230.000000 FOR IVERIC bio, Inc. 46583P102 US46583P1021 07/06/2023 To approve, by non-binding, advisory vote, compensation that may be paid or become payable by IVERIC to its named executive officers in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 12230.000000 0 FOR 12230.000000 FOR IVERIC bio, Inc. 46583P102 US46583P1021 07/06/2023 To approve the adjournment of the special meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the special meeting. CORPORATE GOVERNANCE ISSUER 12230.000000 0 FOR 12230.000000 FOR Abcam Plc 000380204 US0003802040 07/12/2023 THAT Peter Allen be removed from office as a director of the Company with immediate effect. DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 Abcam Plc 000380204 US0003802040 07/12/2023 THAT Michael S. Baldock be removed from office as a director of the Company with immediate effect. DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 Abcam Plc 000380204 US0003802040 07/12/2023 THAT Sally W. Crawford be removed from office as a director of the Company with immediate effect. DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 Abcam Plc 000380204 US0003802040 07/12/2023 THAT in the event any director of the Company is appointed after the Company's receipt of the general meeting request dated May 30, 2023 and prior to this meeting, each such director be removed from office as a director of the Company with immediate effect. DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 Abcam Plc 000380204 US0003802040 07/12/2023 THAT Dr. Jonathan Milner, having consented to act, be appointed as Director of the Company with immediate effect. DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 Abcam Plc 000380204 US0003802040 07/12/2023 THAT Dr. Jonathan Milner, having been appointed a Director of the Company, be further appointed to the position of Executive Chairman of the Company with immediate effect. CORPORATE GOVERNANCE SECURITY HOLDER 0.000000 0 Abcam Plc 000380204 US0003802040 07/12/2023 Appoint Two Additional Directors To The Board Whose Qualifications Will Include Significant Capital Allocation And Biotechnology Company Operating Experience CORPORATE GOVERNANCE SECURITY HOLDER 0.000000 0 Abcam Plc 000380204 US0003802040 07/12/2023 THAT the expenses incurred by Dr. Milner and those acting on his behalf in connection with his engagement with the Company in respect of the request to convene a general meeting be reimbursed by the Company. CORPORATE GOVERNANCE SECURITY HOLDER 0.000000 0 Abcam Plc 000380204 US0003802040 07/12/2023 That Peter Allen be removed from office as a director of the Company with immediate effect. DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 Abcam Plc 000380204 US0003802040 07/12/2023 That Michael S. Baldock be removed from office as a director of the Company with immediate effect. DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 Abcam Plc 000380204 US0003802040 07/12/2023 That Sally W. Crawford be removed from office as a director of the Company with immediate effect. DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 Abcam Plc 000380204 US0003802040 07/12/2023 That in the event any director of the Company is appointed after the Company's receipt of the general meeting request dated May 30, 2023 and prior to this meeting, each such director be removed from office as a director of the Company with immediate effect. DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 Abcam Plc 000380204 US0003802040 07/12/2023 That Dr. Jonathan Milner, having consented to act, be appointed as a Director of the Company with immediate effect. DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 Abcam Plc 000380204 US0003802040 07/12/2023 That Dr. Jonathan Milner, having been appointed a Director of the Company, be further appointed to the position of Executive Chairman of the Company with immediate effect. CORPORATE GOVERNANCE SECURITY HOLDER 0.000000 0 Abcam Plc 000380204 US0003802040 07/12/2023 That it is the consensus of the shareholders that, promptly after the conclusion of this meeting, the Board of Directors shall conduct a thorough search for candidates and shall appoint at least two additional, independent, highly qualified Directors to the Board whose qualifications will include significant capital allocation and biotechnology company operating experience. CORPORATE GOVERNANCE SECURITY HOLDER 0.000000 0 Abcam Plc 000380204 US0003802040 07/12/2023 That the expenses incurred by Dr. Milner and those acting on his behalf in connection with his engagement with the Company in respect of the request to convene a general meeting be reimbursed by the Company. CORPORATE GOVERNANCE SECURITY HOLDER 0.000000 0 McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Election of eleven directors for a one-year term: Richard H. Carmona, M.D. DIRECTOR ELECTIONS ISSUER 26075.000000 0 FOR 26075.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Election of eleven directors for a one-year term: Dominic J. Caruso DIRECTOR ELECTIONS ISSUER 26075.000000 0 FOR 26075.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Election of eleven directors for a one-year term: W. Roy Dunbar DIRECTOR ELECTIONS ISSUER 26075.000000 0 FOR 26075.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Election of eleven directors for a one-year term: James H. Hinton DIRECTOR ELECTIONS ISSUER 26075.000000 0 FOR 26075.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Election of eleven directors for a one-year term: Donald R. Knauss DIRECTOR ELECTIONS ISSUER 26075.000000 0 FOR 26075.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Election of eleven directors for a one-year term: Bradley E. Lerman DIRECTOR ELECTIONS ISSUER 26075.000000 0 FOR 26075.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Election of eleven directors for a one-year term: Linda P. Mantia DIRECTOR ELECTIONS ISSUER 26075.000000 0 FOR 26075.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Election of eleven directors for a one-year term: Maria Martinez DIRECTOR ELECTIONS ISSUER 26075.000000 0 FOR 26075.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Election of eleven directors for a one-year term: Susan R. Salka DIRECTOR ELECTIONS ISSUER 26075.000000 0 FOR 26075.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Election of eleven directors for a one-year term: Brian S. Tyler DIRECTOR ELECTIONS ISSUER 26075.000000 0 FOR 26075.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Election of eleven directors for a one-year term: Kathleen Wilson-Thompson DIRECTOR ELECTIONS ISSUER 26075.000000 0 FOR 26075.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Ratification of Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2024. AUDIT-RELATED ISSUER 26075.000000 0 FOR 26075.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 26075.000000 0 FOR 26075.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Advisory vote on the frequency of the advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 26075.000000 0 ONE YEAR 26075.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/21/2023 Submit Severance Agreement (Change-in-Control) to Shareholder Vote COMPENSATION SECURITY HOLDER 26075.000000 0 AGAINST 26075.000000 FOR ICON plc G4705A100 IE0005711209 07/25/2023 Election of Directors: Mr. Ciaran Murray DIRECTOR ELECTIONS ISSUER 8210.000000 0 FOR 8210.000000 FOR ICON plc G4705A100 IE0005711209 07/25/2023 Election of Directors: Dr. Steve Cutler DIRECTOR ELECTIONS ISSUER 8210.000000 0 FOR 8210.000000 FOR ICON plc G4705A100 IE0005711209 07/25/2023 Election of Directors: Mr. Ronan Murphy DIRECTOR ELECTIONS ISSUER 8210.000000 0 FOR 8210.000000 FOR ICON plc G4705A100 IE0005711209 07/25/2023 Election of Directors: Dr. John Climax DIRECTOR ELECTIONS ISSUER 8210.000000 0 FOR 8210.000000 FOR ICON plc G4705A100 IE0005711209 07/25/2023 Election of Directors: Mr. Eugene McCague DIRECTOR ELECTIONS ISSUER 8210.000000 0 FOR 8210.000000 FOR ICON plc G4705A100 IE0005711209 07/25/2023 Election of Directors: Ms. Joan Garahy DIRECTOR ELECTIONS ISSUER 8210.000000 0 FOR 8210.000000 FOR ICON plc G4705A100 IE0005711209 07/25/2023 Election of Directors: Ms. Julie O'Neill DIRECTOR ELECTIONS ISSUER 8210.000000 0 FOR 8210.000000 FOR ICON plc G4705A100 IE0005711209 07/25/2023 Election of Directors: Dr. Linda Grais DIRECTOR ELECTIONS ISSUER 8210.000000 0 FOR 8210.000000 FOR ICON plc G4705A100 IE0005711209 07/25/2023 To review the Company's affairs and consider the Accounts and Reports CORPORATE GOVERNANCE ISSUER 8210.000000 0 FOR 8210.000000 FOR ICON plc G4705A100 IE0005711209 07/25/2023 To authorize the fixing of the Auditors' Remuneration AUDIT-RELATED ISSUER 8210.000000 0 FOR 8210.000000 FOR ICON plc G4705A100 IE0005711209 07/25/2023 To authorize the Company to allot shares CAPITAL STRUCTURE ISSUER 8210.000000 0 FOR 8210.000000 FOR ICON plc G4705A100 IE0005711209 07/25/2023 To disapply the statutory pre-emption rights CAPITAL STRUCTURE ISSUER 8210.000000 0 FOR 8210.000000 FOR ICON plc G4705A100 IE0005711209 07/25/2023 To authorize the Company to make market purchases of shares CAPITAL STRUCTURE ISSUER 8210.000000 0 FOR 8210.000000 FOR ICON plc G4705A100 IE0005711209 07/25/2023 To authorize the price range at which the Company can reissue shares that it holds as treasury shares CAPITAL STRUCTURE ISSUER 8210.000000 0 FOR 8210.000000 FOR Horizon Therapeutics Public Limited Company G46188101 IE00BQPVQZ61 07/27/2023 Election of Class III Director Nominees: Gino Santini DIRECTOR ELECTIONS ISSUER 7410.000000 0 FOR 7410.000000 FOR Horizon Therapeutics Public Limited Company G46188101 IE00BQPVQZ61 07/27/2023 Election of Class III Director Nominees: James Shannon, M.D. DIRECTOR ELECTIONS ISSUER 7410.000000 0 FOR 7410.000000 FOR Horizon Therapeutics Public Limited Company G46188101 IE00BQPVQZ61 07/27/2023 Election of Class III Director Nominees: Timothy P. Walbert DIRECTOR ELECTIONS ISSUER 7410.000000 0 FOR 7410.000000 FOR Horizon Therapeutics Public Limited Company G46188101 IE00BQPVQZ61 07/27/2023 Approval of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2023, and authorization of the Audit Committee to determine the auditors' remuneration. AUDIT-RELATED ISSUER 7410.000000 0 FOR 7410.000000 FOR Horizon Therapeutics Public Limited Company G46188101 IE00BQPVQZ61 07/27/2023 Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in this Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 7410.000000 0 FOR 7410.000000 FOR STERIS plc G8473T100 IE00BFY8C754 07/27/2023 Re-election of Directors: Dr. Esther M. Alegria DIRECTOR ELECTIONS ISSUER 9590.000000 0 FOR 9590.000000 FOR STERIS plc G8473T100 IE00BFY8C754 07/27/2023 Re-election of Directors: Richard C. Breeden DIRECTOR ELECTIONS ISSUER 9590.000000 0 FOR 9590.000000 FOR STERIS plc G8473T100 IE00BFY8C754 07/27/2023 Re-election of Directors: Daniel A. Carestio DIRECTOR ELECTIONS ISSUER 9590.000000 0 FOR 9590.000000 FOR STERIS plc G8473T100 IE00BFY8C754 07/27/2023 Re-election of Directors: Cynthia L. Feldmann DIRECTOR ELECTIONS ISSUER 9590.000000 0 FOR 9590.000000 FOR STERIS plc G8473T100 IE00BFY8C754 07/27/2023 Re-election of Directors: Christopher S. Holland DIRECTOR ELECTIONS ISSUER 9590.000000 0 FOR 9590.000000 FOR STERIS plc G8473T100 IE00BFY8C754 07/27/2023 Re-election of Directors: Dr. Jacqueline B. Kosecoff DIRECTOR ELECTIONS ISSUER 9590.000000 0 FOR 9590.000000 FOR STERIS plc G8473T100 IE00BFY8C754 07/27/2023 Re-election of Directors: Paul E. Martin DIRECTOR ELECTIONS ISSUER 9590.000000 0 FOR 9590.000000 FOR STERIS plc G8473T100 IE00BFY8C754 07/27/2023 Re-election of Directors: Dr. Nirav R. Shah DIRECTOR ELECTIONS ISSUER 9590.000000 0 FOR 9590.000000 FOR STERIS plc G8473T100 IE00BFY8C754 07/27/2023 Re-election of Directors: Dr. Mohsen M. Sohi DIRECTOR ELECTIONS ISSUER 9590.000000 0 FOR 9590.000000 FOR STERIS plc G8473T100 IE00BFY8C754 07/27/2023 Re-election of Directors: Dr. Richard M. Steeves DIRECTOR ELECTIONS ISSUER 9590.000000 0 FOR 9590.000000 FOR STERIS plc G8473T100 IE00BFY8C754 07/27/2023 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending March 31, 2024. AUDIT-RELATED ISSUER 9590.000000 0 FOR 9590.000000 FOR STERIS plc G8473T100 IE00BFY8C754 07/27/2023 To appoint Ernst & Young Chartered Accountants as the Company's statutory auditor under Irish law to hold office until the conclusion of the Company's next annual general meeting. AUDIT-RELATED ISSUER 9590.000000 0 FOR 9590.000000 FOR STERIS plc G8473T100 IE00BFY8C754 07/27/2023 To authorize the Board of Directors of the Company or the Audit Committee of the Board of Directors to determine the remuneration of Ernst & Young Chartered Accountants as the Company's statutory auditor under Irish law. AUDIT-RELATED ISSUER 9590.000000 0 FOR 9590.000000 FOR STERIS plc G8473T100 IE00BFY8C754 07/27/2023 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed pursuant to the disclosure rules of the U.S. Securities and Exchange Commission, including the compensation discussion and analysis and the tabular and narrative disclosure contained in the Company's proxy statement dated June 7, 2023. SECTION 14A SAY-ON-PAY VOTES ISSUER 9590.000000 0 FOR 9590.000000 FOR STERIS plc G8473T100 IE00BFY8C754 07/27/2023 To approve, on a non-binding advisory basis, whether the non-binding advisory vote on named executive officer compensation should be held every one, two, or three years. SECTION 14A SAY-ON-PAY VOTES ISSUER 9590.000000 0 ONE YEAR 9590.000000 FOR STERIS plc G8473T100 IE00BFY8C754 07/27/2023 To approve a proposal renewing the Board of Director's authority to issue shares under Irish law. CAPITAL STRUCTURE ISSUER 9590.000000 0 FOR 9590.000000 FOR STERIS plc G8473T100 IE00BFY8C754 07/27/2023 To approve a proposal renewing the Board of Director's authority to opt-out of statutory pre-emption rights under Irish law. CAPITAL STRUCTURE ISSUER 9590.000000 0 FOR 9590.000000 FOR Legend Biotech Corporation 52490G102 US52490G1022 09/21/2023 To receive the audited consolidated financial statements of the Company for the fiscal year ended December 31, 2022. CORPORATE GOVERNANCE ISSUER 32098.000000 0 FOR 32098.000000 FOR Legend Biotech Corporation 52490G102 US52490G1022 09/21/2023 To ratify the appointment of Ernst & Young LLP as independent auditor of the Company (the "Independent Auditor") for the fiscal year ending December 31, 2023. AUDIT-RELATED ISSUER 32098.000000 0 FOR 32098.000000 FOR Legend Biotech Corporation 52490G102 US52490G1022 09/21/2023 To re-elect Dr. Li Zhu, whose term of office will expire pursuant to article 88(b) of the Company's memorandum of association, to serve as a Class III director of the Company for a full term of three (3) years. DIRECTOR ELECTIONS ISSUER 32098.000000 0 FOR 32098.000000 FOR Legend Biotech Corporation 52490G102 US52490G1022 09/21/2023 To re-elect Dr. Corazon D. Sanders, whose term of office will expire pursuant to article 88(b) of the Company's memorandum of association, to serve as a Class III director of the Company for a full term of three (3) years. DIRECTOR ELECTIONS ISSUER 32098.000000 0 FOR 32098.000000 FOR Legend Biotech Corporation 52490G102 US52490G1022 09/21/2023 To re-elect Dr. Li Mao, whose term of office will expire pursuant to article 88(b) of the Company's memorandum of association, to serve as a Class III director of the Company for a full term of three (3) years. DIRECTOR ELECTIONS ISSUER 32098.000000 0 FOR 32098.000000 FOR Legend Biotech Corporation 52490G102 US52490G1022 09/21/2023 To authorize each of the directors and officers of the Company to take any and every action that might be necessary to effect the foregoing resolutions as such director or officer, in his or her absolute discretion, thinks fit. CORPORATE GOVERNANCE ISSUER 32098.000000 0 FOR 32098.000000 FOR Reata Pharmaceuticals, Inc. 75615P103 US75615P1030 09/21/2023 To approve and adopt the Agreement and Plan of Merger, dated as of July 28, 2023, as such agreement may be amended from time to time (the "Merger Agreement"), by and among Biogen Inc., a Delaware corporation ("Biogen"), River Acquisition, Inc., a Delaware corporation and wholly-owned subsidiary of Biogen ("Merger Sub"), and Reata Pharmaceuticals, Inc. ("Reata"), pursuant to which Merger Sub will be merged with and into Reata, with Reata surviving as a wholly-owned subsidiary of Biogen (the "Merger"). EXTRAORDINARY TRANSACTIONS ISSUER 6242.000000 2600.000000 FOR 6242.000000 FOR Reata Pharmaceuticals, Inc. 75615P103 US75615P1030 09/21/2023 To approve, on an advisory, non-binding basis, compensation that will or may be paid or become payable to Reata's named executive officers in connection with the Merger contemplated by the Merger Agreement. SECTION 14A SAY-ON-PAY VOTES ISSUER 6242.000000 2600.000000 AGAINST 6242.000000 AGAINST Reata Pharmaceuticals, Inc. 75615P103 US75615P1030 09/21/2023 To approve to adjourn the Special Meeting to a later date if necessary and appropriate to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting. CORPORATE GOVERNANCE ISSUER 6242.000000 2600.000000 FOR 6242.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Craig Arnold DIRECTOR ELECTIONS ISSUER 114551.000000 0 FOR 114551.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Scott C. Donnelly DIRECTOR ELECTIONS ISSUER 114551.000000 0 FOR 114551.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Lidia L. Fonseca DIRECTOR ELECTIONS ISSUER 114551.000000 0 FOR 114551.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Andrea J. Goldsmith, Ph.D. DIRECTOR ELECTIONS ISSUER 114551.000000 0 FOR 114551.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Randall J. Hogan, III DIRECTOR ELECTIONS ISSUER 114551.000000 0 FOR 114551.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Gregory P. Lewis DIRECTOR ELECTIONS ISSUER 114551.000000 0 FOR 114551.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Kevin E. Lofton DIRECTOR ELECTIONS ISSUER 114551.000000 0 FOR 114551.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Geoffrey S. Martha DIRECTOR ELECTIONS ISSUER 114551.000000 0 FOR 114551.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Elizabeth G. Nabel, M.D. DIRECTOR ELECTIONS ISSUER 114551.000000 0 FOR 114551.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Denise M. O'Leary DIRECTOR ELECTIONS ISSUER 114551.000000 0 FOR 114551.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Kendall J. Powell DIRECTOR ELECTIONS ISSUER 114551.000000 0 FOR 114551.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2024 and authorizing, in binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration; AUDIT-RELATED ISSUER 114551.000000 0 FOR 114551.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Approving, on an advisory basis, the Company's executive compensation; SECTION 14A SAY-ON-PAY VOTES ISSUER 114551.000000 0 FOR 114551.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Approving the Company's 2024 Employee Stock Purchase Plan; COMPENSATION ISSUER 114551.000000 0 FOR 114551.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Renewing the Board of Directors' authority to issue shares under Irish law; CAPITAL STRUCTURE ISSUER 114551.000000 0 FOR 114551.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Renewing the Board of Directors' authority to opt out of pre-emption rights under Irish law; and CAPITAL STRUCTURE ISSUER 114551.000000 0 FOR 114551.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/19/2023 Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares. CAPITAL STRUCTURE ISSUER 114551.000000 0 FOR 114551.000000 FOR Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 To set the number of Directors at nine. CORPORATE GOVERNANCE ISSUER 10888.000000 0 FOR 10888.000000 FOR Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Election of Directors: Robert V. Baumgartner DIRECTOR ELECTIONS ISSUER 10888.000000 0 AGAINST 10888.000000 AGAINST Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Election of Directors: Julie L. Bushman DIRECTOR ELECTIONS ISSUER 10888.000000 0 FOR 10888.000000 FOR Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Election of Directors: John L. Higgins DIRECTOR ELECTIONS ISSUER 10888.000000 0 AGAINST 10888.000000 AGAINST Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Election of Directors: Joseph D. Keegan DIRECTOR ELECTIONS ISSUER 10888.000000 0 FOR 10888.000000 FOR Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Election of Directors: Charles R. Kummeth DIRECTOR ELECTIONS ISSUER 10888.000000 0 FOR 10888.000000 FOR Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Election of Directors: Roeland Nusse DIRECTOR ELECTIONS ISSUER 10888.000000 0 FOR 10888.000000 FOR Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Election of Directors: Alpna Seth DIRECTOR ELECTIONS ISSUER 10888.000000 0 FOR 10888.000000 FOR Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Election of Directors: Randolph Steer DIRECTOR ELECTIONS ISSUER 10888.000000 0 AGAINST 10888.000000 AGAINST Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Election of Directors: Rupert Vessey DIRECTOR ELECTIONS ISSUER 10888.000000 0 FOR 10888.000000 FOR Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Approve, on an advisory basis, the compensation of our executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 10888.000000 0 AGAINST 10888.000000 AGAINST Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Approve, on an advisory bass, the frequency of advisory votes on executive compensation to occur every (1) year. SECTION 14A SAY-ON-PAY VOTES ISSUER 10888.000000 0 ONE YEAR 10888.000000 FOR Bio-Techne Corporation 09073M104 US09073M1045 10/26/2023 Ratify the appointment of KPMG, LLP as the Company's independent registered public accounting firm for the 2024 fiscal year. AUDIT-RELATED ISSUER 10888.000000 0 FOR 10888.000000 FOR Frequency Therapeutics, Inc. 500946108 US5009461089 11/03/2023 To approve the issuance of shares of common stock of Frequency to stockholders of Korro Bio, Inc., or Korro Bio, pursuant to the terms of the Agreement and Plan of Merger dated as of July 14, 2023, by and among Frequency, Korro Bio, and Frequency Merger Sub, Inc., a direct, wholly owned subsidiary of Frequency, or Merger Sub, a copy of which is attached as Annex A to the accompanying proxy statement/prospectus, pursuant to which Merger Sub will merge with and into Korro Bio, with Korro Bio surviving as a wholly owned subsidiary of Frequency, and the surviving corporation of the merger, or the Merger, and the change of control resulting from the Merger; EXTRAORDINARY TRANSACTIONS ISSUER 28060.000000 0 FOR 28060.000000 FOR Frequency Therapeutics, Inc. 500946108 US5009461089 11/03/2023 To approve an amendment to the Restated Certificate of Incorporation of Frequency, a copy of which is attached as Annex H to the accompanying proxy statement/prospectus, to effect a reverse stock split of Frequency's issued and outstanding common stock at a ratio ranging from any whole number between 1-for-25 and 1-for-50, as determined by the Frequency board of directors in its discretion subject to the Frequency board of directors' authority to abandon such amendment; CAPITAL STRUCTURE ISSUER 28060.000000 0 FOR 28060.000000 FOR Frequency Therapeutics, Inc. 500946108 US5009461089 11/03/2023 To elect David L. Lucchino as a Class I director to hold office until the annual meeting of stockholders to be held in 2026 and until his respective successor has been duly elected and qualified or until his earlier death, resignation or removal; DIRECTOR ELECTIONS ISSUER 28060.000000 0 FOR 28060.000000 FOR Frequency Therapeutics, Inc. 500946108 US5009461089 11/03/2023 To ratify, in a non-binding vote, the appointment of RSM US LLP as Frequency's independent registered public accounting firm for the fiscal year ending December 31, 2023; AUDIT-RELATED ISSUER 28060.000000 0 FOR 28060.000000 FOR Frequency Therapeutics, Inc. 500946108 US5009461089 11/03/2023 To approve the 2023 Stock Option and Incentive Plan a copy of which is attached as Annex I to the accompanying proxy statement/prospectus. COMPENSATION ISSUER 28060.000000 0 AGAINST 28060.000000 AGAINST Frequency Therapeutics, Inc. 500946108 US5009461089 11/03/2023 To approve the 2023 Employee Stock Purchase Plan a copy of which is attached as Annex J to the accompanying proxy statement/prospectus. COMPENSATION ISSUER 28060.000000 0 AGAINST 28060.000000 AGAINST Frequency Therapeutics, Inc. 500946108 US5009461089 11/03/2023 To consider and vote upon an adjournment of the Frequency Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal Nos. 1 and 2; CORPORATE GOVERNANCE ISSUER 28060.000000 0 FOR 28060.000000 FOR Abcam Plc 000380204 US0003802040 11/06/2023 Approve Scheme of Arrangement EXTRAORDINARY TRANSACTIONS ISSUER 73298.000000 0 FOR 73298.000000 FOR Abcam Plc 000380204 US0003802040 11/06/2023 Approve Scheme of Arrangement EXTRAORDINARY TRANSACTIONS ISSUER 73298.000000 0 FOR 73298.000000 FOR Abcam Plc 000380204 US0003802040 11/06/2023 Approve Scheme of Arrangement EXTRAORDINARY TRANSACTIONS ISSUER 0.000000 0 Revolution Medicines, Inc. 76155X100 US76155X1000 11/08/2023 To approve the issuance of shares of Revolution Medicines common stock (including securities convertible into or exercisable for shares of Revolution Medicines common stock) to certain equityholders of EQRX, Inc., which is referred to as EQRX, pursuant to the Agreement and Plan of Merger, dated as of July 31, 2023 (as it may be amended from time to time), by and among Revolution Medicines, Equinox Merger Sub I, Inc., Equinox Merger Sub II LLC, and EQRX, which proposal is referred to as the Revolution Medicines share issuance proposal; and EXTRAORDINARY TRANSACTIONS ISSUER 27479.000000 0 FOR 27479.000000 FOR Revolution Medicines, Inc. 76155X100 US76155X1000 11/08/2023 To approve the adjournment of the Revolution Medicines special meeting, to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes at the time of the Revolution Medicines special meeting to approve the Revolution Medicines share issuance proposal. CORPORATE GOVERNANCE ISSUER 27479.000000 0 FOR 27479.000000 FOR Mirati Therapeutics, Inc. 60468T105 US60468T1051 12/13/2023 To adopt the Agreement and Plan of Merger (the "Merger Agreement"), dated October 8, 2023, by and among Mirati Therapeutics, Inc. ("Mirati"), Bristol-Myers Squibb Company ("Parent") and Vineyard Merger Sub Inc., a wholly owned subsidiary of Parent ("Merger Sub"), including the form of contingent value rights agreement to be entered into at or immediately prior to the effective time of the Merger by Parent and a rights agent reasonably acceptable to Mirati, pursuant to which Merger Sub will merge with and into Mirati (the "Merger "), with Mirati surviving the Merger as a wholly owned subsidiary of Parent. EXTRAORDINARY TRANSACTIONS ISSUER 15747.000000 0 FOR 15747.000000 FOR Mirati Therapeutics, Inc. 60468T105 US60468T1051 12/13/2023 To approve, by non-binding, advisory vote, compensation that may be paid or become payable by Mirati to its named executive officers in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 15747.000000 0 AGAINST 15747.000000 AGAINST Mirati Therapeutics, Inc. 60468T105 US60468T1051 12/13/2023 To approve the adjournment of the special meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the special meeting. CORPORATE GOVERNANCE ISSUER 15747.000000 0 FOR 15747.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Election of Directors: William M. Brown DIRECTOR ELECTIONS ISSUER 39171.000000 0 FOR 39171.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Election of Directors: Catherine M. Burzik DIRECTOR ELECTIONS ISSUER 39171.000000 0 FOR 39171.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Election of Directors: Carrie L. Byington DIRECTOR ELECTIONS ISSUER 39171.000000 0 FOR 39171.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Election of Directors: R. Andrew Eckert DIRECTOR ELECTIONS ISSUER 39171.000000 0 FOR 39171.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Election of Directors: Claire M. Fraser DIRECTOR ELECTIONS ISSUER 39171.000000 0 FOR 39171.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Election of Directors: Jeffrey W. Henderson DIRECTOR ELECTIONS ISSUER 39171.000000 0 FOR 39171.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Election of Directors: Christopher Jones DIRECTOR ELECTIONS ISSUER 39171.000000 0 FOR 39171.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Election of Directors: Thomas E. Polen DIRECTOR ELECTIONS ISSUER 39171.000000 0 FOR 39171.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Election of Directors: Timothy M. Ring DIRECTOR ELECTIONS ISSUER 39171.000000 0 FOR 39171.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Election of Directors: Bertram L. Scott DIRECTOR ELECTIONS ISSUER 39171.000000 0 FOR 39171.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Election of Directors: Joanne Waldstreicher DIRECTOR ELECTIONS ISSUER 39171.000000 0 FOR 39171.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Ratification of the selection of the independent registered public accounting firm. AUDIT-RELATED ISSUER 39171.000000 0 FOR 39171.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/23/2024 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 39171.000000 0 FOR 39171.000000 FOR Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: Michael J. Barber DIRECTOR ELECTIONS ISSUER 20853.000000 0 FOR 20853.000000 FOR Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: Steven K. Barg DIRECTOR ELECTIONS ISSUER 20853.000000 0 FOR 20853.000000 FOR Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: J. Martin Carroll DIRECTOR ELECTIONS ISSUER 20853.000000 0 FOR 20853.000000 FOR Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: Rolf Classon DIRECTOR ELECTIONS ISSUER 20853.000000 0 FOR 20853.000000 FOR Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: Frank A. D'Amelio DIRECTOR ELECTIONS ISSUER 20853.000000 0 FOR 20853.000000 FOR Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: John J. Greisch DIRECTOR ELECTIONS ISSUER 20853.000000 0 FOR 20853.000000 FOR Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: Gregory T. Lucier DIRECTOR ELECTIONS ISSUER 20853.000000 0 FOR 20853.000000 FOR Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: Alessandro Maselli DIRECTOR ELECTIONS ISSUER 20853.000000 0 FOR 20853.000000 FOR Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: Donald E. Morel, Jr. DIRECTOR ELECTIONS ISSUER 20853.000000 0 FOR 20853.000000 FOR Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: Stephanie Okey DIRECTOR ELECTIONS ISSUER 20853.000000 0 FOR 20853.000000 FOR Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: Michelle R. Ryan DIRECTOR ELECTIONS ISSUER 20853.000000 0 FOR 20853.000000 FOR Catalent, Inc. 148806102 US1488061029 01/25/2024 Election of Twelve Director Nominees: Jack Stahl DIRECTOR ELECTIONS ISSUER 20853.000000 0 FOR 20853.000000 FOR Catalent, Inc. 148806102 US1488061029 01/25/2024 Ratification of Appointment of Ernst & Young LLP as Independent Auditor for Fiscal 2024 AUDIT-RELATED ISSUER 20853.000000 0 FOR 20853.000000 FOR Catalent, Inc. 148806102 US1488061029 01/25/2024 Advisory Vote to Approve Our Executive Compensation. (Say-on-Pay). SECTION 14A SAY-ON-PAY VOTES ISSUER 20853.000000 0 FOR 20853.000000 FOR Catalent, Inc. 148806102 US1488061029 01/25/2024 Approval of Amendment to Catalent, Inc. 2018 Omnibus Incentive Plan. COMPENSATION ISSUER 20853.000000 0 FOR 20853.000000 FOR Cerevel Therapeutics Holdings, Inc. 15678U128 US15678U1280 02/16/2024 To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the ''Merger Agreement''), dated as of December 6, 2023, by and among AbbVie Inc., a Delaware corporation (''AbbVie''), Symphony Harlan LLC, a Delaware limited liability company and a wholly owned subsidiary of AbbVie (''Intermediate Holdco''), Symphony Harlan Merger Sub Inc., a Delaware corporation and a direct wholly owned subsidiary of Intermediate Holdco (''Merger Sub''), and Cerevel Therapeutics Holdings, Inc. (''Cerevel''), pursuant to which Merger Sub will be merged with and into Cerevel, with Cerevel surviving as a wholly owned subsidiary of AbbVie (the ''Merger''); EXTRAORDINARY TRANSACTIONS ISSUER 16659.000000 0 FOR 16659.000000 FOR Cerevel Therapeutics Holdings, Inc. 15678U128 US15678U1280 02/16/2024 To approve, on a non-binding, advisory basis, certain compensation that will or may be paid or become payable to Cerevel's named executive officers that is based on or otherwise relates to the Merger; and SECTION 14A SAY-ON-PAY VOTES ISSUER 16659.000000 0 AGAINST 16659.000000 AGAINST Cerevel Therapeutics Holdings, Inc. 15678U128 US15678U1280 02/16/2024 To approve the adjournment of the special meeting to a later date or dates if necessary to solicit additional proxies if there are insufficient votes in person or by proxy to approve the proposal to adopt the Merger Agreement at the time of the special meeting. CORPORATE GOVERNANCE ISSUER 16659.000000 0 FOR 16659.000000 FOR Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Election of Eleven Directors: Ornella Barra DIRECTOR ELECTIONS ISSUER 62148.000000 0 FOR 62148.000000 FOR Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Election of Eleven Directors: Werner Baumann DIRECTOR ELECTIONS ISSUER 62148.000000 0 FOR 62148.000000 FOR Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Election of Eleven Directors: Steven H. Collis DIRECTOR ELECTIONS ISSUER 62148.000000 0 FOR 62148.000000 FOR Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Election of Eleven Directors: D. Mark Durcan DIRECTOR ELECTIONS ISSUER 62148.000000 0 FOR 62148.000000 FOR Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Election of Eleven Directors: Richard W. Gochnauer DIRECTOR ELECTIONS ISSUER 62148.000000 0 FOR 62148.000000 FOR Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Election of Eleven Directors: Lon R. Greenberg DIRECTOR ELECTIONS ISSUER 62148.000000 0 FOR 62148.000000 FOR Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Election of Eleven Directors: Kathleen W. Hyle DIRECTOR ELECTIONS ISSUER 62148.000000 0 FOR 62148.000000 FOR Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Election of Eleven Directors: Lorence H. Kim, M.D. DIRECTOR ELECTIONS ISSUER 62148.000000 0 FOR 62148.000000 FOR Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Election of Eleven Directors: Redonda G. Miller, M.D. DIRECTOR ELECTIONS ISSUER 62148.000000 0 FOR 62148.000000 FOR Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Election of Eleven Directors: Dennis M. Nally DIRECTOR ELECTIONS ISSUER 62148.000000 0 FOR 62148.000000 FOR Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Election of Eleven Directors: Lauren M. Tyler DIRECTOR ELECTIONS ISSUER 62148.000000 0 FOR 62148.000000 FOR Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Advisory vote to approve the compensation of the Company's names executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 62148.000000 0 FOR 62148.000000 FOR Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Ratification of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2024 AUDIT-RELATED ISSUER 62148.000000 0 FOR 62148.000000 FOR Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Approval of an amendment of the certificate of incorporation to provide for the exculpation of officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 62148.000000 0 FOR 62148.000000 FOR Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Approval of miscellaneous amendments to the certificate of incorporation. CORPORATE GOVERNANCE ISSUER 62148.000000 0 FOR 62148.000000 FOR Cencora, Inc. 03073E105 US03073E1055 03/12/2024 Enhance Majority Vote for the Election of Directors CORPORATE GOVERNANCE SECURITY HOLDER 62148.000000 0 AGAINST 62148.000000 FOR Karuna Therapeutics, Inc. 48576A100 US48576A1007 03/12/2024 To adopt the Agreement and Plan of Merger, dated as of December 22, 2023 (the "merger agreement"), among Karuna Therapeutics, Inc. ("Karuna"), Bristol-Myers Squibb Company ("Bristol-Myers Squibb"), and Miramar Merger Sub Inc., a wholly owned subsidiary of Bristol-Myers Squibb Company ("Merger Sub"), pursuant to which, subject to the terms and conditions set forth therein, Merger Sub will be merged with and into Karuna, and Karuna will survive the merger as a wholly owned subsidiary of Bristol-Myers Squibb. EXTRAORDINARY TRANSACTIONS ISSUER 2127.000000 0 FOR 2127.000000 FOR Karuna Therapeutics, Inc. 48576A100 US48576A1007 03/12/2024 To approve, on an advisory, non-binding basis, certain compensation that will or may be paid by Karuna to its named executive officers that is based on or otherwise relates to the merger of Merger Sub with and into Karuna pursuant to the merger agreement. SECTION 14A SAY-ON-PAY VOTES ISSUER 2127.000000 0 FOR 2127.000000 FOR Karuna Therapeutics, Inc. 48576A100 US48576A1007 03/12/2024 To adjourn the special meeting from time to time, if necessary or appropriate, as determined in good faith by the board of directors of Karuna including for the purpose of soliciting additional votes for the approval of the proposal to adopt the merger agreement if there are insufficient votes at the time of the special meeting to approve the proposal to adopt the merger agreement. CORPORATE GOVERNANCE ISSUER 2127.000000 0 FOR 2127.000000 FOR Genmab A/S 372303206 US3723032062 03/13/2024 Accept Financial Statements and Statutory Reports; Approve Discharge of Management and Board CAPITAL STRUCTURE CORPORATE GOVERNANCE ISSUER 19943.000000 0 FOR 19943.000000 FOR Genmab A/S 372303206 US3723032062 03/13/2024 Approve Allocation of Income and Omission of Dividends CAPITAL STRUCTURE ISSUER 19943.000000 0 FOR 19943.000000 FOR Genmab A/S 372303206 US3723032062 03/13/2024 Approve Remuneration Report (Advisory Vote) COMPENSATION ISSUER 19943.000000 0 FOR 19943.000000 FOR Genmab A/S 372303206 US3723032062 03/13/2024 Reelect Deirdre P. Connelly as Director DIRECTOR ELECTIONS ISSUER 19943.000000 0 ABSTAIN 19943.000000 AGAINST Genmab A/S 372303206 US3723032062 03/13/2024 Reelect Pernille Erenbjerg as Director DIRECTOR ELECTIONS ISSUER 19943.000000 0 FOR 19943.000000 FOR Genmab A/S 372303206 US3723032062 03/13/2024 Reelect Rolf Hoffmann as Director DIRECTOR ELECTIONS ISSUER 19943.000000 0 FOR 19943.000000 FOR Genmab A/S 372303206 US3723032062 03/13/2024 Reelect Elizabeth OFarrell as Director DIRECTOR ELECTIONS ISSUER 19943.000000 0 FOR 19943.000000 FOR Genmab A/S 372303206 US3723032062 03/13/2024 Reelect Paolo Paoletti as Director DIRECTOR ELECTIONS ISSUER 19943.000000 0 FOR 19943.000000 FOR Genmab A/S 372303206 US3723032062 03/13/2024 Reelect Anders Gersel Pedersen as Director DIRECTOR ELECTIONS ISSUER 19943.000000 0 FOR 19943.000000 FOR Genmab A/S 372303206 US3723032062 03/13/2024 Ratify Deloitte as Auditors AUDIT-RELATED ISSUER 19943.000000 0 FOR 19943.000000 FOR Genmab A/S 372303206 US3723032062 03/13/2024 Approve Remuneration of Directors in the Amount of DKK 3 Million for Chairman, DKK 2.4 million for Vice Chairman, and DKK 2.1 million for Other Directors; Approve Remuneration for Committee Work COMPENSATION ISSUER 19943.000000 0 FOR 19943.000000 FOR Genmab A/S 372303206 US3723032062 03/13/2024 Approve Director Indemnification CORPORATE GOVERNANCE ISSUER 19943.000000 0 FOR 19943.000000 FOR Genmab A/S 372303206 US3723032062 03/13/2024 Amend Articles Re: Indemnification CORPORATE GOVERNANCE ISSUER 19943.000000 0 FOR 19943.000000 FOR Genmab A/S 372303206 US3723032062 03/13/2024 Approve Guidelines for Incentive-Based Compensation for Executive Management and Board COMPENSATION ISSUER 19943.000000 0 FOR 19943.000000 FOR Genmab A/S 372303206 US3723032062 03/13/2024 Approve Creation of DKK 6.6 Million Pool of Capital with Preemptive Rights; Approve Creation of DKK 6.6 Million Pool of Capital without Preemptive Rights CAPITAL STRUCTURE ISSUER 19943.000000 0 FOR 19943.000000 FOR Genmab A/S 372303206 US3723032062 03/13/2024 Approve Equity Plan Financing Through Issuance of Warrants up to a Nominal Value of DKK 750,000 COMPENSATION ISSUER 19943.000000 0 FOR 19943.000000 FOR Genmab A/S 372303206 US3723032062 03/13/2024 Authorize Share Repurchase Program CAPITAL STRUCTURE ISSUER 19943.000000 0 FOR 19943.000000 FOR Genmab A/S 372303206 US3723032062 03/13/2024 Authorize Editorial Changes to Adopted Resolutions in Connection with Registration with Danish Authorities CORPORATE GOVERNANCE ISSUER 19943.000000 0 FOR 19943.000000 FOR Genmab A/S K3967W102 DK0010272202 03/13/2024 Accept Financial Statements and Statutory Reports; Approve Discharge of Management and Board CAPITAL STRUCTURE CORPORATE GOVERNANCE ISSUER 2927.000000 0 FOR 2927.000000 FOR Genmab A/S K3967W102 DK0010272202 03/13/2024 Approve Allocation of Income and Omission of Dividends CAPITAL STRUCTURE ISSUER 2927.000000 0 FOR 2927.000000 FOR Genmab A/S K3967W102 DK0010272202 03/13/2024 Approve Remuneration Report (Advisory Vote) COMPENSATION ISSUER 2927.000000 0 FOR 2927.000000 FOR Genmab A/S K3967W102 DK0010272202 03/13/2024 Reelect Deirdre P. Connelly as Director DIRECTOR ELECTIONS ISSUER 2927.000000 0 ABSTAIN 2927.000000 AGAINST Genmab A/S K3967W102 DK0010272202 03/13/2024 Reelect Pernille Erenbjerg as Director DIRECTOR ELECTIONS ISSUER 2927.000000 0 FOR 2927.000000 FOR Genmab A/S K3967W102 DK0010272202 03/13/2024 Reelect Rolf Hoffmann as Director DIRECTOR ELECTIONS ISSUER 2927.000000 0 FOR 2927.000000 FOR Genmab A/S K3967W102 DK0010272202 03/13/2024 Reelect Elizabeth OFarrell as Director DIRECTOR ELECTIONS ISSUER 2927.000000 0 FOR 2927.000000 FOR Genmab A/S K3967W102 DK0010272202 03/13/2024 Reelect Paolo Paoletti as Director DIRECTOR ELECTIONS ISSUER 2927.000000 0 FOR 2927.000000 FOR Genmab A/S K3967W102 DK0010272202 03/13/2024 Reelect Anders Gersel Pedersen as Director DIRECTOR ELECTIONS ISSUER 2927.000000 0 FOR 2927.000000 FOR Genmab A/S K3967W102 DK0010272202 03/13/2024 Ratify Deloitte as Auditors AUDIT-RELATED ISSUER 2927.000000 0 FOR 2927.000000 FOR Genmab A/S K3967W102 DK0010272202 03/13/2024 Approve Remuneration of Directors in the Amount of DKK 3 Million for Chairman, DKK 2.4 million for Vice Chairman, and DKK 2.1 million for Other Directors; Approve Remuneration for Committee Work COMPENSATION ISSUER 2927.000000 0 FOR 2927.000000 FOR Genmab A/S K3967W102 DK0010272202 03/13/2024 Approve Director Indemnification CORPORATE GOVERNANCE ISSUER 2927.000000 0 FOR 2927.000000 FOR Genmab A/S K3967W102 DK0010272202 03/13/2024 Amend Articles Re: Indemnification CORPORATE GOVERNANCE ISSUER 2927.000000 0 FOR 2927.000000 FOR Genmab A/S K3967W102 DK0010272202 03/13/2024 Approve Guidelines for Incentive-Based Compensation for Executive Management and Board COMPENSATION ISSUER 2927.000000 0 FOR 2927.000000 FOR Genmab A/S K3967W102 DK0010272202 03/13/2024 Approve Creation of DKK 6.6 Million Pool of Capital with Preemptive Rights; Approve Creation of DKK 6.6 Million Pool of Capital without Preemptive Rights CAPITAL STRUCTURE ISSUER 2927.000000 0 FOR 2927.000000 FOR Genmab A/S K3967W102 DK0010272202 03/13/2024 Approve Equity Plan Financing Through Issuance of Warrants up to a Nominal Value of DKK 750,000 COMPENSATION ISSUER 2927.000000 0 FOR 2927.000000 FOR Genmab A/S K3967W102 DK0010272202 03/13/2024 Authorize Share Repurchase Program CAPITAL STRUCTURE ISSUER 2927.000000 0 FOR 2927.000000 FOR Genmab A/S K3967W102 DK0010272202 03/13/2024 Authorize Editorial Changes to Adopted Resolutions in Connection with Registration with Danish Authorities CORPORATE GOVERNANCE ISSUER 2927.000000 0 FOR 2927.000000 FOR Agilent Technologies, Inc. 00846U101 US00846U1016 03/14/2024 Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Mala Anand DIRECTOR ELECTIONS ISSUER 23561.000000 0 FOR 23561.000000 FOR Agilent Technologies, Inc. 00846U101 US00846U1016 03/14/2024 Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Koh Boon Hwee DIRECTOR ELECTIONS ISSUER 23561.000000 0 FOR 23561.000000 FOR Agilent Technologies, Inc. 00846U101 US00846U1016 03/14/2024 Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Michael R. McMullen DIRECTOR ELECTIONS ISSUER 23561.000000 0 FOR 23561.000000 FOR Agilent Technologies, Inc. 00846U101 US00846U1016 03/14/2024 Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Daniel K. Podolsky, M.D DIRECTOR ELECTIONS ISSUER 23561.000000 0 FOR 23561.000000 FOR Agilent Technologies, Inc. 00846U101 US00846U1016 03/14/2024 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 23561.000000 0 FOR 23561.000000 FOR Agilent Technologies, Inc. 00846U101 US00846U1016 03/14/2024 To ratify the Audit and Finance Committee's appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm. AUDIT-RELATED ISSUER 23561.000000 0 FOR 23561.000000 FOR Agilent Technologies, Inc. 00846U101 US00846U1016 03/14/2024 Adopt Simple Majority Vote SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 23561.000000 0 FOR 23561.000000 NONE The Cooper Companies, Inc. 216648501 US2166485019 03/19/2024 Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: Colleen E. Jay DIRECTOR ELECTIONS ISSUER 13642.000000 0 FOR 13642.000000 FOR The Cooper Companies, Inc. 216648501 US2166485019 03/19/2024 Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: William A. Kozy DIRECTOR ELECTIONS ISSUER 13642.000000 0 FOR 13642.000000 FOR The Cooper Companies, Inc. 216648501 US2166485019 03/19/2024 Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: Lawrence E. Kurzius DIRECTOR ELECTIONS ISSUER 13642.000000 0 FOR 13642.000000 FOR The Cooper Companies, Inc. 216648501 US2166485019 03/19/2024 Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: Cynthia L. Lucchese DIRECTOR ELECTIONS ISSUER 13642.000000 0 FOR 13642.000000 FOR The Cooper Companies, Inc. 216648501 US2166485019 03/19/2024 Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: Teresa S. Madden DIRECTOR ELECTIONS ISSUER 13642.000000 0 FOR 13642.000000 FOR The Cooper Companies, Inc. 216648501 US2166485019 03/19/2024 Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: Maria Rivas, M.D. DIRECTOR ELECTIONS ISSUER 13642.000000 0 FOR 13642.000000 FOR The Cooper Companies, Inc. 216648501 US2166485019 03/19/2024 Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: Robert S. Weiss DIRECTOR ELECTIONS ISSUER 13642.000000 0 FOR 13642.000000 FOR The Cooper Companies, Inc. 216648501 US2166485019 03/19/2024 Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: Albert G. White III DIRECTOR ELECTIONS ISSUER 13642.000000 0 FOR 13642.000000 FOR The Cooper Companies, Inc. 216648501 US2166485019 03/19/2024 Ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending October 31, 2024. AUDIT-RELATED ISSUER 13642.000000 0 FOR 13642.000000 FOR The Cooper Companies, Inc. 216648501 US2166485019 03/19/2024 Approve, on a non-binding, advisory basis, the compensation of our Named Executive Officers ("Say on Pay Proposal"). SECTION 14A SAY-ON-PAY VOTES ISSUER 13642.000000 0 FOR 13642.000000 FOR Zealand Pharma A/S K9898X127 DK0060257814 03/20/2024 Accept Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 4395.000000 0 FOR 4395.000000 FOR Zealand Pharma A/S K9898X127 DK0060257814 03/20/2024 Approve Treatment of Net Loss CAPITAL STRUCTURE ISSUER 4395.000000 0 FOR 4395.000000 FOR Zealand Pharma A/S K9898X127 DK0060257814 03/20/2024 Reelect Alf Gunnar Martin Nicklasson as Director DIRECTOR ELECTIONS ISSUER 4395.000000 0 ABSTAIN 4395.000000 AGAINST Zealand Pharma A/S K9898X127 DK0060257814 03/20/2024 Reelect Kirsten Aarup Drejer as Director DIRECTOR ELECTIONS ISSUER 4395.000000 0 FOR 4395.000000 FOR Zealand Pharma A/S K9898X127 DK0060257814 03/20/2024 Reelect Jeffrey Berkowitz as Director DIRECTOR ELECTIONS ISSUER 4395.000000 0 FOR 4395.000000 FOR Zealand Pharma A/S K9898X127 DK0060257814 03/20/2024 Reelect Leonard Kruimer as Director DIRECTOR ELECTIONS ISSUER 4395.000000 0 ABSTAIN 4395.000000 AGAINST Zealand Pharma A/S K9898X127 DK0060257814 03/20/2024 Reelect Bernadette Mary Connaughton as Director DIRECTOR ELECTIONS ISSUER 4395.000000 0 FOR 4395.000000 FOR Zealand Pharma A/S K9898X127 DK0060257814 03/20/2024 Elect Elaine Sullivan as New Director DIRECTOR ELECTIONS ISSUER 4395.000000 0 ABSTAIN 4395.000000 AGAINST Zealand Pharma A/S K9898X127 DK0060257814 03/20/2024 Elect Enrique Conterno as New Director DIRECTOR ELECTIONS ISSUER 4395.000000 0 FOR 4395.000000 FOR Zealand Pharma A/S K9898X127 DK0060257814 03/20/2024 Ratify Pricewaterhouse Coopers as Auditors AUDIT-RELATED ISSUER 4395.000000 0 FOR 4395.000000 FOR Zealand Pharma A/S K9898X127 DK0060257814 03/20/2024 Authorize Share Repurchase Program CAPITAL STRUCTURE ISSUER 4395.000000 0 FOR 4395.000000 FOR Zealand Pharma A/S K9898X127 DK0060257814 03/20/2024 Amend Guidelines for Incentive-Based Compensation for Executive Management and Board COMPENSATION ISSUER 4395.000000 0 FOR 4395.000000 FOR Zealand Pharma A/S K9898X127 DK0060257814 03/20/2024 Approve Remuneration Report (Advisory Vote) COMPENSATION ISSUER 4395.000000 0 FOR 4395.000000 FOR Zealand Pharma A/S K9898X127 DK0060257814 03/20/2024 Approve Remuneration of Directors in the Amount of DKK 100,000 for Each Director, and 5,000 RSU for Chair, 1,000 RSU for Vice Chair and 1,500 RSU for Other Directors; Approve Remuneration for Committee Work in RSUs COMPENSATION ISSUER 4395.000000 0 FOR 4395.000000 FOR Zealand Pharma A/S K9898X127 DK0060257814 03/20/2024 Approve Creation of DKK 12.5 Million Pool of Capital without Preemptive Rights CAPITAL STRUCTURE ISSUER 4395.000000 0 AGAINST 4395.000000 AGAINST Zealand Pharma A/S K9898X127 DK0060257814 03/20/2024 Approve Issuance of Warrants without Preemptive Rights up to Aggregate Nominal Amount of DKK 767,687 CAPITAL STRUCTURE ISSUER 4395.000000 0 FOR 4395.000000 FOR Zealand Pharma A/S K9898X127 DK0060257814 03/20/2024 Approve Indemnification of Members of the Board of Directors and Executive Management CORPORATE GOVERNANCE ISSUER 4395.000000 0 FOR 4395.000000 FOR Novo Nordisk A/S K72807140 DK0062498333 03/21/2024 Accept Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 62629.000000 0 FOR 62629.000000 FOR Novo Nordisk A/S K72807140 DK0062498333 03/21/2024 Approve Allocation of Income and Dividends of DKK 6.40 Per Share CAPITAL STRUCTURE ISSUER 62629.000000 0 FOR 62629.000000 FOR Novo Nordisk A/S K72807140 DK0062498333 03/21/2024 Approve Remuneration Report (Advisory Vote) COMPENSATION ISSUER 62629.000000 0 FOR 62629.000000 FOR Novo Nordisk A/S K72807140 DK0062498333 03/21/2024 Approve Remuneration of Directors in the Amount of DKK 3.4 Million for the Chairman, DKK 1.7 Million for the Vice Chairman and DKK 840,000 for Other Directors; Approve Remuneration for Committee Work COMPENSATION ISSUER 62629.000000 0 FOR 62629.000000 FOR Novo Nordisk A/S K72807140 DK0062498333 03/21/2024 Approve Indemnification of Board of Directors CORPORATE GOVERNANCE ISSUER 62629.000000 0 FOR 62629.000000 FOR Novo Nordisk A/S K72807140 DK0062498333 03/21/2024 Approve Indemnification of Executive Management CORPORATE GOVERNANCE ISSUER 62629.000000 0 FOR 62629.000000 FOR Novo Nordisk A/S K72807140 DK0062498333 03/21/2024 Amend Articles Re: Indemnification Scheme CORPORATE GOVERNANCE ISSUER 62629.000000 0 FOR 62629.000000 FOR Novo Nordisk A/S K72807140 DK0062498333 03/21/2024 Approve Guidelines for Incentive-Based Compensation for Executive Management and Board COMPENSATION ISSUER 62629.000000 0 FOR 62629.000000 FOR Novo Nordisk A/S K72807140 DK0062498333 03/21/2024 Reelect Helge Lund (Chair) as Director DIRECTOR ELECTIONS ISSUER 62629.000000 0 ABSTAIN 62629.000000 AGAINST Novo Nordisk A/S K72807140 DK0062498333 03/21/2024 Reelect Henrik Poulsen (Vice Chair) as Director DIRECTOR ELECTIONS ISSUER 62629.000000 0 FOR 62629.000000 FOR Novo Nordisk A/S K72807140 DK0062498333 03/21/2024 Reelect Laurence Debroux as Director DIRECTOR ELECTIONS ISSUER 62629.000000 0 FOR 62629.000000 FOR Novo Nordisk A/S K72807140 DK0062498333 03/21/2024 Reelect Andreas Fibig as Director DIRECTOR ELECTIONS ISSUER 62629.000000 0 FOR 62629.000000 FOR Novo Nordisk A/S K72807140 DK0062498333 03/21/2024 Reelect Sylvie Gregoire as Director DIRECTOR ELECTIONS ISSUER 62629.000000 0 FOR 62629.000000 FOR Novo Nordisk A/S K72807140 DK0062498333 03/21/2024 Reelect Kasim Kutay as Director DIRECTOR ELECTIONS ISSUER 62629.000000 0 FOR 62629.000000 FOR Novo Nordisk A/S K72807140 DK0062498333 03/21/2024 Reelect Christina Law as Director DIRECTOR ELECTIONS ISSUER 62629.000000 0 FOR 62629.000000 FOR Novo Nordisk A/S K72807140 DK0062498333 03/21/2024 Reelect Martin Mackay as Director DIRECTOR ELECTIONS ISSUER 62629.000000 0 ABSTAIN 62629.000000 AGAINST Novo Nordisk A/S K72807140 DK0062498333 03/21/2024 Ratify Deloitte as Auditor AUDIT-RELATED ISSUER 62629.000000 0 FOR 62629.000000 FOR Novo Nordisk A/S K72807140 DK0062498333 03/21/2024 Approve DKK 4.5 Million Reduction in Share Capital via Share Cancellation of B Shares CAPITAL STRUCTURE ISSUER 62629.000000 0 FOR 62629.000000 FOR Novo Nordisk A/S K72807140 DK0062498333 03/21/2024 Authorize Share Repurchase Program CAPITAL STRUCTURE ISSUER 62629.000000 0 FOR 62629.000000 FOR Novo Nordisk A/S K72807140 DK0062498333 03/21/2024 Approve Creation of DKK 44.7 Million Pool of Capital with Preemptive Rights; Approve Creation of DKK 44.7 Million Pool of Capital without Preemptive Rights; Maximum Increase in Share Capital under Both Authorizations up to DKK 44.7 Million CAPITAL STRUCTURE ISSUER 62629.000000 0 FOR 62629.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Accept Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Approve Dividends CAPITAL STRUCTURE ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Reappoint PricewaterhouseCoopers LLP as Auditors AUDIT-RELATED ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Authorise Board to Fix Remuneration of Auditors AUDIT-RELATED ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Re-elect Michel Demare as Director DIRECTOR ELECTIONS ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Re-elect Pascal Soriot as Director DIRECTOR ELECTIONS ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Re-elect Aradhana Sarin as Director DIRECTOR ELECTIONS ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Re-elect Philip Broadley as Director DIRECTOR ELECTIONS ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Re-elect Euan Ashley as Director DIRECTOR ELECTIONS ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Re-elect Deborah DiSanzo as Director DIRECTOR ELECTIONS ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Re-elect Diana Layfield as Director DIRECTOR ELECTIONS ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Elect Anna Manz as Director DIRECTOR ELECTIONS ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Re-elect Sheri McCoy as Director DIRECTOR ELECTIONS ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Re-elect Tony Mok as Director DIRECTOR ELECTIONS ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Re-elect Nazneen Rahman as Director DIRECTOR ELECTIONS ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Re-elect Andreas Rummelt as Director DIRECTOR ELECTIONS ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Re-elect Marcus Wallenberg as Director DIRECTOR ELECTIONS ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Approve Remuneration Report COMPENSATION ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Approve Remuneration Policy COMPENSATION ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Amend Performance Share Plan 2020 COMPENSATION ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Authorise UK Political Donations and Expenditure OTHER SOCIAL ISSUES ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Authorise Issue of Equity CAPITAL STRUCTURE ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Authorise Issue of Equity without Pre-emptive Rights CAPITAL STRUCTURE ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital Investment CAPITAL STRUCTURE ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Authorise Market Purchase of Ordinary Shares CAPITAL STRUCTURE ISSUER 24269.000000 0 FOR 24269.000000 FOR AstraZeneca PLC G0593M107 GB0009895292 04/11/2024 Authorise the Company to Call General Meeting with Two Weeks' Notice CORPORATE GOVERNANCE ISSUER 24269.000000 0 FOR 24269.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/16/2024 The election of six directors: Ari Bousbib DIRECTOR ELECTIONS ISSUER 9048.000000 0 FOR 9048.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/16/2024 The election of six directors: Carol J. Burt DIRECTOR ELECTIONS ISSUER 9048.000000 0 FOR 9048.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/16/2024 The election of six directors: Colleen A. Goggins DIRECTOR ELECTIONS ISSUER 9048.000000 0 FOR 9048.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/16/2024 The election of six directors: John M. Leonard, M.D. DIRECTOR ELECTIONS ISSUER 9048.000000 0 FOR 9048.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/16/2024 The election of six directors: Todd B. Sisitsky DIRECTOR ELECTIONS ISSUER 9048.000000 0 AGAINST 9048.000000 AGAINST IQVIA Holdings Inc. 46266C105 US46266C1053 04/16/2024 The election of six directors: Sheila A. Stamps DIRECTOR ELECTIONS ISSUER 9048.000000 0 FOR 9048.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/16/2024 Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay). SECTION 14A SAY-ON-PAY VOTES ISSUER 9048.000000 0 FOR 9048.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/16/2024 Report on Political Contributions and Expenditures OTHER SOCIAL ISSUES SECURITY HOLDER 9048.000000 0 AGAINST 9048.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/16/2024 Ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA's independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 9048.000000 0 FOR 9048.000000 FOR Humana Inc. 444859102 US4448591028 04/18/2024 Election of Directors: Raquel C.Bono, M.D. DIRECTOR ELECTIONS ISSUER 14550.000000 0 FOR 14550.000000 FOR Humana Inc. 444859102 US4448591028 04/18/2024 Election of Directors: Bruce D. Broussard DIRECTOR ELECTIONS ISSUER 14550.000000 0 FOR 14550.000000 FOR Humana Inc. 444859102 US4448591028 04/18/2024 Election of Directors: Frank A. D'Amelio DIRECTOR ELECTIONS ISSUER 14550.000000 0 FOR 14550.000000 FOR Humana Inc. 444859102 US4448591028 04/18/2024 Election of Directors: David T. Feinberg, M.D. DIRECTOR ELECTIONS ISSUER 14550.000000 0 FOR 14550.000000 FOR Humana Inc. 444859102 US4448591028 04/18/2024 Election of Directors: Wayne A. I. Frederick, M.D. DIRECTOR ELECTIONS ISSUER 14550.000000 0 FOR 14550.000000 FOR Humana Inc. 444859102 US4448591028 04/18/2024 Election of Directors: John W. Garratt DIRECTOR ELECTIONS ISSUER 14550.000000 0 FOR 14550.000000 FOR Humana Inc. 444859102 US4448591028 04/18/2024 Election of Directors: Kurt J. Hilzinger DIRECTOR ELECTIONS ISSUER 14550.000000 0 FOR 14550.000000 FOR Humana Inc. 444859102 US4448591028 04/18/2024 Election of Directors: Karen W. Katz DIRECTOR ELECTIONS ISSUER 14550.000000 0 FOR 14550.000000 FOR Humana Inc. 444859102 US4448591028 04/18/2024 Election of Directors: Marcy S. Klevorn DIRECTOR ELECTIONS ISSUER 14550.000000 0 FOR 14550.000000 FOR Humana Inc. 444859102 US4448591028 04/18/2024 Election of Directors: Jorge S. Mesquita DIRECTOR ELECTIONS ISSUER 14550.000000 0 FOR 14550.000000 FOR Humana Inc. 444859102 US4448591028 04/18/2024 Election of Directors: Brad D. Smith DIRECTOR ELECTIONS ISSUER 14550.000000 0 FOR 14550.000000 FOR Humana Inc. 444859102 US4448591028 04/18/2024 The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm. AUDIT-RELATED ISSUER 14550.000000 0 FOR 14550.000000 FOR Humana Inc. 444859102 US4448591028 04/18/2024 Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2024 proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 14550.000000 0 FOR 14550.000000 FOR Humana Inc. 444859102 US4448591028 04/18/2024 The approval of the amendment to the Company's Restated Certificate of Incorporation to limit the liability of certain officers of the Company as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 14550.000000 0 FOR 14550.000000 FOR Humana Inc. 444859102 US4448591028 04/18/2024 The approval of the amendment to the Company's Restated Certificate of Incorporation to eliminate supermajority voting requirement in connection with certain transactions. CORPORATE GOVERNANCE ISSUER 14550.000000 0 FOR 14550.000000 FOR Humana Inc. 444859102 US4448591028 04/18/2024 Adopt Simple Majority Vote SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 14550.000000 0 AGAINST 14550.000000 FOR West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Election of Directors: Mark A. Buthman DIRECTOR ELECTIONS ISSUER 10207.000000 0 FOR 10207.000000 FOR West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Election of Directors: William F. Feehery DIRECTOR ELECTIONS ISSUER 10207.000000 0 FOR 10207.000000 FOR West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Election of Directors: Robert F. Friel DIRECTOR ELECTIONS ISSUER 10207.000000 0 FOR 10207.000000 FOR West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Election of Directors: Eric M. Green DIRECTOR ELECTIONS ISSUER 10207.000000 0 FOR 10207.000000 FOR West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Election of Directors: Thomas W. Hofmann DIRECTOR ELECTIONS ISSUER 10207.000000 0 FOR 10207.000000 FOR West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Election of Directors: Molly E. Joseph DIRECTOR ELECTIONS ISSUER 10207.000000 0 FOR 10207.000000 FOR West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Election of Directors: Deborah L. V. Keller DIRECTOR ELECTIONS ISSUER 10207.000000 0 FOR 10207.000000 FOR West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Election of Directors: Myla P. Lai-Goldman DIRECTOR ELECTIONS ISSUER 10207.000000 0 FOR 10207.000000 FOR West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Election of Directors: Stephen H. Lockhart DIRECTOR ELECTIONS ISSUER 10207.000000 0 FOR 10207.000000 FOR West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Election of Directors: Douglas A. Michels DIRECTOR ELECTIONS ISSUER 10207.000000 0 FOR 10207.000000 FOR West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Election of Directors: Paolo Pucci DIRECTOR ELECTIONS ISSUER 10207.000000 0 FOR 10207.000000 FOR West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Advisory vote to approve named executive officer compensation; SECTION 14A SAY-ON-PAY VOTES ISSUER 10207.000000 0 FOR 10207.000000 FOR West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Amend and Restate Our Amended and Restated Articles of Incorporation to Eliminate Supermajority Transaction Requirement; CORPORATE GOVERNANCE ISSUER 10207.000000 0 FOR 10207.000000 FOR West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Amend and Restate Our Amended and Restated Articles of Incorporation to Eliminate Supermajority Amendment Requirement; CORPORATE GOVERNANCE ISSUER 10207.000000 0 FOR 10207.000000 FOR West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Ratification of the appointment of PricewaterhouseCoopers LLP ("PwC") as our independent registered public accounting firm for 2024; and AUDIT-RELATED ISSUER 10207.000000 0 FOR 10207.000000 FOR West Pharmaceutical Services, Inc. 955306105 US9553061055 04/23/2024 Adopt Simple Majority Vote SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 10207.000000 0 AGAINST 10207.000000 FOR The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: David M. Cordani DIRECTOR ELECTIONS ISSUER 31736.000000 0 FOR 31736.000000 FOR The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: William J. DeLaney DIRECTOR ELECTIONS ISSUER 31736.000000 0 FOR 31736.000000 FOR The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: Eric J. Foss DIRECTOR ELECTIONS ISSUER 31736.000000 0 FOR 31736.000000 FOR The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: Retired Maj. Gen. Elder Granger, M.D. DIRECTOR ELECTIONS ISSUER 31736.000000 0 FOR 31736.000000 FOR The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: Neesha Hathi DIRECTOR ELECTIONS ISSUER 31736.000000 0 FOR 31736.000000 FOR The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: George Kurian DIRECTOR ELECTIONS ISSUER 31736.000000 0 FOR 31736.000000 FOR The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: Kathleen M. Mazzarella DIRECTOR ELECTIONS ISSUER 31736.000000 0 FOR 31736.000000 FOR The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: Mark B. McClellan, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 31736.000000 0 FOR 31736.000000 FOR The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: Philip O. Ozuah, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 31736.000000 0 FOR 31736.000000 FOR The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: Kimberly A. Ross DIRECTOR ELECTIONS ISSUER 31736.000000 0 FOR 31736.000000 FOR The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: Eric C. Wiseman DIRECTOR ELECTIONS ISSUER 31736.000000 0 FOR 31736.000000 FOR The Cigna Group 125523100 US1255231003 04/24/2024 Election of Directors: Donna F. Zarcone DIRECTOR ELECTIONS ISSUER 31736.000000 0 FOR 31736.000000 FOR The Cigna Group 125523100 US1255231003 04/24/2024 Advisory approval of The Cigna Group's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 31736.000000 0 FOR 31736.000000 FOR The Cigna Group 125523100 US1255231003 04/24/2024 Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group's independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 31736.000000 0 FOR 31736.000000 FOR The Cigna Group 125523100 US1255231003 04/24/2024 Reduce Ownership Threshold for Shareholders to Call Special Meeting SHAREHOLDER RIGHTS AND DEFENSES CORPORATE GOVERNANCE SECURITY HOLDER 31736.000000 0 AGAINST 31736.000000 FOR The Cigna Group 125523100 US1255231003 04/24/2024 Report on Risks Created by the Company's Diversity, Equity, and Inclusion Efforts HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 31736.000000 0 AGAINST 31736.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Election of Directors: Thomas F. Frist III DIRECTOR ELECTIONS ISSUER 21723.000000 0 FOR 21723.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Election of Directors: Samuel N. Hazen DIRECTOR ELECTIONS ISSUER 21723.000000 0 FOR 21723.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Election of Directors: Meg G. Crofton DIRECTOR ELECTIONS ISSUER 21723.000000 0 FOR 21723.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Election of Directors: Robert J. Dennis DIRECTOR ELECTIONS ISSUER 21723.000000 0 FOR 21723.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Election of Directors: Nancy-Ann DeParle DIRECTOR ELECTIONS ISSUER 21723.000000 0 FOR 21723.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Election of Directors: William R. Frist DIRECTOR ELECTIONS ISSUER 21723.000000 0 FOR 21723.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Election of Directors: Hugh F. Johnston DIRECTOR ELECTIONS ISSUER 21723.000000 0 FOR 21723.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Election of Directors: Michael W. Michelson DIRECTOR ELECTIONS ISSUER 21723.000000 0 FOR 21723.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Election of Directors: Wayne J. Riley M.D. DIRECTOR ELECTIONS ISSUER 21723.000000 0 FOR 21723.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Election of Directors: Andrea B. Smith DIRECTOR ELECTIONS ISSUER 21723.000000 0 FOR 21723.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 21723.000000 0 FOR 21723.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 21723.000000 0 FOR 21723.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Advisory vote to approve the frequency of future advisory votes to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 21723.000000 0 ONE YEAR 21723.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Report on Risks Regarding Patients' Right to Access Abortions in Emergencies HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 21723.000000 0 AGAINST 21723.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Report on Patient Feedback Regarding Quality Care HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 21723.000000 0 AGAINST 21723.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/25/2024 Report on Maternal Health Outcomes HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 21723.000000 0 AGAINST 21723.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 Election of Directors: Craig H. Barratt, Ph.D. DIRECTOR ELECTIONS ISSUER 38915.000000 4800.000000 FOR 38915.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 Election of Directors: Joseph C. Beery DIRECTOR ELECTIONS ISSUER 38915.000000 4800.000000 FOR 38915.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 Election of Directors: Lewis Chew DIRECTOR ELECTIONS ISSUER 38915.000000 4800.000000 FOR 38915.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 Election of Directors: Gary S. Guthart, Ph.D. DIRECTOR ELECTIONS ISSUER 38915.000000 4800.000000 FOR 38915.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 Election of Directors: Amal M. Johnson DIRECTOR ELECTIONS ISSUER 38915.000000 4800.000000 FOR 38915.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 Election of Directors: Sreelakshmi Kolli DIRECTOR ELECTIONS ISSUER 38915.000000 4800.000000 FOR 38915.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 Election of Directors: Amy L. Ladd, M.D. DIRECTOR ELECTIONS ISSUER 38915.000000 4800.000000 FOR 38915.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 Election of Directors: Keith R. Leonard, Jr. DIRECTOR ELECTIONS ISSUER 38915.000000 4800.000000 FOR 38915.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 Election of Directors: Jami Dover Nachtsheim DIRECTOR ELECTIONS ISSUER 38915.000000 4800.000000 FOR 38915.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 Election of Directors: Monica P. Reed, M.D. DIRECTOR ELECTIONS ISSUER 38915.000000 4800.000000 FOR 38915.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 Election of Directors: Mark J. Rubash DIRECTOR ELECTIONS ISSUER 38915.000000 4800.000000 FOR 38915.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 To approve, by advisory vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 38915.000000 4800.000000 FOR 38915.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 38915.000000 4800.000000 FOR 38915.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 The amendment and restatement of the Amended and Restated 2010 Incentive Award Plan. COMPENSATION ISSUER 38915.000000 4800.000000 FOR 38915.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 The amendment and restatement of the Amended and Restated 2000 Employee Stock Purchase Plan. COMPENSATION ISSUER 38915.000000 4800.000000 FOR 38915.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/25/2024 Report on Gender/Racial Pay Gap DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 38915.000000 4800.000000 AGAINST 38915.000000 FOR Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Darius Adamczyk DIRECTOR ELECTIONS ISSUER 44168.000000 0 FOR 44168.000000 FOR Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Mary C. Beckerle DIRECTOR ELECTIONS ISSUER 44168.000000 0 FOR 44168.000000 FOR Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: D. Scott Davis DIRECTOR ELECTIONS ISSUER 44168.000000 0 FOR 44168.000000 FOR Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Jennifer A. Doudna DIRECTOR ELECTIONS ISSUER 44168.000000 0 FOR 44168.000000 FOR Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Joaquin Duato DIRECTOR ELECTIONS ISSUER 44168.000000 0 FOR 44168.000000 FOR Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Marillyn A. Hewson DIRECTOR ELECTIONS ISSUER 44168.000000 0 FOR 44168.000000 FOR Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Paula A. Johnson DIRECTOR ELECTIONS ISSUER 44168.000000 0 FOR 44168.000000 FOR Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Hubert Joly DIRECTOR ELECTIONS ISSUER 44168.000000 0 FOR 44168.000000 FOR Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Mark B. McClellan DIRECTOR ELECTIONS ISSUER 44168.000000 0 FOR 44168.000000 FOR Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Anne M. Mulcahy DIRECTOR ELECTIONS ISSUER 44168.000000 0 FOR 44168.000000 FOR Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Mark A. Weinberger DIRECTOR ELECTIONS ISSUER 44168.000000 0 FOR 44168.000000 FOR Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Nadja Y. West DIRECTOR ELECTIONS ISSUER 44168.000000 0 FOR 44168.000000 FOR Johnson & Johnson 478160104 US4781601046 04/25/2024 Election of Directors: Eugene A. Woods DIRECTOR ELECTIONS ISSUER 44168.000000 0 FOR 44168.000000 FOR Johnson & Johnson 478160104 US4781601046 04/25/2024 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 44168.000000 0 FOR 44168.000000 FOR Johnson & Johnson 478160104 US4781601046 04/25/2024 Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 44168.000000 0 FOR 44168.000000 FOR Johnson & Johnson 478160104 US4781601046 04/25/2024 Report on Gender-Based Compensation and Benefits Inequities DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 44168.000000 0 AGAINST 44168.000000 FOR Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: Ronald E. Blaylock DIRECTOR ELECTIONS ISSUER 137816.000000 0 FOR 137816.000000 FOR Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: Albert Bourla DIRECTOR ELECTIONS ISSUER 137816.000000 0 FOR 137816.000000 FOR Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: Susan Desmond-Hellmann DIRECTOR ELECTIONS ISSUER 137816.000000 0 FOR 137816.000000 FOR Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: Joseph J. Echevarria DIRECTOR ELECTIONS ISSUER 137816.000000 0 FOR 137816.000000 FOR Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: Scott Gottlieb DIRECTOR ELECTIONS ISSUER 137816.000000 0 FOR 137816.000000 FOR Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: Helen H. Hobbs DIRECTOR ELECTIONS ISSUER 137816.000000 0 FOR 137816.000000 FOR Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: Susan Hockfield DIRECTOR ELECTIONS ISSUER 137816.000000 0 FOR 137816.000000 FOR Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: Dan R. Littman DIRECTOR ELECTIONS ISSUER 137816.000000 0 FOR 137816.000000 FOR Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: Shantanu Narayen DIRECTOR ELECTIONS ISSUER 137816.000000 0 FOR 137816.000000 FOR Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: Suzanne Nora Johnson DIRECTOR ELECTIONS ISSUER 137816.000000 0 FOR 137816.000000 FOR Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: James Quincey DIRECTOR ELECTIONS ISSUER 137816.000000 0 FOR 137816.000000 FOR Pfizer Inc. 717081103 US7170811035 04/25/2024 Election of Directors: James C. Smith DIRECTOR ELECTIONS ISSUER 137816.000000 0 FOR 137816.000000 FOR Pfizer Inc. 717081103 US7170811035 04/25/2024 Ratify the selection of KPMG LLP as our independent registered public accounting firm for 2024 AUDIT-RELATED ISSUER 137816.000000 0 FOR 137816.000000 FOR Pfizer Inc. 717081103 US7170811035 04/25/2024 Approval of the Amended and Restated Pfizer Inc. 2019 Stock Plan COMPENSATION ISSUER 137816.000000 0 FOR 137816.000000 FOR Pfizer Inc. 717081103 US7170811035 04/25/2024 2024 advisory approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 137816.000000 0 FOR 137816.000000 FOR Pfizer Inc. 717081103 US7170811035 04/25/2024 Require Independent Board Chair CORPORATE GOVERNANCE SECURITY HOLDER 137816.000000 0 AGAINST 137816.000000 FOR Pfizer Inc. 717081103 US7170811035 04/25/2024 Report on Congruency of Political Spending with Company Stated Values and Priorities OTHER SOCIAL ISSUES SECURITY HOLDER 137816.000000 0 AGAINST 137816.000000 FOR Pfizer Inc. 717081103 US7170811035 04/25/2024 Report on Corporate Contributions OTHER SOCIAL ISSUES SECURITY HOLDER 137816.000000 0 AGAINST 137816.000000 FOR Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: R. J. Alpern DIRECTOR ELECTIONS ISSUER 80037.000000 0 FOR 80037.000000 FOR Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: C. Babineaux-Fontenot DIRECTOR ELECTIONS ISSUER 80037.000000 0 FOR 80037.000000 FOR Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: S. E. Blount DIRECTOR ELECTIONS ISSUER 80037.000000 0 FOR 80037.000000 FOR Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: R. B. Ford DIRECTOR ELECTIONS ISSUER 80037.000000 0 FOR 80037.000000 FOR Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: P. Gonzalez DIRECTOR ELECTIONS ISSUER 80037.000000 0 FOR 80037.000000 FOR Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: M. A. Kumbier DIRECTOR ELECTIONS ISSUER 80037.000000 0 FOR 80037.000000 FOR Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: D. W. McDew DIRECTOR ELECTIONS ISSUER 80037.000000 0 FOR 80037.000000 FOR Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: N. McKinstry DIRECTOR ELECTIONS ISSUER 80037.000000 0 AGAINST 80037.000000 AGAINST Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: M. G. O'Grady DIRECTOR ELECTIONS ISSUER 80037.000000 0 FOR 80037.000000 FOR Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: M. F. Roman DIRECTOR ELECTIONS ISSUER 80037.000000 0 FOR 80037.000000 FOR Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: D. J. Starks DIRECTOR ELECTIONS ISSUER 80037.000000 0 FOR 80037.000000 FOR Abbott Laboratories 002824100 US0028241000 04/26/2024 Election of 12 Directors: J. G. Stratton DIRECTOR ELECTIONS ISSUER 80037.000000 0 AGAINST 80037.000000 AGAINST Abbott Laboratories 002824100 US0028241000 04/26/2024 Ratification of Ernst & Young LLP As Auditors AUDIT-RELATED ISSUER 80037.000000 0 FOR 80037.000000 FOR Abbott Laboratories 002824100 US0028241000 04/26/2024 Say on Pay - An Advisory Vote on the Approval of Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 80037.000000 0 FOR 80037.000000 FOR Sanofi F5548N101 FR0000120578 04/30/2024 Approve Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 26788.000000 0 FOR 26788.000000 FOR Sanofi F5548N101 FR0000120578 04/30/2024 Approve Consolidated Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 26788.000000 0 FOR 26788.000000 FOR Sanofi F5548N101 FR0000120578 04/30/2024 Approve Allocation of Income and Dividends of EUR 3.76 per Share CAPITAL STRUCTURE ISSUER 26788.000000 0 FOR 26788.000000 FOR Sanofi F5548N101 FR0000120578 04/30/2024 Reelect Rachel Duan as Director DIRECTOR ELECTIONS ISSUER 26788.000000 0 FOR 26788.000000 FOR Sanofi F5548N101 FR0000120578 04/30/2024 Reelect Lise Kingo as Director DIRECTOR ELECTIONS ISSUER 26788.000000 0 FOR 26788.000000 FOR Sanofi F5548N101 FR0000120578 04/30/2024 Elect Clotilde Delbosas Director DIRECTOR ELECTIONS ISSUER 26788.000000 0 FOR 26788.000000 FOR Sanofi F5548N101 FR0000120578 04/30/2024 Elect Anne-Francoise Nesmes as Director DIRECTOR ELECTIONS ISSUER 26788.000000 0 FOR 26788.000000 FOR Sanofi F5548N101 FR0000120578 04/30/2024 Elect John Sundy as Director DIRECTOR ELECTIONS ISSUER 26788.000000 0 FOR 26788.000000 FOR Sanofi F5548N101 FR0000120578 04/30/2024 Approve Compensation Report of Corporate Officers COMPENSATION ISSUER 26788.000000 0 FOR 26788.000000 FOR Sanofi F5548N101 FR0000120578 04/30/2024 Approve Compensation of Serge Weinberg, Chairman of the Board from January 1, 2023 to May 25, 2023 COMPENSATION ISSUER 26788.000000 0 FOR 26788.000000 FOR Sanofi F5548N101 FR0000120578 04/30/2024 Approve Compensation of Frederic Oudea, Chairman of the Board Since May 25, 2023 COMPENSATION ISSUER 26788.000000 0 FOR 26788.000000 FOR Sanofi F5548N101 FR0000120578 04/30/2024 Approve Compensation of Paul Hudson, CEO COMPENSATION ISSUER 26788.000000 0 FOR 26788.000000 FOR Sanofi F5548N101 FR0000120578 04/30/2024 Approve Remuneration Policy of Directors COMPENSATION ISSUER 26788.000000 0 FOR 26788.000000 FOR Sanofi F5548N101 FR0000120578 04/30/2024 Approve Remuneration Policy of Chairman of the Board COMPENSATION ISSUER 26788.000000 0 FOR 26788.000000 FOR Sanofi F5548N101 FR0000120578 04/30/2024 Approve Remuneration Policy of CEO COMPENSATION ISSUER 26788.000000 0 FOR 26788.000000 FOR Sanofi F5548N101 FR0000120578 04/30/2024 Appoint Mazars as Auditor AUDIT-RELATED ISSUER 26788.000000 0 FOR 26788.000000 FOR Sanofi F5548N101 FR0000120578 04/30/2024 Appoint Mazars as Auditor Responsible for Certifying Sustainability Information CORPORATE GOVERNANCE ISSUER 26788.000000 0 FOR 26788.000000 FOR Sanofi F5548N101 FR0000120578 04/30/2024 Appoint PricewaterhouseCoopers Audit as Auditor Responsible for Certifying Sustainability Information CORPORATE GOVERNANCE ISSUER 26788.000000 0 FOR 26788.000000 FOR Sanofi F5548N101 FR0000120578 04/30/2024 Authorize Repurchase of Up to 10 Percent of Issued Share Capital CAPITAL STRUCTURE ISSUER 26788.000000 0 FOR 26788.000000 FOR Sanofi F5548N101 FR0000120578 04/30/2024 Authorize up to 1.5 Percent of Issued Capital for Use in Restricted Stock Plans COMPENSATION ISSUER 26788.000000 0 FOR 26788.000000 FOR Sanofi F5548N101 FR0000120578 04/30/2024 Authorize Capital Issuances for Use in Employee Stock Purchase Plans COMPENSATION ISSUER 26788.000000 0 FOR 26788.000000 FOR Sanofi F5548N101 FR0000120578 04/30/2024 Authorize Capital Issuances for Use in Employee Stock Purchase Plans Reserved for Employees and Corporate Officers of International Subsidiaries COMPENSATION ISSUER 26788.000000 0 FOR 26788.000000 FOR Sanofi F5548N101 FR0000120578 04/30/2024 Authorize Filing of Required Documents/Other Formalities CORPORATE GOVERNANCE ISSUER 26788.000000 0 FOR 26788.000000 FOR Boston Scientific Corporation 101137107 US1011371077 05/02/2024 Proposal to elect nine Directors: Charles J. Dockendorff DIRECTOR ELECTIONS ISSUER 451864.000000 0 FOR 451864.000000 FOR Boston Scientific Corporation 101137107 US1011371077 05/02/2024 Proposal to elect nine Directors: Yoshiaki Fujimori DIRECTOR ELECTIONS ISSUER 451864.000000 0 FOR 451864.000000 FOR Boston Scientific Corporation 101137107 US1011371077 05/02/2024 Proposal to elect nine Directors: Edward J. Ludwig DIRECTOR ELECTIONS ISSUER 451864.000000 0 FOR 451864.000000 FOR Boston Scientific Corporation 101137107 US1011371077 05/02/2024 Proposal to elect nine Directors: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 451864.000000 0 FOR 451864.000000 FOR Boston Scientific Corporation 101137107 US1011371077 05/02/2024 Proposal to elect nine Directors: Jessica L. Mega DIRECTOR ELECTIONS ISSUER 451864.000000 0 FOR 451864.000000 FOR Boston Scientific Corporation 101137107 US1011371077 05/02/2024 Proposal to elect nine Directors: Susan E. Morano DIRECTOR ELECTIONS ISSUER 451864.000000 0 FOR 451864.000000 FOR Boston Scientific Corporation 101137107 US1011371077 05/02/2024 Proposal to elect nine Directors: John E. Sununu DIRECTOR ELECTIONS ISSUER 451864.000000 0 FOR 451864.000000 FOR Boston Scientific Corporation 101137107 US1011371077 05/02/2024 Proposal to elect nine Directors: David S. Wichmann DIRECTOR ELECTIONS ISSUER 451864.000000 0 FOR 451864.000000 FOR Boston Scientific Corporation 101137107 US1011371077 05/02/2024 Proposal to elect nine Directors: Ellen M. Zane DIRECTOR ELECTIONS ISSUER 451864.000000 0 FOR 451864.000000 FOR Boston Scientific Corporation 101137107 US1011371077 05/02/2024 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 451864.000000 0 FOR 451864.000000 FOR Boston Scientific Corporation 101137107 US1011371077 05/02/2024 To approve an amendment and restatement of our By-Laws to provide for advance notice and universal proxy rule updates. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 451864.000000 0 FOR 451864.000000 FOR Boston Scientific Corporation 101137107 US1011371077 05/02/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2024 fiscal year. AUDIT-RELATED ISSUER 451864.000000 0 FOR 451864.000000 FOR Inspire Medical Systems, Inc. 457730109 US4577301090 05/02/2024 Election of Class III Directors: Shelley G. Broader DIRECTOR ELECTIONS ISSUER 5782.000000 0 FOR 5782.000000 FOR Inspire Medical Systems, Inc. 457730109 US4577301090 05/02/2024 Election of Class III Directors: Myriam J. Curet, M.D. DIRECTOR ELECTIONS ISSUER 5782.000000 0 FOR 5782.000000 FOR Inspire Medical Systems, Inc. 457730109 US4577301090 05/02/2024 Election of Class III Directors: Casey M. Tansey DIRECTOR ELECTIONS ISSUER 5782.000000 0 FOR 5782.000000 FOR Inspire Medical Systems, Inc. 457730109 US4577301090 05/02/2024 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 5782.000000 0 FOR 5782.000000 FOR Inspire Medical Systems, Inc. 457730109 US4577301090 05/02/2024 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 5782.000000 0 FOR 5782.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Election of Class III Directors: Roxanne S. Austin DIRECTOR ELECTIONS ISSUER 184866.000000 0 FOR 184866.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Election of Class III Directors: Richard A. Gonzalez DIRECTOR ELECTIONS ISSUER 184866.000000 0 FOR 184866.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Election of Class III Directors: Susan E. Quaggin DIRECTOR ELECTIONS ISSUER 184866.000000 0 FOR 184866.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Election of Class III Directors: Rebecca B. Roberts DIRECTOR ELECTIONS ISSUER 184866.000000 0 FOR 184866.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Election of Class III Directors: Glenn F. Tilton DIRECTOR ELECTIONS ISSUER 184866.000000 0 FOR 184866.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2024 AUDIT-RELATED ISSUER 184866.000000 0 FOR 184866.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Say on Pay - An advisory vote on the approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 184866.000000 0 FOR 184866.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Say on Pay - An advisory vote on the frequency of the advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 184866.000000 0 ONE YEAR 184866.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting CORPORATE GOVERNANCE ISSUER 184866.000000 0 FOR 184866.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Adopt Simple Majority Vote SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 184866.000000 0 AGAINST 184866.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Report on Lobbying Payments and Policy OTHER SOCIAL ISSUES SECURITY HOLDER 184866.000000 0 AGAINST 184866.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/03/2024 Report on Impact of Extended Patent Exclusivities on Product Access OTHER SOCIAL ISSUES SECURITY HOLDER 184866.000000 0 AGAINST 184866.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/06/2024 Election of the following directors, each to serve a three-year term: Katherine Baicker, Ph.D. DIRECTOR ELECTIONS ISSUER 81287.000000 0 FOR 81287.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/06/2024 Election of the following directors, each to serve a three-year term: J. Erik Fyrwald DIRECTOR ELECTIONS ISSUER 81287.000000 0 FOR 81287.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/06/2024 Election of the following directors, each to serve a three-year term: Jamere Jackson DIRECTOR ELECTIONS ISSUER 81287.000000 0 FOR 81287.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/06/2024 Election of the following directors, each to serve a three-year term: Gabrielle Sulzberger DIRECTOR ELECTIONS ISSUER 81287.000000 0 FOR 81287.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/06/2024 Approval, on an advisory basis, of the compensation paid to the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 81287.000000 0 FOR 81287.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/06/2024 Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2024. AUDIT-RELATED ISSUER 81287.000000 0 FOR 81287.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/06/2024 Approval of amendments to the company's Articles of Incorporation to eliminate the classified board structure. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 81287.000000 0 FOR 81287.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/06/2024 Approval of amendments to the company's Articles of Incorporation to eliminate supermajority voting provisions. CORPORATE GOVERNANCE ISSUER 81287.000000 0 FOR 81287.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/06/2024 Report on Lobbying Payments and Policy OTHER SOCIAL ISSUES SECURITY HOLDER 81287.000000 0 AGAINST 81287.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/06/2024 Report on Effectiveness of Diversity, Equity, and Inclusion Efforts DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 81287.000000 0 AGAINST 81287.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/06/2024 Report on Impact of Extended Patent Exclusivities on Product Access OTHER SOCIAL ISSUES SECURITY HOLDER 81287.000000 0 AGAINST 81287.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/06/2024 Adopt a Comprehensive Human Rights Policy HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 81287.000000 0 AGAINST 81287.000000 FOR IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/06/2024 Election of Directors (Proposal One): Irene Chang Britt DIRECTOR ELECTIONS ISSUER 7516.000000 0 FOR 7516.000000 FOR IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/06/2024 Election of Directors (Proposal One): Bruce L. Claflin DIRECTOR ELECTIONS ISSUER 7516.000000 0 FOR 7516.000000 FOR IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/06/2024 Election of Directors (Proposal One): Asha S. Collins, PhD DIRECTOR ELECTIONS ISSUER 7516.000000 0 FOR 7516.000000 FOR IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/06/2024 Election of Directors (Proposal One): Sam Samad DIRECTOR ELECTIONS ISSUER 7516.000000 0 FOR 7516.000000 FOR IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/06/2024 Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year (Proposal Two). AUDIT-RELATED ISSUER 7516.000000 0 FOR 7516.000000 FOR IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/06/2024 Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three). SECTION 14A SAY-ON-PAY VOTES ISSUER 7516.000000 0 FOR 7516.000000 FOR IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/06/2024 Adopt Simple Majority Vote SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 7516.000000 0 FOR 7516.000000 NONE Moderna, Inc. 60770K107 US60770K1079 05/06/2024 To elect three Class III director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2027 annual meeting of shareholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Robert Langer DIRECTOR ELECTIONS ISSUER 33556.000000 0 AGAINST 33556.000000 AGAINST Moderna, Inc. 60770K107 US60770K1079 05/06/2024 To elect three Class III director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2027 annual meeting of shareholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Elizabeth Nabel, M.D. DIRECTOR ELECTIONS ISSUER 33556.000000 0 FOR 33556.000000 FOR Moderna, Inc. 60770K107 US60770K1079 05/06/2024 To elect three Class III director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2027 annual meeting of shareholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Elizabeth Tallett DIRECTOR ELECTIONS ISSUER 33556.000000 0 FOR 33556.000000 FOR Moderna, Inc. 60770K107 US60770K1079 05/06/2024 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 33556.000000 0 FOR 33556.000000 FOR Moderna, Inc. 60770K107 US60770K1079 05/06/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 33556.000000 0 FOR 33556.000000 FOR Moderna, Inc. 60770K107 US60770K1079 05/06/2024 To approve an amendment to the Amended and Restated Certificate of Incorporation to provide shareholders the right to call a special meeting. CORPORATE GOVERNANCE ISSUER 33556.000000 0 FOR 33556.000000 FOR Moderna, Inc. 60770K107 US60770K1079 05/06/2024 To approve an amendment to the Amended and Restated Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation. CORPORATE GOVERNANCE ISSUER 33556.000000 0 FOR 33556.000000 FOR argenx SE 04016X101 US04016X1019 05/07/2024 Approve Remuneration Report COMPENSATION ISSUER 11223.000000 3900.000000 FOR 11223.000000 FOR argenx SE 04016X101 US04016X1019 05/07/2024 Adopt Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 11223.000000 3900.000000 FOR 11223.000000 FOR argenx SE 04016X101 US04016X1019 05/07/2024 Approve Allocation of Losses to the Retained Earnings of the Company CAPITAL STRUCTURE ISSUER 11223.000000 3900.000000 FOR 11223.000000 FOR argenx SE 04016X101 US04016X1019 05/07/2024 Approve Discharge of Directors CORPORATE GOVERNANCE ISSUER 11223.000000 3900.000000 FOR 11223.000000 FOR argenx SE 04016X101 US04016X1019 05/07/2024 Approve Remuneration Policy COMPENSATION ISSUER 11223.000000 3900.000000 FOR 11223.000000 FOR argenx SE 04016X101 US04016X1019 05/07/2024 Elect Brian L. Kotzin as Non-Executive Director DIRECTOR ELECTIONS ISSUER 11223.000000 3900.000000 FOR 11223.000000 FOR argenx SE 04016X101 US04016X1019 05/07/2024 Reelect Peter Verhaeghe as Non-Executive Director DIRECTOR ELECTIONS ISSUER 11223.000000 3900.000000 FOR 11223.000000 FOR argenx SE 04016X101 US04016X1019 05/07/2024 Reelect Pamela Klein as Non-Executive Director DIRECTOR ELECTIONS ISSUER 11223.000000 3900.000000 FOR 11223.000000 FOR argenx SE 04016X101 US04016X1019 05/07/2024 Grant Board Authority to Issue Shares Up To 10 Percent of Issued Capital and Exclude Pre-emptive Rights CAPITAL STRUCTURE ISSUER 11223.000000 3900.000000 FOR 11223.000000 FOR argenx SE 04016X101 US04016X1019 05/07/2024 Amend Articles of Association and Authorization to Execute the Deed of Amendment CORPORATE GOVERNANCE ISSUER 11223.000000 3900.000000 AGAINST 11223.000000 AGAINST argenx SE 04016X101 US04016X1019 05/07/2024 Ratify Deloitte Accountants B.V. as Auditors for the 2024 Financial Year AUDIT-RELATED ISSUER 11223.000000 3900.000000 FOR 11223.000000 FOR argenx SE 04016X101 US04016X1019 05/07/2024 Ratify Ernst & Young Accountants LLP as Auditors for the 2025 Financial Year AUDIT-RELATED ISSUER 11223.000000 3900.000000 FOR 11223.000000 FOR Baxter International Inc. 071813109 US0718131099 05/07/2024 Election of Directors: Jose (Joe) E. Almeida DIRECTOR ELECTIONS ISSUER 60439.000000 0 FOR 60439.000000 FOR Baxter International Inc. 071813109 US0718131099 05/07/2024 Election of Directors: William A. Ampofo II DIRECTOR ELECTIONS ISSUER 60439.000000 0 FOR 60439.000000 FOR Baxter International Inc. 071813109 US0718131099 05/07/2024 Election of Directors: Patricia B. Morrison DIRECTOR ELECTIONS ISSUER 60439.000000 0 FOR 60439.000000 FOR Baxter International Inc. 071813109 US0718131099 05/07/2024 Election of Directors: Stephen N. Oesterle, M.D. DIRECTOR ELECTIONS ISSUER 60439.000000 0 FOR 60439.000000 FOR Baxter International Inc. 071813109 US0718131099 05/07/2024 Election of Directors: Stephen H. Rusckowski DIRECTOR ELECTIONS ISSUER 60439.000000 0 FOR 60439.000000 FOR Baxter International Inc. 071813109 US0718131099 05/07/2024 Election of Directors: Nancy M. Schlichting DIRECTOR ELECTIONS ISSUER 60439.000000 0 FOR 60439.000000 FOR Baxter International Inc. 071813109 US0718131099 05/07/2024 Election of Directors: Brent Shafer DIRECTOR ELECTIONS ISSUER 60439.000000 0 FOR 60439.000000 FOR Baxter International Inc. 071813109 US0718131099 05/07/2024 Election of Directors: Cathy R. Smith DIRECTOR ELECTIONS ISSUER 60439.000000 0 FOR 60439.000000 FOR Baxter International Inc. 071813109 US0718131099 05/07/2024 Election of Directors: Amy A. Wendell DIRECTOR ELECTIONS ISSUER 60439.000000 0 FOR 60439.000000 FOR Baxter International Inc. 071813109 US0718131099 05/07/2024 Election of Directors: David S. Wilkes, M.D. DIRECTOR ELECTIONS ISSUER 60439.000000 0 FOR 60439.000000 FOR Baxter International Inc. 071813109 US0718131099 05/07/2024 Election of Directors: Peter M. Wilver DIRECTOR ELECTIONS ISSUER 60439.000000 0 FOR 60439.000000 FOR Baxter International Inc. 071813109 US0718131099 05/07/2024 Advisory vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 60439.000000 0 FOR 60439.000000 FOR Baxter International Inc. 071813109 US0718131099 05/07/2024 Ratification of Appointment of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 60439.000000 0 FOR 60439.000000 FOR Baxter International Inc. 071813109 US0718131099 05/07/2024 Approve the Company's Amended and Restated 2021 Incentive Plan COMPENSATION ISSUER 60439.000000 0 FOR 60439.000000 FOR Baxter International Inc. 071813109 US0718131099 05/07/2024 Approve an Amendment to the Amended and Restated Certificate of Incorporation to Permit Officer Exculpation CORPORATE GOVERNANCE ISSUER 60439.000000 0 FOR 60439.000000 FOR Baxter International Inc. 071813109 US0718131099 05/07/2024 Adopt Share Retention Policy For Senior Executives COMPENSATION SECURITY HOLDER 60439.000000 0 AGAINST 60439.000000 FOR Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Rainer M. Blair DIRECTOR ELECTIONS ISSUER 78006.000000 0 FOR 78006.000000 FOR Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Feroz Dewan DIRECTOR ELECTIONS ISSUER 78006.000000 0 FOR 78006.000000 FOR Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Linda Filler DIRECTOR ELECTIONS ISSUER 78006.000000 0 FOR 78006.000000 FOR Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Teri List DIRECTOR ELECTIONS ISSUER 78006.000000 0 FOR 78006.000000 FOR Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Jessica L. Mega, MD, MPH DIRECTOR ELECTIONS ISSUER 78006.000000 0 FOR 78006.000000 FOR Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Mitchell P. Rales DIRECTOR ELECTIONS ISSUER 78006.000000 0 FOR 78006.000000 FOR Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Steven M. Rales DIRECTOR ELECTIONS ISSUER 78006.000000 0 FOR 78006.000000 FOR Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Pardis C. Sabeti, MD, D. PHIL DIRECTOR ELECTIONS ISSUER 78006.000000 0 FOR 78006.000000 FOR Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: A. Shane Sanders DIRECTOR ELECTIONS ISSUER 78006.000000 0 FOR 78006.000000 FOR Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: John T. Schwieters DIRECTOR ELECTIONS ISSUER 78006.000000 0 FOR 78006.000000 FOR Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Alan G. Spoon DIRECTOR ELECTIONS ISSUER 78006.000000 0 FOR 78006.000000 FOR Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Raymond C. Stevens, Ph.D DIRECTOR ELECTIONS ISSUER 78006.000000 0 FOR 78006.000000 FOR Danaher Corporation 235851102 US2358511028 05/07/2024 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Elias A. Zerhouni, MD DIRECTOR ELECTIONS ISSUER 78006.000000 0 FOR 78006.000000 FOR Danaher Corporation 235851102 US2358511028 05/07/2024 To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 78006.000000 0 FOR 78006.000000 FOR Danaher Corporation 235851102 US2358511028 05/07/2024 To approve on an advisory basis the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 78006.000000 0 FOR 78006.000000 FOR Danaher Corporation 235851102 US2358511028 05/07/2024 Reduce Ownership Threshold for Shareholders to Call Special Meeting SHAREHOLDER RIGHTS AND DEFENSES CORPORATE GOVERNANCE SECURITY HOLDER 78006.000000 0 AGAINST 78006.000000 FOR Danaher Corporation 235851102 US2358511028 05/07/2024 Report on Effectiveness of Diversity, Equity, and Inclusion Efforts DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 78006.000000 0 AGAINST 78006.000000 FOR Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2024 Election of Directors: Leslie C. Davis DIRECTOR ELECTIONS ISSUER 46055.000000 0 FOR 46055.000000 FOR Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2024 Election of Directors: Kieran T. Gallahue DIRECTOR ELECTIONS ISSUER 46055.000000 0 FOR 46055.000000 FOR Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2024 Election of Directors: Leslie S. Heisz DIRECTOR ELECTIONS ISSUER 46055.000000 0 FOR 46055.000000 FOR Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2024 Election of Directors: Paul A. LaViolette DIRECTOR ELECTIONS ISSUER 46055.000000 0 FOR 46055.000000 FOR Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2024 Election of Directors: Steven R. Loranger DIRECTOR ELECTIONS ISSUER 46055.000000 0 FOR 46055.000000 FOR Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2024 Election of Directors: Ramona Sequeira DIRECTOR ELECTIONS ISSUER 46055.000000 0 FOR 46055.000000 FOR Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2024 Election of Directors: Nicholas J. Valeriani DIRECTOR ELECTIONS ISSUER 46055.000000 0 FOR 46055.000000 FOR Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2024 Election of Directors: Bernard J. Zovighian DIRECTOR ELECTIONS ISSUER 46055.000000 0 FOR 46055.000000 FOR Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2024 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 46055.000000 0 FOR 46055.000000 FOR Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2024 Ratification of Appointment of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 46055.000000 0 FOR 46055.000000 FOR Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2024 Approval of the Amended and Restated Long-Term Stock Incentive Compensation COMPENSATION ISSUER 46055.000000 0 FOR 46055.000000 FOR Merus N.V. N5749R100 NL0011606264 05/07/2024 Adoption of Merus N.V.'s Dutch statutory annual accounts in the English language for the financial year 2023, CORPORATE GOVERNANCE ISSUER 22655.000000 0 FOR 22655.000000 FOR Merus N.V. N5749R100 NL0011606264 05/07/2024 Appointment of KPMG Accountants N.V. as Merus N.V.'s external auditor for the financial year 2024 for purposes of Dutch law. AUDIT-RELATED ISSUER 22655.000000 0 FOR 22655.000000 FOR Merus N.V. N5749R100 NL0011606264 05/07/2024 Release of each member of Merus N.V.'s board of directors from liability for the exercise of their duties during the financial year 2023. CORPORATE GOVERNANCE ISSUER 22655.000000 0 FOR 22655.000000 FOR Merus N.V. N5749R100 NL0011606264 05/07/2024 Re-appointment of Mark Iwicki as non-executive director. DIRECTOR ELECTIONS ISSUER 22655.000000 0 AGAINST 22655.000000 AGAINST Merus N.V. N5749R100 NL0011606264 05/07/2024 Re-appointment of Paolo Pucci as non-executive director. DIRECTOR ELECTIONS ISSUER 22655.000000 0 FOR 22655.000000 FOR Merus N.V. N5749R100 NL0011606264 05/07/2024 Appointment of Jason Haddock as non-executive director. DIRECTOR ELECTIONS ISSUER 22655.000000 0 FOR 22655.000000 FOR Merus N.V. N5749R100 NL0011606264 05/07/2024 Articles Amendment A - Approval of the amendment of the Articles of Association to increase the authorized share capital to the amount of EUR 18,900,000 and divided into 105,000,000 common shares and 105,000,000 preferred shares and authorization to implement such amendment. CAPITAL STRUCTURE ISSUER 22655.000000 0 FOR 22655.000000 FOR Merus N.V. N5749R100 NL0011606264 05/07/2024 Articles Amendment B - Approval of the amendment of the Articles of Association to reflect the Large Company Regime and authorization to implement such amendment. CORPORATE GOVERNANCE ISSUER 22655.000000 0 AGAINST 22655.000000 AGAINST Merus N.V. N5749R100 NL0011606264 05/07/2024 Granting authorization to Menus N.V.'s board of directors to acquire shares (or depository receipts for such shares) in Merus N.V.'s capital. CAPITAL STRUCTURE ISSUER 22655.000000 0 FOR 22655.000000 FOR Merus N.V. N5749R100 NL0011606264 05/07/2024 Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 22655.000000 0 FOR 22655.000000 FOR Merus N.V. N5749R100 NL0011606264 05/07/2024 Approval of the amendment of the Merus N.V.'s Non- Executive Director Compensation Program ("NED Program") to allow the board of directors to determine the number of common shares that may be awarded to a non-executive director for initial and annual awards under the NED Program to more closely align with the 50th percentile of the Company's peer group. COMPENSATION ISSUER 22655.000000 0 AGAINST 22655.000000 AGAINST Merus N.V. N5749R100 NL0011606264 05/07/2024 Approval of the amendment and restatement of the Merus NV. 2016 Incentive Award Plan (the "2016 Plan"), to extend the term of the 2016 Plan to December 31, 2031, which includes a corresponding extension to the annual "evergreen" feature from and including January 1, 2026, to January 1, 2029, along with other minor amendments updated for best practices. COMPENSATION ISSUER 22655.000000 0 AGAINST 22655.000000 AGAINST Alcon Inc. H01301128 CH0432492467 05/08/2024 Accept Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 36135.000000 0 FOR 36135.000000 FOR Alcon Inc. H01301128 CH0432492467 05/08/2024 Approve Discharge of Board and Senior Management CORPORATE GOVERNANCE ISSUER 36135.000000 0 FOR 36135.000000 FOR Alcon Inc. H01301128 CH0432492467 05/08/2024 Approve Allocation of Income and Dividends of CHF 0.24 per Share CAPITAL STRUCTURE ISSUER 36135.000000 0 FOR 36135.000000 FOR Alcon Inc. H01301128 CH0432492467 05/08/2024 Approve Non-Financial Report (Non-Binding) CORPORATE GOVERNANCE ENVIRONMENT OR CLIMATE HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES ISSUER 36135.000000 0 FOR 36135.000000 FOR Alcon Inc. H01301128 CH0432492467 05/08/2024 Approve Remuneration Report (Non-Binding) COMPENSATION ISSUER 36135.000000 0 AGAINST 36135.000000 AGAINST Alcon Inc. H01301128 CH0432492467 05/08/2024 Approve Remuneration of Directors in the Amount of CHF 3.9 Million COMPENSATION ISSUER 36135.000000 0 FOR 36135.000000 FOR Alcon Inc. H01301128 CH0432492467 05/08/2024 Approve Remuneration of Executive Committee in the Amount of CHF 43 Million COMPENSATION ISSUER 36135.000000 0 FOR 36135.000000 FOR Alcon Inc. H01301128 CH0432492467 05/08/2024 Reelect Michael Ball as Director and Board Chair DIRECTOR ELECTIONS ISSUER 36135.000000 0 FOR 36135.000000 FOR Alcon Inc. H01301128 CH0432492467 05/08/2024 Reelect Lynn Bleil as Director DIRECTOR ELECTIONS ISSUER 36135.000000 0 FOR 36135.000000 FOR Alcon Inc. H01301128 CH0432492467 05/08/2024 Reelect Raquel Bono as Director DIRECTOR ELECTIONS ISSUER 36135.000000 0 FOR 36135.000000 FOR Alcon Inc. H01301128 CH0432492467 05/08/2024 Reelect Arthur Cummings as Director DIRECTOR ELECTIONS ISSUER 36135.000000 0 FOR 36135.000000 FOR Alcon Inc. H01301128 CH0432492467 05/08/2024 Reelect David Endicott as Director DIRECTOR ELECTIONS ISSUER 36135.000000 0 FOR 36135.000000 FOR Alcon Inc. H01301128 CH0432492467 05/08/2024 Reelect Thomas Glanzmann as Director DIRECTOR ELECTIONS ISSUER 36135.000000 0 FOR 36135.000000 FOR Alcon Inc. H01301128 CH0432492467 05/08/2024 Reelect Keith Grossman as Director DIRECTOR ELECTIONS ISSUER 36135.000000 0 FOR 36135.000000 FOR Alcon Inc. H01301128 CH0432492467 05/08/2024 Reelect Scott Maw as Director DIRECTOR ELECTIONS ISSUER 36135.000000 0 FOR 36135.000000 FOR Alcon Inc. H01301128 CH0432492467 05/08/2024 Reelect Karen May as Director DIRECTOR ELECTIONS ISSUER 36135.000000 0 FOR 36135.000000 FOR Alcon Inc. H01301128 CH0432492467 05/08/2024 Reelect Ines Poeschel as Director DIRECTOR ELECTIONS ISSUER 36135.000000 0 FOR 36135.000000 FOR Alcon Inc. H01301128 CH0432492467 05/08/2024 Reelect Dieter Spaelti as Director DIRECTOR ELECTIONS ISSUER 36135.000000 0 FOR 36135.000000 FOR Alcon Inc. H01301128 CH0432492467 05/08/2024 Reappoint Thomas Glanzmann as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 36135.000000 0 AGAINST 36135.000000 AGAINST Alcon Inc. H01301128 CH0432492467 05/08/2024 Reappoint Scott Maw as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 36135.000000 0 AGAINST 36135.000000 AGAINST Alcon Inc. H01301128 CH0432492467 05/08/2024 Reappoint Karen May as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 36135.000000 0 AGAINST 36135.000000 AGAINST Alcon Inc. H01301128 CH0432492467 05/08/2024 Reappoint Ines Poeschel as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 36135.000000 0 AGAINST 36135.000000 AGAINST Alcon Inc. H01301128 CH0432492467 05/08/2024 Designate Hartmann Dreyer as Independent Proxy CORPORATE GOVERNANCE ISSUER 36135.000000 0 FOR 36135.000000 FOR Alcon Inc. H01301128 CH0432492467 05/08/2024 Ratify PricewaterhouseCoopers SA as Auditors AUDIT-RELATED ISSUER 36135.000000 0 FOR 36135.000000 FOR Alcon Inc. H01301128 CH0432492467 05/08/2024 Transact Other Business (Voting) CORPORATE GOVERNANCE ISSUER 36135.000000 0 ABSTAIN 36135.000000 AGAINST Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jacqueline K. Barton, Ph.D. DIRECTOR ELECTIONS ISSUER 111030.000000 0 FOR 111030.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jeffrey A. Bluestone, Ph.D. DIRECTOR ELECTIONS ISSUER 111030.000000 0 FOR 111030.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Sandra J. Horning, M.D. DIRECTOR ELECTIONS ISSUER 111030.000000 0 FOR 111030.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Kelly A. Kramer DIRECTOR ELECTIONS ISSUER 111030.000000 0 FOR 111030.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Ted W. Love, M.D. DIRECTOR ELECTIONS ISSUER 111030.000000 0 FOR 111030.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Harish Manwani DIRECTOR ELECTIONS ISSUER 111030.000000 0 FOR 111030.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Daniel P. O'Day DIRECTOR ELECTIONS ISSUER 111030.000000 0 FOR 111030.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Javier J. Rodriguez DIRECTOR ELECTIONS ISSUER 111030.000000 0 FOR 111030.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Anthony Welters DIRECTOR ELECTIONS ISSUER 111030.000000 0 FOR 111030.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 111030.000000 0 FOR 111030.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 111030.000000 0 FOR 111030.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 To approve an amendment to our Restated Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation. CORPORATE GOVERNANCE ISSUER 111030.000000 0 FOR 111030.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 Adopt a Policy to Include Non-Management Employees as Prospective Director Candidates CORPORATE GOVERNANCE SECURITY HOLDER 111030.000000 0 AGAINST 111030.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 Report on Risks of Supporting Abortion OTHER SOCIAL ISSUES SECURITY HOLDER 111030.000000 0 AGAINST 111030.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/08/2024 Adopt Share Retention Policy For Senior Executives COMPENSATION SECURITY HOLDER 111030.000000 0 AGAINST 111030.000000 FOR Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Election of Directors: Juan Andres DIRECTOR ELECTIONS ISSUER 55614.000000 0 FOR 55614.000000 FOR Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Election of Directors: John Carethers DIRECTOR ELECTIONS ISSUER 55614.000000 0 FOR 55614.000000 FOR Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Election of Directors: Lan Kang DIRECTOR ELECTIONS ISSUER 55614.000000 0 FOR 55614.000000 FOR Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Election of Directors: Joseph Massaro DIRECTOR ELECTIONS ISSUER 55614.000000 0 FOR 55614.000000 FOR Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Election of Directors: Mala Murthy DIRECTOR ELECTIONS ISSUER 55614.000000 0 FOR 55614.000000 FOR Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Election of Directors: Jonathan Peacock DIRECTOR ELECTIONS ISSUER 55614.000000 0 FOR 55614.000000 FOR Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Election of Directors: Michael Severino DIRECTOR ELECTIONS ISSUER 55614.000000 0 FOR 55614.000000 FOR Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Election of Directors: Michael Stubblefield DIRECTOR ELECTIONS ISSUER 55614.000000 0 FOR 55614.000000 FOR Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Election of Directors: Gregory Summe DIRECTOR ELECTIONS ISSUER 55614.000000 0 FOR 55614.000000 FOR Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Approve the Officer Exculpation Amendment and Other Immaterial Amendments to our Certificate of Incorporation. CORPORATE GOVERNANCE ISSUER 55614.000000 0 FOR 55614.000000 FOR Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Ratification of the Appointment of Deloitte & Touche LLP as the Company's independent registered accounting firm for 2024. AUDIT-RELATED ISSUER 55614.000000 0 FOR 55614.000000 FOR Avantor, Inc. 05352A100 US05352A1007 05/09/2024 Approve, on an Advisory Basis, Named Executive Officer Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 55614.000000 0 FOR 55614.000000 FOR Mettler-Toledo International Inc. 592688105 US5926881054 05/09/2024 ELECTION OF DIRECTORS: Roland Diggelmann DIRECTOR ELECTIONS ISSUER 1010.000000 0 FOR 1010.000000 FOR Mettler-Toledo International Inc. 592688105 US5926881054 05/09/2024 ELECTION OF DIRECTORS: Domitille Doat-Le Bigot DIRECTOR ELECTIONS ISSUER 1010.000000 0 FOR 1010.000000 FOR Mettler-Toledo International Inc. 592688105 US5926881054 05/09/2024 ELECTION OF DIRECTORS: Elisha W. Finney DIRECTOR ELECTIONS ISSUER 1010.000000 0 FOR 1010.000000 FOR Mettler-Toledo International Inc. 592688105 US5926881054 05/09/2024 ELECTION OF DIRECTORS: Richard Francis DIRECTOR ELECTIONS ISSUER 1010.000000 0 FOR 1010.000000 FOR Mettler-Toledo International Inc. 592688105 US5926881054 05/09/2024 ELECTION OF DIRECTORS: Michael A. Kelly DIRECTOR ELECTIONS ISSUER 1010.000000 0 FOR 1010.000000 FOR Mettler-Toledo International Inc. 592688105 US5926881054 05/09/2024 ELECTION OF DIRECTORS: Thomas P. Salice DIRECTOR ELECTIONS ISSUER 1010.000000 0 FOR 1010.000000 FOR Mettler-Toledo International Inc. 592688105 US5926881054 05/09/2024 ELECTION OF DIRECTORS: Wolfgang Wienand DIRECTOR ELECTIONS ISSUER 1010.000000 0 FOR 1010.000000 FOR Mettler-Toledo International Inc. 592688105 US5926881054 05/09/2024 ELECTION OF DIRECTORS: Ingrid Zhang DIRECTOR ELECTIONS ISSUER 1010.000000 0 FOR 1010.000000 FOR Mettler-Toledo International Inc. 592688105 US5926881054 05/09/2024 RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM AUDIT-RELATED ISSUER 1010.000000 0 FOR 1010.000000 FOR Mettler-Toledo International Inc. 592688105 US5926881054 05/09/2024 ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION SECTION 14A SAY-ON-PAY VOTES ISSUER 1010.000000 0 FOR 1010.000000 FOR Stryker Corporation 863667101 US8636671013 05/09/2024 Election of Ten Directors: Mary K. Brainerd DIRECTOR ELECTIONS ISSUER 49107.000000 0 FOR 49107.000000 FOR Stryker Corporation 863667101 US8636671013 05/09/2024 Election of Ten Directors: Giovanni Caforio, M.D. DIRECTOR ELECTIONS ISSUER 49107.000000 0 FOR 49107.000000 FOR Stryker Corporation 863667101 US8636671013 05/09/2024 Election of Ten Directors: Allan C. Golston DIRECTOR ELECTIONS ISSUER 49107.000000 0 FOR 49107.000000 FOR Stryker Corporation 863667101 US8636671013 05/09/2024 Election of Ten Directors: Kevin A. Lobo DIRECTOR ELECTIONS ISSUER 49107.000000 0 FOR 49107.000000 FOR Stryker Corporation 863667101 US8636671013 05/09/2024 Election of Ten Directors: Sherilyn S. McCoy DIRECTOR ELECTIONS ISSUER 49107.000000 0 FOR 49107.000000 FOR Stryker Corporation 863667101 US8636671013 05/09/2024 Election of Ten Directors: Rachel Ruggeri DIRECTOR ELECTIONS ISSUER 49107.000000 0 FOR 49107.000000 FOR Stryker Corporation 863667101 US8636671013 05/09/2024 Election of Ten Directors: Andrew K. Silvernail DIRECTOR ELECTIONS ISSUER 49107.000000 0 FOR 49107.000000 FOR Stryker Corporation 863667101 US8636671013 05/09/2024 Election of Ten Directors: Lisa M. Skeete Tatum DIRECTOR ELECTIONS ISSUER 49107.000000 0 FOR 49107.000000 FOR Stryker Corporation 863667101 US8636671013 05/09/2024 Election of Ten Directors: Ronda E. Stryker DIRECTOR ELECTIONS ISSUER 49107.000000 0 FOR 49107.000000 FOR Stryker Corporation 863667101 US8636671013 05/09/2024 Election of Ten Directors: Rajeev Suri DIRECTOR ELECTIONS ISSUER 49107.000000 0 FOR 49107.000000 FOR Stryker Corporation 863667101 US8636671013 05/09/2024 Ratification of Appointment of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for 2024. AUDIT-RELATED ISSUER 49107.000000 0 FOR 49107.000000 FOR Stryker Corporation 863667101 US8636671013 05/09/2024 Advisory Vote to Approve Named Executive Officer Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 49107.000000 0 FOR 49107.000000 FOR Stryker Corporation 863667101 US8636671013 05/09/2024 Report on Political Contributions and Expenditures OTHER SOCIAL ISSUES SECURITY HOLDER 49107.000000 0 AGAINST 49107.000000 FOR Insmed Incorporated 457669307 US4576693075 05/13/2024 Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., to serve until the 2027 Annual Meeting of Shareholders: David R. Brennan DIRECTOR ELECTIONS ISSUER 16685.000000 0 FOR 16685.000000 FOR Insmed Incorporated 457669307 US4576693075 05/13/2024 Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., to serve until the 2027 Annual Meeting of Shareholders: Leo Lee DIRECTOR ELECTIONS ISSUER 16685.000000 0 FOR 16685.000000 FOR Insmed Incorporated 457669307 US4576693075 05/13/2024 Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., to serve until the 2027 Annual Meeting of Shareholders: Carol A. Schafer DIRECTOR ELECTIONS ISSUER 16685.000000 0 FOR 16685.000000 FOR Insmed Incorporated 457669307 US4576693075 05/13/2024 Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., to serve until the 2027 Annual Meeting of Shareholders: Melvin Sharoky, M.D. DIRECTOR ELECTIONS ISSUER 16685.000000 0 FOR 16685.000000 FOR Insmed Incorporated 457669307 US4576693075 05/13/2024 An advisory vote on the 2023 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 16685.000000 0 FOR 16685.000000 FOR Insmed Incorporated 457669307 US4576693075 05/13/2024 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 16685.000000 0 FOR 16685.000000 FOR Insmed Incorporated 457669307 US4576693075 05/13/2024 Approval of Amendment No. 1 to the Insmed Incorporated Amended and Restated 2019 Incentive Plan. COMPENSATION ISSUER 16685.000000 0 FOR 16685.000000 FOR Centene Corporation 15135B101 US15135B1017 05/14/2024 ELECTION OF DIRECTORS: Jessica L. Blume DIRECTOR ELECTIONS ISSUER 87074.000000 0 FOR 87074.000000 FOR Centene Corporation 15135B101 US15135B1017 05/14/2024 ELECTION OF DIRECTORS: Kenneth A. Burdick DIRECTOR ELECTIONS ISSUER 87074.000000 0 FOR 87074.000000 FOR Centene Corporation 15135B101 US15135B1017 05/14/2024 ELECTION OF DIRECTORS: Christopher J. Coughlin DIRECTOR ELECTIONS ISSUER 87074.000000 0 FOR 87074.000000 FOR Centene Corporation 15135B101 US15135B1017 05/14/2024 ELECTION OF DIRECTORS: H. James Dallas DIRECTOR ELECTIONS ISSUER 87074.000000 0 FOR 87074.000000 FOR Centene Corporation 15135B101 US15135B1017 05/14/2024 ELECTION OF DIRECTORS: Wayne S. DeVeydt DIRECTOR ELECTIONS ISSUER 87074.000000 0 FOR 87074.000000 FOR Centene Corporation 15135B101 US15135B1017 05/14/2024 ELECTION OF DIRECTORS: Frederick H. Eppinger DIRECTOR ELECTIONS ISSUER 87074.000000 0 FOR 87074.000000 FOR Centene Corporation 15135B101 US15135B1017 05/14/2024 ELECTION OF DIRECTORS: Monte E. Ford DIRECTOR ELECTIONS ISSUER 87074.000000 0 FOR 87074.000000 FOR Centene Corporation 15135B101 US15135B1017 05/14/2024 ELECTION OF DIRECTORS: Sarah M. London DIRECTOR ELECTIONS ISSUER 87074.000000 0 FOR 87074.000000 FOR Centene Corporation 15135B101 US15135B1017 05/14/2024 ELECTION OF DIRECTORS: Lori J. Robinson DIRECTOR ELECTIONS ISSUER 87074.000000 0 FOR 87074.000000 FOR Centene Corporation 15135B101 US15135B1017 05/14/2024 ELECTION OF DIRECTORS: Theodore R. Samuels DIRECTOR ELECTIONS ISSUER 87074.000000 0 FOR 87074.000000 FOR Centene Corporation 15135B101 US15135B1017 05/14/2024 ADVISORY RESOLUTION TO APPROVE EXECUTIVE COMPENSATION. SECTION 14A SAY-ON-PAY VOTES ISSUER 87074.000000 0 FOR 87074.000000 FOR Centene Corporation 15135B101 US15135B1017 05/14/2024 RATIFICATION OF APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2024. AUDIT-RELATED ISSUER 87074.000000 0 FOR 87074.000000 FOR Centene Corporation 15135B101 US15135B1017 05/14/2024 Adopt Near and Long-Term Science-Based GHG Emissions Reduction Targets Aligned with Paris Agreement Goal ENVIRONMENT OR CLIMATE SECURITY HOLDER 87074.000000 0 AGAINST 87074.000000 FOR Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Election of the members of the Company's Board of Directors: Kerrii B. Anderson DIRECTOR ELECTIONS ISSUER 6745.000000 0 FOR 6745.000000 FOR Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Election of the members of the Company's Board of Directors: Jeffrey A. Davis DIRECTOR ELECTIONS ISSUER 6745.000000 0 FOR 6745.000000 FOR Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Election of the members of the Company's Board of Directors: D. Gary Gilliland, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 6745.000000 0 FOR 6745.000000 FOR Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Election of the members of the Company's Board of Directors: Kirsten M. Kliphouse DIRECTOR ELECTIONS ISSUER 6745.000000 0 FOR 6745.000000 FOR Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Election of the members of the Company's Board of Directors: Garheng Kong, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 6745.000000 0 FOR 6745.000000 FOR Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Election of the members of the Company's Board of Directors: Peter M. Neupert DIRECTOR ELECTIONS ISSUER 6745.000000 0 FOR 6745.000000 FOR Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Election of the members of the Company's Board of Directors: Richelle P. Parham DIRECTOR ELECTIONS ISSUER 6745.000000 0 FOR 6745.000000 FOR Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Election of the members of the Company's Board of Directors: Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 6745.000000 0 FOR 6745.000000 FOR Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Election of the members of the Company's Board of Directors: Adam H. Schechter DIRECTOR ELECTIONS ISSUER 6745.000000 0 FOR 6745.000000 FOR Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Election of the members of the Company's Board of Directors: Kathryn E. Wengel DIRECTOR ELECTIONS ISSUER 6745.000000 0 FOR 6745.000000 FOR Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 To approve, by non-binding vote, the compensation of the Laboratory Corporation of America Holdings' named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 6745.000000 0 FOR 6745.000000 FOR Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Ratification of the appointment of Deloitte and Touche LLP as Laboratory Corporation of America Holdings' independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 6745.000000 0 FOR 6745.000000 FOR Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Submit Severance Agreement (Change-in-Control) to Shareholder Vote COMPENSATION SECURITY HOLDER 6745.000000 0 AGAINST 6745.000000 FOR Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Report on Transport of Nonhuman Primates Within the U.S. OTHER SOCIAL ISSUES SECURITY HOLDER 6745.000000 0 AGAINST 6745.000000 FOR Laboratory Corporation of America Holdings 504922105 US5049221055 05/14/2024 Report on Risks Related to Fulfilling Information Requests for Enforcing Laws Criminalizing Abortion Access OTHER SOCIAL ISSUES SECURITY HOLDER 6745.000000 0 AGAINST 6745.000000 FOR Elevance Health, Inc. 036752103 US0367521038 05/15/2024 Election of Directors: Lewis Hay, III DIRECTOR ELECTIONS ISSUER 25602.000000 0 FOR 25602.000000 FOR Elevance Health, Inc. 036752103 US0367521038 05/15/2024 Election of Directors: Antonio F. Neri DIRECTOR ELECTIONS ISSUER 25602.000000 0 FOR 25602.000000 FOR Elevance Health, Inc. 036752103 US0367521038 05/15/2024 Election of Directors: Ramiro G. Peru DIRECTOR ELECTIONS ISSUER 25602.000000 0 FOR 25602.000000 FOR Elevance Health, Inc. 036752103 US0367521038 05/15/2024 Advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 25602.000000 0 FOR 25602.000000 FOR Elevance Health, Inc. 036752103 US0367521038 05/15/2024 To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 25602.000000 0 FOR 25602.000000 FOR Elevance Health, Inc. 036752103 US0367521038 05/15/2024 Adopt a Policy Requiring Third Party Groups to Report Their Political Expenditures OTHER SOCIAL ISSUES SECURITY HOLDER 25602.000000 0 AGAINST 25602.000000 FOR Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Election of Directors: Sangeeta Bhatia DIRECTOR ELECTIONS ISSUER 26679.000000 0 FOR 26679.000000 FOR Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Election of Directors: Lloyd Carney DIRECTOR ELECTIONS ISSUER 26679.000000 0 FOR 26679.000000 FOR Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Election of Directors: Alan Garber DIRECTOR ELECTIONS ISSUER 26679.000000 0 FOR 26679.000000 FOR Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Election of Directors: Reshma Kewalramani DIRECTOR ELECTIONS ISSUER 26679.000000 0 FOR 26679.000000 FOR Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Election of Directors: Michel Lagarde DIRECTOR ELECTIONS ISSUER 26679.000000 0 FOR 26679.000000 FOR Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Election of Directors: Jeffrey Leiden DIRECTOR ELECTIONS ISSUER 26679.000000 0 FOR 26679.000000 FOR Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Election of Directors: Diana McKenzie DIRECTOR ELECTIONS ISSUER 26679.000000 0 FOR 26679.000000 FOR Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Election of Directors: Bruce Sachs DIRECTOR ELECTIONS ISSUER 26679.000000 0 FOR 26679.000000 FOR Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Election of Directors: Jennifer Schneider DIRECTOR ELECTIONS ISSUER 26679.000000 0 FOR 26679.000000 FOR Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Election of Directors: Nancy Thornberry DIRECTOR ELECTIONS ISSUER 26679.000000 0 FOR 26679.000000 FOR Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Election of Directors: Suketu Upadhyay DIRECTOR ELECTIONS ISSUER 26679.000000 0 FOR 26679.000000 FOR Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 26679.000000 0 FOR 26679.000000 FOR Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Advisory vote to approve named executive office compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 26679.000000 0 FOR 26679.000000 FOR Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Reduce Ownership Threshold for Shareholders to Call Special Meeting SHAREHOLDER RIGHTS AND DEFENSES CORPORATE GOVERNANCE SECURITY HOLDER 26679.000000 0 AGAINST 26679.000000 FOR Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/15/2024 Report on Median and Adjusted Gender/Racial Pay Gaps DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 26679.000000 0 AGAINST 26679.000000 FOR Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/16/2024 To elect the following nominees as Class II directors of Alnylam: Dennis A. Ausiello, M.D. DIRECTOR ELECTIONS ISSUER 24255.000000 0 FOR 24255.000000 FOR Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/16/2024 To elect the following nominees as Class II directors of Alnylam: Olivier Brandicourt, M.D. DIRECTOR ELECTIONS ISSUER 24255.000000 0 FOR 24255.000000 FOR Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/16/2024 To elect the following nominees as Class II directors of Alnylam: Peter N. Kellogg DIRECTOR ELECTIONS ISSUER 24255.000000 0 FOR 24255.000000 FOR Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/16/2024 To elect the following nominees as Class II directors of Alnylam: David E.I. Pyott DIRECTOR ELECTIONS ISSUER 24255.000000 0 FOR 24255.000000 FOR Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/16/2024 To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 24255.000000 0 FOR 24255.000000 FOR Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/16/2024 To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 24255.000000 0 FOR 24255.000000 FOR Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Election of Directors: James E. Davis DIRECTOR ELECTIONS ISSUER 11479.000000 0 FOR 11479.000000 FOR Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Election of Directors: Luis A. Diaz, Jr., M.D. DIRECTOR ELECTIONS ISSUER 11479.000000 0 FOR 11479.000000 FOR Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Election of Directors: Tracey C. Doi DIRECTOR ELECTIONS ISSUER 11479.000000 0 FOR 11479.000000 FOR Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Election of Directors: Vicky B. Gregg DIRECTOR ELECTIONS ISSUER 11479.000000 0 FOR 11479.000000 FOR Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Election of Directors: Wright L. Lassiter, III DIRECTOR ELECTIONS ISSUER 11479.000000 0 FOR 11479.000000 FOR Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Election of Directors: Timothy L. Main DIRECTOR ELECTIONS ISSUER 11479.000000 0 FOR 11479.000000 FOR Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Election of Directors: Denise M. Morrison DIRECTOR ELECTIONS ISSUER 11479.000000 0 FOR 11479.000000 FOR Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Election of Directors: Gary M. Pfeiffer DIRECTOR ELECTIONS ISSUER 11479.000000 0 FOR 11479.000000 FOR Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Election of Directors: Timothy M. Ring DIRECTOR ELECTIONS ISSUER 11479.000000 0 FOR 11479.000000 FOR Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 An advisory resolution to approve the executive officer compensation disclosed in the Company's 2024 proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 11479.000000 0 FOR 11479.000000 FOR Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Ratification of the appointment of our independent registered public accounting firm for 2024 AUDIT-RELATED ISSUER 11479.000000 0 FOR 11479.000000 FOR Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Approval of an amendment to Company's Restated Certificate of Incorporation to provide for the exculpation of officers of the Company as permitted by law CORPORATE GOVERNANCE ISSUER 11479.000000 0 FOR 11479.000000 FOR Quest Diagnostics Incorporated 74834L100 US74834L1008 05/16/2024 Adopt Near and Long-Term Science-Based GHG Emissions Reduction Targets Aligned with Paris Agreement Goal ENVIRONMENT OR CLIMATE SECURITY HOLDER 11479.000000 0 AGAINST 11479.000000 FOR Repligen Corporation 759916109 US7599161095 05/16/2024 Election of Directors: Tony J. Hunt DIRECTOR ELECTIONS ISSUER 8125.000000 0 FOR 8125.000000 FOR Repligen Corporation 759916109 US7599161095 05/16/2024 Election of Directors: Karen A. Dawes DIRECTOR ELECTIONS ISSUER 8125.000000 0 FOR 8125.000000 FOR Repligen Corporation 759916109 US7599161095 05/16/2024 Election of Directors: Nicolas M. Barthelemy DIRECTOR ELECTIONS ISSUER 8125.000000 0 FOR 8125.000000 FOR Repligen Corporation 759916109 US7599161095 05/16/2024 Election of Directors: Carrie Eglinton Manner DIRECTOR ELECTIONS ISSUER 8125.000000 0 FOR 8125.000000 FOR Repligen Corporation 759916109 US7599161095 05/16/2024 Election of Directors: Konstantin Konstantinov, Ph.D. DIRECTOR ELECTIONS ISSUER 8125.000000 0 FOR 8125.000000 FOR Repligen Corporation 759916109 US7599161095 05/16/2024 Election of Directors: Martin D. Madaus, D.V.M., Ph.D. DIRECTOR ELECTIONS ISSUER 8125.000000 0 FOR 8125.000000 FOR Repligen Corporation 759916109 US7599161095 05/16/2024 Election of Directors: Rohin Mhatre, Ph.D. DIRECTOR ELECTIONS ISSUER 8125.000000 0 FOR 8125.000000 FOR Repligen Corporation 759916109 US7599161095 05/16/2024 Election of Directors: Glenn P. Muir DIRECTOR ELECTIONS ISSUER 8125.000000 0 FOR 8125.000000 FOR Repligen Corporation 759916109 US7599161095 05/16/2024 Election of Directors: Margaret A. Pax DIRECTOR ELECTIONS ISSUER 8125.000000 0 FOR 8125.000000 FOR Repligen Corporation 759916109 US7599161095 05/16/2024 Ratification of the selection of Ernst & Young LLP as Repligen Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 8125.000000 0 FOR 8125.000000 FOR Repligen Corporation 759916109 US7599161095 05/16/2024 Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 8125.000000 0 FOR 8125.000000 FOR 4D Molecular Therapeutics, Inc. 35104E100 US35104E1001 05/21/2024 Election of one Class I director to hold office until the 2027 Annual Meeting of Stockholders or until their successor is elected: David Kirn, M.D. DIRECTOR ELECTIONS ISSUER 17173.000000 0 FOR 17173.000000 FOR 4D Molecular Therapeutics, Inc. 35104E100 US35104E1001 05/21/2024 Ratification of the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 17173.000000 0 FOR 17173.000000 FOR BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 Election of Directors: Elizabeth M. Anderson DIRECTOR ELECTIONS ISSUER 45161.000000 0 FOR 45161.000000 FOR BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 Election of Directors: Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 45161.000000 0 FOR 45161.000000 FOR BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 Election of Directors: Athena Countouriotis DIRECTOR ELECTIONS ISSUER 45161.000000 0 FOR 45161.000000 FOR BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 Election of Directors: Willard Dere DIRECTOR ELECTIONS ISSUER 45161.000000 0 FOR 45161.000000 FOR BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 Election of Directors: Mark J. Enyedy DIRECTOR ELECTIONS ISSUER 45161.000000 0 FOR 45161.000000 FOR BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 Election of Directors: Alexander Hardy DIRECTOR ELECTIONS ISSUER 45161.000000 0 FOR 45161.000000 FOR BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 Election of Directors: Elaine J. Heron DIRECTOR ELECTIONS ISSUER 45161.000000 0 FOR 45161.000000 FOR BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 Election of Directors: Maykin Ho DIRECTOR ELECTIONS ISSUER 45161.000000 0 FOR 45161.000000 FOR BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 Election of Directors: Robert J. Hombach DIRECTOR ELECTIONS ISSUER 45161.000000 0 FOR 45161.000000 FOR BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 Election of Directors: Richard A. Meier DIRECTOR ELECTIONS ISSUER 45161.000000 0 FOR 45161.000000 FOR BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 Election of Directors: David E.I. Pyott DIRECTOR ELECTIONS ISSUER 45161.000000 0 FOR 45161.000000 FOR BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 To ratify the selection of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 45161.000000 0 FOR 45161.000000 FOR BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/21/2024 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 45161.000000 0 FOR 45161.000000 FOR Envista Holdings Corporation 29415F104 US29415F1049 05/21/2024 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2025 annual meeting: Wendy Carruthers DIRECTOR ELECTIONS ISSUER 22246.000000 0 FOR 22246.000000 FOR Envista Holdings Corporation 29415F104 US29415F1049 05/21/2024 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2025 annual meeting: Kieran Gallahue DIRECTOR ELECTIONS ISSUER 22246.000000 0 FOR 22246.000000 FOR Envista Holdings Corporation 29415F104 US29415F1049 05/21/2024 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2025 annual meeting: Scott Huennekens DIRECTOR ELECTIONS ISSUER 22246.000000 0 FOR 22246.000000 FOR Envista Holdings Corporation 29415F104 US29415F1049 05/21/2024 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2025 annual meeting: Barbara Hulit DIRECTOR ELECTIONS ISSUER 22246.000000 0 FOR 22246.000000 FOR Envista Holdings Corporation 29415F104 US29415F1049 05/21/2024 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2025 annual meeting: Vivek Jain DIRECTOR ELECTIONS ISSUER 22246.000000 0 FOR 22246.000000 FOR Envista Holdings Corporation 29415F104 US29415F1049 05/21/2024 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2025 annual meeting: Daniel Raskas DIRECTOR ELECTIONS ISSUER 22246.000000 0 FOR 22246.000000 FOR Envista Holdings Corporation 29415F104 US29415F1049 05/21/2024 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2025 annual meeting: Christine Tsingos DIRECTOR ELECTIONS ISSUER 22246.000000 0 FOR 22246.000000 FOR Envista Holdings Corporation 29415F104 US29415F1049 05/21/2024 To ratify the selection of Ernst and Young LLP as Envista's independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 22246.000000 0 FOR 22246.000000 FOR Envista Holdings Corporation 29415F104 US29415F1049 05/21/2024 To approve on an advisory basis Envista's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 22246.000000 0 FOR 22246.000000 FOR Envista Holdings Corporation 29415F104 US29415F1049 05/21/2024 To approve a proposal to amend our Second Amended and Restated Certificate of Incorporation to include an officer exculpation provision. CORPORATE GOVERNANCE ISSUER 22246.000000 0 FOR 22246.000000 FOR Envista Holdings Corporation 29415F104 US29415F1049 05/21/2024 To elect Paul Keel as a director, for a one-year term expiring at the 2025 annual meeting: Paul Keel DIRECTOR ELECTIONS ISSUER 22246.000000 0 FOR 22246.000000 FOR GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Election of Directors: Peter J. Arduini DIRECTOR ELECTIONS ISSUER 42353.000000 0 FOR 42353.000000 FOR GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Election of Directors: H. Lawrence Culp, Jr. DIRECTOR ELECTIONS ISSUER 42353.000000 0 FOR 42353.000000 FOR GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Election of Directors: Rodney F. Hochman DIRECTOR ELECTIONS ISSUER 42353.000000 0 FOR 42353.000000 FOR GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Election of Directors: Lloyd W. Howell, Jr. DIRECTOR ELECTIONS ISSUER 42353.000000 0 FOR 42353.000000 FOR GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Election of Directors: Risa Lavizzo-Mourey DIRECTOR ELECTIONS ISSUER 42353.000000 0 FOR 42353.000000 FOR GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Election of Directors: Catherine Lesjak DIRECTOR ELECTIONS ISSUER 42353.000000 0 FOR 42353.000000 FOR GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Election of Directors: Anne T. Madden DIRECTOR ELECTIONS ISSUER 42353.000000 0 FOR 42353.000000 FOR GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Election of Directors: Tomislav Mihaljevic DIRECTOR ELECTIONS ISSUER 42353.000000 0 FOR 42353.000000 FOR GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Election of Directors: William J. Stromberg DIRECTOR ELECTIONS ISSUER 42353.000000 0 FOR 42353.000000 FOR GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Election of Directors: Phoebe L. Yang DIRECTOR ELECTIONS ISSUER 42353.000000 0 FOR 42353.000000 FOR GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Approval of our named executive officers' compensation in an advisory vote. SECTION 14A SAY-ON-PAY VOTES ISSUER 42353.000000 0 FOR 42353.000000 FOR GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/21/2024 Ratification of the appointment of Deloitte & Touche LLP as our independent auditor for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 42353.000000 0 FOR 42353.000000 FOR Viking Therapeutics, Inc. 92686J106 US92686J1060 05/21/2024 ELECTION OF DIRECTORS FOR CLASS III (term to expire in 2027): Brian Lian, Ph.D. DIRECTOR ELECTIONS ISSUER 25612.000000 0 FOR 25612.000000 FOR Viking Therapeutics, Inc. 92686J106 US92686J1060 05/21/2024 ELECTION OF DIRECTORS FOR CLASS III (term to expire in 2027): Lawson Macartney, DVM, Ph.D. DIRECTOR ELECTIONS ISSUER 25612.000000 0 WITHHOLD 25612.000000 AGAINST Viking Therapeutics, Inc. 92686J106 US92686J1060 05/21/2024 RATIFICATION OF THE SELECTION OF MARCUM LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2024. AUDIT-RELATED ISSUER 25612.000000 0 FOR 25612.000000 FOR Viking Therapeutics, Inc. 92686J106 US92686J1060 05/21/2024 TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 25612.000000 0 FOR 25612.000000 FOR Viking Therapeutics, Inc. 92686J106 US92686J1060 05/21/2024 TO APPROVE OUR 2024 EQUITY INCENTIVE PLAN. COMPENSATION ISSUER 25612.000000 0 FOR 25612.000000 FOR Viking Therapeutics, Inc. 92686J106 US92686J1060 05/21/2024 TO APPROVE OUR 2024 EMPLOYEE STOCK PURCHASE PLAN. COMPENSATION ISSUER 25612.000000 0 FOR 25612.000000 FOR Align Technology, Inc. 016255101 US0162551016 05/22/2024 Election of Directors: Kevin T. Conroy DIRECTOR ELECTIONS ISSUER 11220.000000 0 FOR 11220.000000 FOR Align Technology, Inc. 016255101 US0162551016 05/22/2024 Election of Directors: Kevin J. Dallas DIRECTOR ELECTIONS ISSUER 11220.000000 0 FOR 11220.000000 FOR Align Technology, Inc. 016255101 US0162551016 05/22/2024 Election of Directors: Joseph M. Hogan DIRECTOR ELECTIONS ISSUER 11220.000000 0 FOR 11220.000000 FOR Align Technology, Inc. 016255101 US0162551016 05/22/2024 Election of Directors: Joseph Lacob DIRECTOR ELECTIONS ISSUER 11220.000000 0 AGAINST 11220.000000 AGAINST Align Technology, Inc. 016255101 US0162551016 05/22/2024 Election of Directors: C. Raymond Larkin, Jr DIRECTOR ELECTIONS ISSUER 11220.000000 0 FOR 11220.000000 FOR Align Technology, Inc. 016255101 US0162551016 05/22/2024 Election of Directors: George J. Morrow DIRECTOR ELECTIONS ISSUER 11220.000000 0 FOR 11220.000000 FOR Align Technology, Inc. 016255101 US0162551016 05/22/2024 Election of Directors: Anne M. Myong DIRECTOR ELECTIONS ISSUER 11220.000000 0 FOR 11220.000000 FOR Align Technology, Inc. 016255101 US0162551016 05/22/2024 Election of Directors: Mojdeh Poul DIRECTOR ELECTIONS ISSUER 11220.000000 0 FOR 11220.000000 FOR Align Technology, Inc. 016255101 US0162551016 05/22/2024 Election of Directors: Andrea L. Saia DIRECTOR ELECTIONS ISSUER 11220.000000 0 FOR 11220.000000 FOR Align Technology, Inc. 016255101 US0162551016 05/22/2024 Election of Directors: Susan E. Siegel DIRECTOR ELECTIONS ISSUER 11220.000000 0 FOR 11220.000000 FOR Align Technology, Inc. 016255101 US0162551016 05/22/2024 RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS: Proposal to ratify the appointment of PricewaterhouseCoopers LLP as Align Technology, Inc.'s independent registered public accountants for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 11220.000000 0 FOR 11220.000000 FOR Align Technology, Inc. 016255101 US0162551016 05/22/2024 ADVISORY VOTE ON NAMED EXECUTIVES' COMPENSATION Consider an Advisory Vote to Approve the Compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 11220.000000 0 FOR 11220.000000 FOR Align Technology, Inc. 016255101 US0162551016 05/22/2024 Adopt Simple Majority Vote SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 11220.000000 0 FOR 11220.000000 AGAINST DexCom, Inc. 252131107 US2521311074 05/22/2024 To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Kevin R. Sayer DIRECTOR ELECTIONS ISSUER 46293.000000 0 FOR 46293.000000 FOR DexCom, Inc. 252131107 US2521311074 05/22/2024 To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Steven R. Altman DIRECTOR ELECTIONS ISSUER 46293.000000 0 FOR 46293.000000 FOR DexCom, Inc. 252131107 US2521311074 05/22/2024 To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Nicholas Augustinos DIRECTOR ELECTIONS ISSUER 46293.000000 0 FOR 46293.000000 FOR DexCom, Inc. 252131107 US2521311074 05/22/2024 To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Richard A. Collins DIRECTOR ELECTIONS ISSUER 46293.000000 0 FOR 46293.000000 FOR DexCom, Inc. 252131107 US2521311074 05/22/2024 To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Karen Dahut DIRECTOR ELECTIONS ISSUER 46293.000000 0 FOR 46293.000000 FOR DexCom, Inc. 252131107 US2521311074 05/22/2024 To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Rimma Driscoll DIRECTOR ELECTIONS ISSUER 46293.000000 0 FOR 46293.000000 FOR DexCom, Inc. 252131107 US2521311074 05/22/2024 To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Mark G. Foletta DIRECTOR ELECTIONS ISSUER 46293.000000 0 FOR 46293.000000 FOR DexCom, Inc. 252131107 US2521311074 05/22/2024 To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Bridgette P. Heller DIRECTOR ELECTIONS ISSUER 46293.000000 0 FOR 46293.000000 FOR DexCom, Inc. 252131107 US2521311074 05/22/2024 To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Kyle Malady DIRECTOR ELECTIONS ISSUER 46293.000000 0 FOR 46293.000000 FOR DexCom, Inc. 252131107 US2521311074 05/22/2024 To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Eric J. Topol, M.D. DIRECTOR ELECTIONS ISSUER 46293.000000 0 FOR 46293.000000 FOR DexCom, Inc. 252131107 US2521311074 05/22/2024 To ratify the selection by the Audit Committee of our Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 46293.000000 0 FOR 46293.000000 FOR DexCom, Inc. 252131107 US2521311074 05/22/2024 To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2023. SECTION 14A SAY-ON-PAY VOTES ISSUER 46293.000000 0 FOR 46293.000000 FOR DexCom, Inc. 252131107 US2521311074 05/22/2024 Report on Median Gender/Racial Pay Gap DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 46293.000000 0 AGAINST 46293.000000 FOR DexCom, Inc. 252131107 US2521311074 05/22/2024 Report on Political Contributions OTHER SOCIAL ISSUES SECURITY HOLDER 46293.000000 0 AGAINST 46293.000000 FOR Dyne Therapeutics, Inc. 26818M108 US26818M1080 05/22/2024 The election of three Class I directors, each to serve for a three-year term expiring at the 2027 annual meeting of stockholders and until his or her respective successor has been duly elected and qualified: Carlo Incerti, M.D. DIRECTOR ELECTIONS ISSUER 11606.000000 0 FOR 11606.000000 FOR Dyne Therapeutics, Inc. 26818M108 US26818M1080 05/22/2024 The election of three Class I directors, each to serve for a three-year term expiring at the 2027 annual meeting of stockholders and until his or her respective successor has been duly elected and qualified: Catherine Stehman-Breen, M.D. DIRECTOR ELECTIONS ISSUER 11606.000000 0 FOR 11606.000000 FOR Dyne Therapeutics, Inc. 26818M108 US26818M1080 05/22/2024 The election of three Class I directors, each to serve for a three-year term expiring at the 2027 annual meeting of stockholders and until his or her respective successor has been duly elected and qualified: John G. Cox DIRECTOR ELECTIONS ISSUER 11606.000000 0 FOR 11606.000000 FOR Dyne Therapeutics, Inc. 26818M108 US26818M1080 05/22/2024 The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 11606.000000 0 FOR 11606.000000 FOR Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/22/2024 Election of Directors: William H. Rastetter, Ph.D. DIRECTOR ELECTIONS ISSUER 9808.000000 0 FOR 9808.000000 FOR Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/22/2024 Election of Directors: George J. Morrow DIRECTOR ELECTIONS ISSUER 9808.000000 0 FOR 9808.000000 FOR Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/22/2024 Election of Directors: Leslie V. Norwalk DIRECTOR ELECTIONS ISSUER 9808.000000 0 FOR 9808.000000 FOR Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/22/2024 Election of Directors: Christine A. Poon DIRECTOR ELECTIONS ISSUER 9808.000000 0 FOR 9808.000000 FOR Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/22/2024 Advisory vote on the compensation paid to the Company's named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 9808.000000 0 FOR 9808.000000 FOR Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/22/2024 To approve an amendment of the Company's 2020 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 3,635,000 shares; and COMPENSATION ISSUER 9808.000000 0 FOR 9808.000000 FOR Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/22/2024 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 9808.000000 0 FOR 9808.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Election of Directors: Marc N. Casper DIRECTOR ELECTIONS ISSUER 24009.000000 0 FOR 24009.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Election of Directors: Nelson J. Chai DIRECTOR ELECTIONS ISSUER 24009.000000 0 FOR 24009.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Election of Directors: Ruby R. Chandy DIRECTOR ELECTIONS ISSUER 24009.000000 0 FOR 24009.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Election of Directors: C. Martin Harris DIRECTOR ELECTIONS ISSUER 24009.000000 0 FOR 24009.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Election of Directors: Tyler Jacks DIRECTOR ELECTIONS ISSUER 24009.000000 0 FOR 24009.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Election of Directors: Jennifer M. Johnson DIRECTOR ELECTIONS ISSUER 24009.000000 0 FOR 24009.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Election of Directors: R. Alexandra Keith DIRECTOR ELECTIONS ISSUER 24009.000000 0 FOR 24009.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Election of Directors: James C. Mullen DIRECTOR ELECTIONS ISSUER 24009.000000 0 FOR 24009.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Election of Directors: Debora L. Spar DIRECTOR ELECTIONS ISSUER 24009.000000 0 FOR 24009.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Election of Directors: Scott M. Sperling DIRECTOR ELECTIONS ISSUER 24009.000000 0 FOR 24009.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Election of Directors: Dion J. Weisler DIRECTOR ELECTIONS ISSUER 24009.000000 0 FOR 24009.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 24009.000000 0 FOR 24009.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2024. AUDIT-RELATED ISSUER 24009.000000 0 FOR 24009.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/22/2024 Adopt Simple Majority Vote Requirement SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 24009.000000 0 AGAINST 24009.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Paul M. Bisaro DIRECTOR ELECTIONS ISSUER 20979.000000 0 FOR 20979.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Vanessa Broadhurst DIRECTOR ELECTIONS ISSUER 20979.000000 0 FOR 20979.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Frank A. D'Amelio DIRECTOR ELECTIONS ISSUER 20979.000000 0 FOR 20979.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Gavin D.K. Hattersley DIRECTOR ELECTIONS ISSUER 20979.000000 0 FOR 20979.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Sanjay Khosla DIRECTOR ELECTIONS ISSUER 20979.000000 0 FOR 20979.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Antoinette R. Leatherberry DIRECTOR ELECTIONS ISSUER 20979.000000 0 FOR 20979.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Michael B. McCallister DIRECTOR ELECTIONS ISSUER 20979.000000 0 FOR 20979.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Gregory Norden DIRECTOR ELECTIONS ISSUER 20979.000000 0 FOR 20979.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Louise M. Parent DIRECTOR ELECTIONS ISSUER 20979.000000 0 FOR 20979.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Kristin C. Peck DIRECTOR ELECTIONS ISSUER 20979.000000 0 FOR 20979.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Willie M. Reed DIRECTOR ELECTIONS ISSUER 20979.000000 0 FOR 20979.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Election of Directors: Robert W. Scully DIRECTOR ELECTIONS ISSUER 20979.000000 0 FOR 20979.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 20979.000000 0 FOR 20979.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 20979.000000 0 FOR 20979.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Approval of an amendment to our Restated Certificate of Incorporation to provide for exculpation of officers as permitted by the Delaware General Corporation Law. CORPORATE GOVERNANCE ISSUER 20979.000000 0 FOR 20979.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/22/2024 Adopt Policy on Improved Majority Voting for Election of Directors CORPORATE GOVERNANCE SECURITY HOLDER 20979.000000 0 AGAINST 20979.000000 FOR Immunocore Holdings Plc 45258D105 US45258D1054 05/23/2024 To re-appoint as a director Bahija Jallal, Ph.D., who retires in accordance with the articles of association. DIRECTOR ELECTIONS ISSUER 12497.000000 0 FOR 12497.000000 FOR Immunocore Holdings Plc 45258D105 US45258D1054 05/23/2024 To re-appoint as a director Professor Sir John Bell, who retires in accordance with the articles of association. DIRECTOR ELECTIONS ISSUER 12497.000000 0 FOR 12497.000000 FOR Immunocore Holdings Plc 45258D105 US45258D1054 05/23/2024 To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 12497.000000 0 FOR 12497.000000 FOR Immunocore Holdings Plc 45258D105 US45258D1054 05/23/2024 To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 12497.000000 0 ONE YEAR 12497.000000 FOR Immunocore Holdings Plc 45258D105 US45258D1054 05/23/2024 To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.S. independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 12497.000000 0 FOR 12497.000000 FOR Immunocore Holdings Plc 45258D105 US45258D1054 05/23/2024 To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders. AUDIT-RELATED ISSUER 12497.000000 0 FOR 12497.000000 FOR Immunocore Holdings Plc 45258D105 US45258D1054 05/23/2024 To authorize the directors to determine the U.K. statutory auditors' remuneration for the year ending December 31, 2024. AUDIT-RELATED ISSUER 12497.000000 0 FOR 12497.000000 FOR Immunocore Holdings Plc 45258D105 US45258D1054 05/23/2024 To receive and adopt the U.K. statutory annual accounts and reports for the year ended December 31, 2023 (the "2023 U.K. Annual Report"). CORPORATE GOVERNANCE ISSUER 12497.000000 0 FOR 12497.000000 FOR Immunocore Holdings Plc 45258D105 US45258D1054 05/23/2024 To approve the directors' remuneration report for the year ended December 31, 2023, which is set forth as Annex A to the proxy statement and on pages 20 to 47 (inclusive) of the 2023 U.K. Annual Report. COMPENSATION ISSUER 12497.000000 0 FOR 12497.000000 FOR Immunocore Holdings Plc 45258D105 US45258D1054 05/23/2024 To authorise the Company to make political donations/ incur political expenditure. OTHER SOCIAL ISSUES ISSUER 12497.000000 0 FOR 12497.000000 FOR Immunocore Holdings Plc 45258D105 US45258D1054 05/23/2024 That, with effect from the conclusion of the AGM, the draft articles of association produced to the AGM and, for the purpose of identification, initialed by the Chairman, be adopted as the articles of association of the Company in substitution for, and to the exclusion of, the Company's existing articles of association. CORPORATE GOVERNANCE ISSUER 12497.000000 0 FOR 12497.000000 FOR Longboard Pharmaceuticals, Inc. 54300N103 US54300N1037 05/23/2024 To elect the two Class III directors named herein to hold office until the Company's 2027 annual meeting of stockholders: Paul J. Sekhri DIRECTOR ELECTIONS ISSUER 2931.000000 0 WITHHOLD 2931.000000 AGAINST Longboard Pharmaceuticals, Inc. 54300N103 US54300N1037 05/23/2024 To elect the two Class III directors named herein to hold office until the Company's 2027 annual meeting of stockholders: Phillip M. Schneider DIRECTOR ELECTIONS ISSUER 2931.000000 0 FOR 2931.000000 FOR Longboard Pharmaceuticals, Inc. 54300N103 US54300N1037 05/23/2024 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to limit the liability of officers of the Company to the maximum extent permitted by law as permitted pursuant to Section 102(b)(7) of the Delaware General Corporation Law. CORPORATE GOVERNANCE ISSUER 2931.000000 0 FOR 2931.000000 FOR Longboard Pharmaceuticals, Inc. 54300N103 US54300N1037 05/23/2024 To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 2931.000000 0 FOR 2931.000000 FOR Rapid Micro Biosystems, Inc. 75340L104 US75340L1044 05/23/2024 To elect three Class III Directors to serve until the 2027 Annual Meeting of Stockholders: Kirk D. Malloy, Ph.D. DIRECTOR ELECTIONS ISSUER 20561.000000 0 FOR 20561.000000 FOR Rapid Micro Biosystems, Inc. 75340L104 US75340L1044 05/23/2024 To elect three Class III Directors to serve until the 2027 Annual Meeting of Stockholders: Melinda Litherland DIRECTOR ELECTIONS ISSUER 20561.000000 0 FOR 20561.000000 FOR Rapid Micro Biosystems, Inc. 75340L104 US75340L1044 05/23/2024 To elect three Class III Directors to serve until the 2027 Annual Meeting of Stockholders: Robert Spignesi DIRECTOR ELECTIONS ISSUER 20561.000000 0 FOR 20561.000000 FOR Rapid Micro Biosystems, Inc. 75340L104 US75340L1044 05/23/2024 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 20561.000000 0 FOR 20561.000000 FOR Rapid Micro Biosystems, Inc. 75340L104 US75340L1044 05/23/2024 To approve an amendment to our Restated Certificate of Incorporation to reflect new Delaware law provisions allowing for officer exculpation. CORPORATE GOVERNANCE ISSUER 20561.000000 0 FOR 20561.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Douglas M. Baker, Jr. DIRECTOR ELECTIONS ISSUER 160212.000000 0 FOR 160212.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Mary Ellen Coe DIRECTOR ELECTIONS ISSUER 160212.000000 0 FOR 160212.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Pamela J. Craig DIRECTOR ELECTIONS ISSUER 160212.000000 0 FOR 160212.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Robert M. Davis DIRECTOR ELECTIONS ISSUER 160212.000000 0 FOR 160212.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Thomas H. Glocer DIRECTOR ELECTIONS ISSUER 160212.000000 0 FOR 160212.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Risa J. Lavizzo-Mourey, M.D. DIRECTOR ELECTIONS ISSUER 160212.000000 0 FOR 160212.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Stephen L. Mayo, Ph.D. DIRECTOR ELECTIONS ISSUER 160212.000000 0 FOR 160212.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 160212.000000 0 FOR 160212.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Patricia F. Russo DIRECTOR ELECTIONS ISSUER 160212.000000 0 FOR 160212.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Christine E. Seidman, M.D. DIRECTOR ELECTIONS ISSUER 160212.000000 0 FOR 160212.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Inge G. Thulin DIRECTOR ELECTIONS ISSUER 160212.000000 0 FOR 160212.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Election of Directors: Kathy J. Warden DIRECTOR ELECTIONS ISSUER 160212.000000 0 FOR 160212.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 160212.000000 0 FOR 160212.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Ratification of the appointment of the Company's independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 160212.000000 0 FOR 160212.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Provide Right to Act by Written Consent SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 160212.000000 0 AGAINST 160212.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Disclose a Government Censorship Transparency Report OTHER SOCIAL ISSUES SECURITY HOLDER 160212.000000 0 AGAINST 160212.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/28/2024 Report on Civil Rights and Non-Discrimination Audit HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 160212.000000 0 AGAINST 160212.000000 FOR Shockwave Medical, Inc. 82489T104 US82489T1043 05/29/2024 To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated April 4, 2024, by and among Shockwave Medical, Inc., a Delaware corporation ("Shockwave"), Johnson & Johnson, a New Jersey corporation ("Johnson & Johnson"), and Sweep Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Johnson & Johnson ("Merger Sub"), pursuant to which the Merger Sub will merge with and into Shockwave (the "Merger"), with Shockwave surviving the Merger as a wholly owned subsidiary of Johnson & Johnson. EXTRAORDINARY TRANSACTIONS ISSUER 3150.000000 0 FOR 3150.000000 FOR Shockwave Medical, Inc. 82489T104 US82489T1043 05/29/2024 To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to Shockwave's named executive officers that is based on or otherwise relates to the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 3150.000000 0 AGAINST 3150.000000 AGAINST Shockwave Medical, Inc. 82489T104 US82489T1043 05/29/2024 To adjourn the Special Meeting of Stockholders to a later date or dates as provided in the Merger Agreement, if necessary or appropriate, including to solicit additional votes if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting of Stockholders. CORPORATE GOVERNANCE ISSUER 3150.000000 0 FOR 3150.000000 FOR Elanco Animal Health Incorporated 28414H103 US28414H1032 05/30/2024 Election of Directors: William Doyle DIRECTOR ELECTIONS ISSUER 97264.000000 0 FOR 97264.000000 FOR Elanco Animal Health Incorporated 28414H103 US28414H1032 05/30/2024 Election of Directors: Art Garcia DIRECTOR ELECTIONS ISSUER 97264.000000 0 FOR 97264.000000 FOR Elanco Animal Health Incorporated 28414H103 US28414H1032 05/30/2024 Election of Directors: Denise Scots-Knight DIRECTOR ELECTIONS ISSUER 97264.000000 0 FOR 97264.000000 FOR Elanco Animal Health Incorporated 28414H103 US28414H1032 05/30/2024 Election of Directors: Jeffrey Simmons DIRECTOR ELECTIONS ISSUER 97264.000000 0 FOR 97264.000000 FOR Elanco Animal Health Incorporated 28414H103 US28414H1032 05/30/2024 Ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 97264.000000 0 FOR 97264.000000 FOR Elanco Animal Health Incorporated 28414H103 US28414H1032 05/30/2024 Advisory vote on the compensation of company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 97264.000000 0 FOR 97264.000000 FOR Elanco Animal Health Incorporated 28414H103 US28414H1032 05/30/2024 Approval of the amendment of the Articles of Incorporation to declassify the Board of Directors. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 97264.000000 0 FOR 97264.000000 FOR Elanco Animal Health Incorporated 28414H103 US28414H1032 05/30/2024 Approval of the amendment of the Articles of Incorporation to adopt a majority vote standard for uncontested elections of Directors. CORPORATE GOVERNANCE ISSUER 97264.000000 0 FOR 97264.000000 FOR Elanco Animal Health Incorporated 28414H103 US28414H1032 05/30/2024 Approval of the amendment of the Articles of Incorporation to provide shareholders with the right to amend the company's Bylaws. CORPORATE GOVERNANCE ISSUER 97264.000000 0 FOR 97264.000000 FOR Elanco Animal Health Incorporated 28414H103 US28414H1032 05/30/2024 Approval of the amendment of the Articles of Incorporation to provide shareholders with the right to request special meetings of shareholders. CORPORATE GOVERNANCE ISSUER 97264.000000 0 FOR 97264.000000 FOR Glaukos Corporation 377322102 US3773221029 05/30/2024 Election of Directors: Thomas W. Burns DIRECTOR ELECTIONS ISSUER 5240.000000 0 FOR 5240.000000 FOR Glaukos Corporation 377322102 US3773221029 05/30/2024 Election of Directors: Leana S. Wen, M.D. DIRECTOR ELECTIONS ISSUER 5240.000000 0 FOR 5240.000000 FOR Glaukos Corporation 377322102 US3773221029 05/30/2024 Election of Directors: Marc A. Stapley DIRECTOR ELECTIONS ISSUER 5240.000000 0 FOR 5240.000000 FOR Glaukos Corporation 377322102 US3773221029 05/30/2024 Approval of the Glaukos Corporation Amended and Restated 2015 Omnibus Incentive Compensation Plan. COMPENSATION ISSUER 5240.000000 0 FOR 5240.000000 FOR Glaukos Corporation 377322102 US3773221029 05/30/2024 Approval, on an advisory basis, of the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 5240.000000 0 ONE YEAR 5240.000000 FOR Glaukos Corporation 377322102 US3773221029 05/30/2024 Approval, on an advisory basis, of the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 5240.000000 0 FOR 5240.000000 FOR Glaukos Corporation 377322102 US3773221029 05/30/2024 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 5240.000000 0 FOR 5240.000000 FOR Tenaya Therapeutics, Inc. 87990A106 US87990A1060 05/30/2024 To elect three Class III directors to hold office until our 2027 annual meeting of stockholders and until their respective successors are elected and qualified: Faraz Ali, M.B.A. DIRECTOR ELECTIONS ISSUER 58697.000000 0 FOR 58697.000000 FOR Tenaya Therapeutics, Inc. 87990A106 US87990A1060 05/30/2024 To elect three Class III directors to hold office until our 2027 annual meeting of stockholders and until their respective successors are elected and qualified: June Lee, M.D. DIRECTOR ELECTIONS ISSUER 58697.000000 0 FOR 58697.000000 FOR Tenaya Therapeutics, Inc. 87990A106 US87990A1060 05/30/2024 To elect three Class III directors to hold office until our 2027 annual meeting of stockholders and until their respective successors are elected and qualified: Deepak Srivastava, M.D. DIRECTOR ELECTIONS ISSUER 58697.000000 0 FOR 58697.000000 FOR Tenaya Therapeutics, Inc. 87990A106 US87990A1060 05/30/2024 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 58697.000000 0 FOR 58697.000000 FOR Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Wanda M. Austin DIRECTOR ELECTIONS ISSUER 44441.000000 0 FOR 44441.000000 FOR Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Bradway DIRECTOR ELECTIONS ISSUER 44441.000000 0 FOR 44441.000000 FOR Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Michael V. Drake DIRECTOR ELECTIONS ISSUER 44441.000000 0 FOR 44441.000000 FOR Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Brian J. Druker DIRECTOR ELECTIONS ISSUER 44441.000000 0 FOR 44441.000000 FOR Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Eckert DIRECTOR ELECTIONS ISSUER 44441.000000 0 FOR 44441.000000 FOR Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Greg C. Garland DIRECTOR ELECTIONS ISSUER 44441.000000 0 FOR 44441.000000 FOR Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Charles M. Holley, Jr. DIRECTOR ELECTIONS ISSUER 44441.000000 0 FOR 44441.000000 FOR Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. S. Omar Ishrak DIRECTOR ELECTIONS ISSUER 44441.000000 0 FOR 44441.000000 FOR Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Tyler Jacks DIRECTOR ELECTIONS ISSUER 44441.000000 0 FOR 44441.000000 FOR Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Mary E. Klotman DIRECTOR ELECTIONS ISSUER 44441.000000 0 FOR 44441.000000 FOR Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Ellen J. Kullman DIRECTOR ELECTIONS ISSUER 44441.000000 0 FOR 44441.000000 FOR Amgen Inc. 031162100 US0311621009 05/31/2024 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Amy E. Miles DIRECTOR ELECTIONS ISSUER 44441.000000 0 FOR 44441.000000 FOR Amgen Inc. 031162100 US0311621009 05/31/2024 Advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 44441.000000 0 FOR 44441.000000 FOR Amgen Inc. 031162100 US0311621009 05/31/2024 To approve our Amgen Inc. Second Amended and Restated 2009 Equity incentive Plan. COMPENSATION ISSUER 44441.000000 0 FOR 44441.000000 FOR Amgen Inc. 031162100 US0311621009 05/31/2024 To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 44441.000000 0 FOR 44441.000000 FOR Denali Therapeutics Inc. 24823R105 US24823R1059 05/31/2024 ELECTION OF DIRECTORS: Jay Flatley DIRECTOR ELECTIONS ISSUER 30843.000000 0 FOR 30843.000000 FOR Denali Therapeutics Inc. 24823R105 US24823R1059 05/31/2024 ELECTION OF DIRECTORS: Marc Tessier-Lavigne, Ph.D. DIRECTOR ELECTIONS ISSUER 30843.000000 0 WITHHOLD 30843.000000 AGAINST Denali Therapeutics Inc. 24823R105 US24823R1059 05/31/2024 ELECTION OF DIRECTORS: Nancy Thornberry DIRECTOR ELECTIONS ISSUER 30843.000000 0 FOR 30843.000000 FOR Denali Therapeutics Inc. 24823R105 US24823R1059 05/31/2024 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024 AUDIT-RELATED ISSUER 30843.000000 0 FOR 30843.000000 FOR Denali Therapeutics Inc. 24823R105 US24823R1059 05/31/2024 Advisory vote on executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 30843.000000 0 FOR 30843.000000 FOR Cabaletta Bio, Inc. 12674W109 US12674W1099 06/03/2024 To elect two class II directors to our board of directors, to serve until the 2027 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Catherine Bollard, MBChB, M.D. DIRECTOR ELECTIONS ISSUER 29605.000000 0 WITHHOLD 29605.000000 AGAINST Cabaletta Bio, Inc. 12674W109 US12674W1099 06/03/2024 To elect two class II directors to our board of directors, to serve until the 2027 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Richard Henriques, MBA DIRECTOR ELECTIONS ISSUER 29605.000000 0 FOR 29605.000000 FOR Cabaletta Bio, Inc. 12674W109 US12674W1099 06/03/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 29605.000000 0 FOR 29605.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Election of Directors: Charles Baker DIRECTOR ELECTIONS ISSUER 39008.000000 0 FOR 39008.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Election of Directors: Timothy Flynn DIRECTOR ELECTIONS ISSUER 39008.000000 0 FOR 39008.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Election of Directors: Paul Garcia DIRECTOR ELECTIONS ISSUER 39008.000000 0 FOR 39008.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Election of Directors: Kristen Gil DIRECTOR ELECTIONS ISSUER 39008.000000 0 FOR 39008.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Election of Directors: Stephen Hemsley DIRECTOR ELECTIONS ISSUER 39008.000000 0 FOR 39008.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Election of Directors: Michele Hooper DIRECTOR ELECTIONS ISSUER 39008.000000 0 FOR 39008.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Election of Directors: F. William McNabb III DIRECTOR ELECTIONS ISSUER 39008.000000 0 FOR 39008.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Election of Directors: Valerie Montgomery Rice, M.D. DIRECTOR ELECTIONS ISSUER 39008.000000 0 FOR 39008.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Election of Directors: John Noseworthy, M.D. DIRECTOR ELECTIONS ISSUER 39008.000000 0 FOR 39008.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Election of Directors: Andrew Witty DIRECTOR ELECTIONS ISSUER 39008.000000 0 FOR 39008.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 39008.000000 0 FOR 39008.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2024. AUDIT-RELATED ISSUER 39008.000000 0 FOR 39008.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/03/2024 Report on Congruency of Political Spending with Company Values and Priorities OTHER SOCIAL ISSUES SECURITY HOLDER 39008.000000 0 AGAINST 39008.000000 FOR Morphic Holding, Inc. 61775R105 US61775R1059 06/04/2024 Election of three Class II directors to our Board of Directors to serve until the 2027 Annual Meeting of Stockholders: Gustav Christensen, MBA DIRECTOR ELECTIONS ISSUER 7827.000000 0 FOR 7827.000000 FOR Morphic Holding, Inc. 61775R105 US61775R1059 06/04/2024 Election of three Class II directors to our Board of Directors to serve until the 2027 Annual Meeting of Stockholders: Susannah Gray, MBA DIRECTOR ELECTIONS ISSUER 7827.000000 0 FOR 7827.000000 FOR Morphic Holding, Inc. 61775R105 US61775R1059 06/04/2024 Election of three Class II directors to our Board of Directors to serve until the 2027 Annual Meeting of Stockholders: Amir Nashat, Sc.D. DIRECTOR ELECTIONS ISSUER 7827.000000 0 WITHHOLD 7827.000000 AGAINST Morphic Holding, Inc. 61775R105 US61775R1059 06/04/2024 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 7827.000000 0 FOR 7827.000000 FOR Morphic Holding, Inc. 61775R105 US61775R1059 06/04/2024 To approve, on a non-binding advisory basis, the compensation paid to the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 7827.000000 0 FOR 7827.000000 FOR Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Election of Directors: Dawn Svoronos DIRECTOR ELECTIONS ISSUER 32241.000000 0 FOR 32241.000000 FOR Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Election of Directors: Gillian Cannon DIRECTOR ELECTIONS ISSUER 32241.000000 0 FOR 32241.000000 FOR Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Election of Directors: Steven Gannon DIRECTOR ELECTIONS ISSUER 32241.000000 0 FOR 32241.000000 FOR Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Election of Directors: Elizabeth Garofalo DIRECTOR ELECTIONS ISSUER 32241.000000 0 FOR 32241.000000 FOR Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Election of Directors: Justin Gover DIRECTOR ELECTIONS ISSUER 32241.000000 0 FOR 32241.000000 FOR Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Election of Directors: Pat Machado DIRECTOR ELECTIONS ISSUER 32241.000000 0 FOR 32241.000000 FOR Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Election of Directors: Ian Mortimer DIRECTOR ELECTIONS ISSUER 32241.000000 0 FOR 32241.000000 FOR Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Election of Directors: Gary Patou DIRECTOR ELECTIONS ISSUER 32241.000000 0 FOR 32241.000000 FOR Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Compensation of Named Executive Officers Approve, on an advisory basis, the compensation of the Corporation's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 32241.000000 0 FOR 32241.000000 FOR Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Amendment to the Amended and Restated 2014 Plan Approve certain amendments to the Amended and Restated 2014 Equity Incentive Plan, including to increase the maximum number of Common Shares available for issuance thereunder by 5,200,000 COMPENSATION ISSUER 32241.000000 0 FOR 32241.000000 FOR Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Appointment of Auditor Appoint KPMG LLP as the Corporation's auditor to hold office until the next annual meeting of the Corporation or until their successors are duly elected AUDIT-RELATED ISSUER 32241.000000 0 FOR 32241.000000 FOR Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2024 Remuneration of Auditor Authorize the Audit Committee of the board of directors of the Corporation to fix the remuneration to be paid to the auditor of the Corporation AUDIT-RELATED ISSUER 32241.000000 0 FOR 32241.000000 FOR Beam Therapeutics Inc. 07373V105 US07373V1052 06/05/2024 Election of the following nominee as a Class I Director for a three-year term ending at our Annual Meeting of Stockholders to be held in 2027: Graham Cooper DIRECTOR ELECTIONS ISSUER 18919.000000 0 FOR 18919.000000 FOR Beam Therapeutics Inc. 07373V105 US07373V1052 06/05/2024 Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 18919.000000 0 FOR 18919.000000 FOR Beam Therapeutics Inc. 07373V105 US07373V1052 06/05/2024 Approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 18919.000000 0 FOR 18919.000000 FOR BeiGene, Ltd. 07725L102 US07725L1026 06/05/2024 Resolution 1 - Ordinary Resolution THAT Dr. Olivier Brandicourt be and is hereby re-elected to serve as a Class II director of the Company until the 2027 annual general meeting of shareholders and until his successor is duly elected and qualified, subject to his earlier resignation or removal. DIRECTOR ELECTIONS ISSUER 6675.000000 0 FOR 6675.000000 FOR BeiGene, Ltd. 07725L102 US07725L1026 06/05/2024 Resolution 2 - Ordinary Resolution THAT Donald W. Glazer be and is hereby re-elected to serve as a Class II director of the Company until the 2027 annual general meeting of shareholders and until his successor is duly elected and qualified, subject to his earlier resignation or removal. DIRECTOR ELECTIONS ISSUER 6675.000000 0 FOR 6675.000000 FOR BeiGene, Ltd. 07725L102 US07725L1026 06/05/2024 Resolution 3 - Ordinary Resolution THAT Michael Goller be and is hereby re-elected to serve as a Class II director of the Company until the 2027 annual general meeting of shareholders and until his successor is duly elected and qualified, subject to his earlier resignation or removal. DIRECTOR ELECTIONS ISSUER 6675.000000 0 FOR 6675.000000 FOR BeiGene, Ltd. 07725L102 US07725L1026 06/05/2024 Resolution 4 - Ordinary Resolution THAT Dr. Corazon (Corsee) D. Sanders be and is hereby re-elected to serve as a Class II director of the Company until the 2027 annual general meeting of shareholders and until her successor is duly elected and qualified, subject to her earlier resignation or removal. DIRECTOR ELECTIONS ISSUER 6675.000000 0 FOR 6675.000000 FOR BeiGene, Ltd. 07725L102 US07725L1026 06/05/2024 Resolution 5 - Ordinary Resolution THAT the appointment of Ernst & Young LLP, Ernst & Young and Ernst & Young Hua Ming LLP as the Company's independent auditors for the fiscal year ending December 31, 2024 be and is hereby approved, ratified and confirmed. AUDIT-RELATED ISSUER 6675.000000 0 FOR 6675.000000 FOR BeiGene, Ltd. 07725L102 US07725L1026 06/05/2024 Resolution 6 - Ordinary Resolution THAT the Board of Directors is hereby authorized to fix the auditors' compensation for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 6675.000000 0 FOR 6675.000000 FOR BeiGene, Ltd. 07725L102 US07725L1026 06/05/2024 Resolution 7 - Ordinary Resolution THAT the granting of a share issue mandate to the Board of Directors to issue, allot or deal with unissued ordinary shares and/or American Depositary Shares ("ADSs") (including any sale or transfer of treasury shares (which shall have the meaning ascribed to it under the HK Listing Rules coming into effect on June 11, 2024) out of treasury) not exceeding 20% of the total number of issued shares of the Company (excluding treasury shares) as of the date of passing of this ordinary resolution up to the next annual general meeting of shareholders of the Company be and is hereby approved. CAPITAL STRUCTURE ISSUER 6675.000000 0 AGAINST 6675.000000 AGAINST BeiGene, Ltd. 07725L102 US07725L1026 06/05/2024 Resolution 8 - Ordinary Resolution THAT the granting of a share repurchase mandate to the Board of Directors to repurchase an amount of ordinary shares (excluding RMB shares) and/or ADSs, not exceeding 10% of the total number of issued ordinary shares (excluding RMB shares and treasury shares) of the Company as of the date of passing of such ordinary resolution up to the next annual general meeting of shareholders of the Company be and is hereby approved. CAPITAL STRUCTURE ISSUER 6675.000000 0 FOR 6675.000000 FOR BeiGene, Ltd. 07725L102 US07725L1026 06/05/2024 Resolution 9 - Ordinary Resolution THAT the Company and its underwriters be and are hereby authorized, in their sole discretion, to allocate to each of Baker Bros. Advisors LP and Hillhouse Capital Management, Ltd. and parties affiliated with each of them (the "Existing Shareholders"), up to a maximum amount of shares in order to maintain the same shareholding percentage of each of the Existing Shareholders (based on the then-outstanding share capital of the Company) before and after the allocation of the corresponding securities issued pursuant to an offering conducted pursuant to the general mandate set forth in Resolution 7 for a period of five years, which period will be subject to an extension on a rolling basis each year. CAPITAL STRUCTURE ISSUER 6675.000000 0 FOR 6675.000000 FOR BeiGene, Ltd. 07725L102 US07725L1026 06/05/2024 Resolution 10 - Ordinary Resolution THAT the Company and its underwriters be and are hereby authorized, in their sole discretion, to allocate to Amgen Inc. ("Amgen"), up to a maximum amount of shares in order to maintain the same shareholding percentage of Amgen (based on the then-outstanding share capital of the Company) before and after the allocation of the corresponding securities issued pursuant to an offering conducted pursuant to the general mandate set forth in Resolution 7 for a period of five years, which period will be subject to an extension on a rolling basis each year. CAPITAL STRUCTURE ISSUER 6675.000000 0 FOR 6675.000000 FOR BeiGene, Ltd. 07725L102 US07725L1026 06/05/2024 Resolution 11 - Ordinary Resolution THAT the grant of restricted share units ("RSUs") with a grant date fair value of US$6,000,000 to Mr. John V. Oyler under the Second Amended and Restated 2016 Share Option and Incentive Plan (as amended, the "2016 Plan"), according to the terms and conditions described in the Proxy Statement, be and is hereby approved. COMPENSATION ISSUER 6675.000000 0 FOR 6675.000000 FOR BeiGene, Ltd. 07725L102 US07725L1026 06/05/2024 Resolution 12 - Ordinary Resolution THAT the grant of performance share units ("PSUs") with a grant date fair value of US$6,000,000 to Mr. John V. Oyler under the 2016 Plan, according to the terms and conditions described in the Proxy Statement, be and is hereby approved. COMPENSATION ISSUER 6675.000000 0 FOR 6675.000000 FOR BeiGene, Ltd. 07725L102 US07725L1026 06/05/2024 Resolution 13 - Ordinary Resolution THAT the grant of RSUs with a grant date fair value of US$1,333,333 to Dr. Xiaodong Wang under the 2016 Plan, according to the terms and conditions described in the Proxy Statement, be and is hereby approved. COMPENSATION ISSUER 6675.000000 0 FOR 6675.000000 FOR BeiGene, Ltd. 07725L102 US07725L1026 06/05/2024 Resolution 14 - Ordinary Resolution THAT the grant of RSUs with a grant date fair value of US$200,000 to each of the independent non-executive directors, Dr. Olivier Brandicourt, Dr. Margaret Dugan, Mr. Donald W. Glazer, Mr. Michael Goller, Mr. Anthony C. Hooper, Mr. Ranjeev Krishana, Dr. Alessandro Riva, Dr. Corazon (Corsee) D. Sanders, and Mr. Qingqing Yi, under the 2016 Plan, according to the terms and conditions described in the Proxy Statement, be and is hereby approved. COMPENSATION ISSUER 6675.000000 0 FOR 6675.000000 FOR BeiGene, Ltd. 07725L102 US07725L1026 06/05/2024 Resolution 15 - Ordinary Resolution THAT, on a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, be and is hereby approved. SECTION 14A SAY-ON-PAY VOTES ISSUER 6675.000000 0 FOR 6675.000000 FOR BeiGene, Ltd. 07725L102 US07725L1026 06/05/2024 Resolution 16 - Ordinary Resolution THAT, on a non-binding, advisory basis, the frequency of future advisory votes on the compensation of the Company's named executive officers will be held at the frequency hereby approved. SECTION 14A SAY-ON-PAY VOTES ISSUER 6675.000000 0 ONE YEAR 6675.000000 FOR BeiGene, Ltd. 07725L102 US07725L1026 06/05/2024 Resolution 17(a) - Ordinary Resolution THAT the Third Amended and Restated 2016 Share Option and Incentive Plan of the Company, as described in the Proxy Statement, be and is hereby approved. COMPENSATION ISSUER 6675.000000 0 FOR 6675.000000 FOR BeiGene, Ltd. 07725L102 US07725L1026 06/05/2024 Resolution 17(b) - Ordinary Resolution THAT the consultant sublimit set out in the Third Amended and Restated 2016 Share Option and Incentive Plan of the Company, as described in the Proxy Statement, be and is hereby approved. COMPENSATION ISSUER 6675.000000 0 FOR 6675.000000 FOR BeiGene, Ltd. 07725L102 US07725L1026 06/05/2024 Resolution 18 - Ordinary Resolution THAT the Fourth Amended and Restated 2018 Employee Share Purchase Plan of the Company, as described in the Proxy Statement, be and is hereby approved. COMPENSATION ISSUER 6675.000000 0 FOR 6675.000000 FOR BeiGene, Ltd. 07725L102 US07725L1026 06/05/2024 Resolution 19 - Ordinary Resolution THAT the adjournment of the Annual Meeting by the chairman, if necessary, to solicit additional proxies if there are insufficient votes at the time of the Annual Meeting to approve any of the proposals described above, be and is hereby approved. CORPORATE GOVERNANCE ISSUER 6675.000000 0 FOR 6675.000000 FOR MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/05/2024 Election of the two Class II director nominees to serve until the 2027 Annual General Meeting of Shareholders and until their successors are duly elected and qualified: Catherine Moukheibir DIRECTOR ELECTIONS ISSUER 10337.000000 0 FOR 10337.000000 FOR MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/05/2024 Election of the two Class II director nominees to serve until the 2027 Annual General Meeting of Shareholders and until their successors are duly elected and qualified: Dr. Ramnik Xavier DIRECTOR ELECTIONS ISSUER 10337.000000 0 FOR 10337.000000 FOR MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/05/2024 Ratification, by ordinary resolution, of the selection of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 10337.000000 0 FOR 10337.000000 FOR MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/05/2024 Approval of, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 10337.000000 0 FOR 10337.000000 FOR MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/05/2024 Non-binding advisory vote on the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 10337.000000 0 ONE YEAR 10337.000000 FOR NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 Election of Directors: Asaf Danziger DIRECTOR ELECTIONS ISSUER 29303.000000 0 FOR 29303.000000 FOR NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 Election of Directors: William Doyle DIRECTOR ELECTIONS ISSUER 29303.000000 0 FOR 29303.000000 FOR NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 Election of Directors: Jeryl Hilleman DIRECTOR ELECTIONS ISSUER 29303.000000 0 FOR 29303.000000 FOR NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 Election of Directors: David Hung DIRECTOR ELECTIONS ISSUER 29303.000000 0 FOR 29303.000000 FOR NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 Election of Directors: Kinyip Gabriel Leung DIRECTOR ELECTIONS ISSUER 29303.000000 0 FOR 29303.000000 FOR NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 Election of Directors: Martin Madden DIRECTOR ELECTIONS ISSUER 29303.000000 0 FOR 29303.000000 FOR NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 Election of Directors: Allyson Ocean DIRECTOR ELECTIONS ISSUER 29303.000000 0 FOR 29303.000000 FOR NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 Election of Directors: Timothy Scannell DIRECTOR ELECTIONS ISSUER 29303.000000 0 FOR 29303.000000 FOR NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 Election of Directors: Kristin Stafford DIRECTOR ELECTIONS ISSUER 29303.000000 0 FOR 29303.000000 FOR NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 Election of Directors: William Vernon DIRECTOR ELECTIONS ISSUER 29303.000000 0 FOR 29303.000000 FOR NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 The approval and ratification of the appointment, by the Audit Committee of our Board of Directors, of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the auditor and independent registered public accounting firm of the Company for the Company's fiscal year ending December 31, 2024 AUDIT-RELATED ISSUER 29303.000000 0 FOR 29303.000000 FOR NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 A non-binding advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 29303.000000 0 FOR 29303.000000 FOR NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 The approval of our 2024 Omnibus Incentive Plan COMPENSATION ISSUER 29303.000000 0 FOR 29303.000000 FOR NovoCure Limited G6674U108 JE00BYSS4X48 06/05/2024 A non-binding advisory vote to approve the frequency of the advisory vote on execute compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 29303.000000 0 ONE YEAR 29303.000000 FOR Penumbra, Inc. 70975L107 US70975L1070 06/05/2024 To elect the nominees for Class III director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Adam Elsesser DIRECTOR ELECTIONS ISSUER 12105.000000 0 FOR 12105.000000 FOR Penumbra, Inc. 70975L107 US70975L1070 06/05/2024 To elect the nominees for Class III director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Harpreet Grewal DIRECTOR ELECTIONS ISSUER 12105.000000 0 FOR 12105.000000 FOR Penumbra, Inc. 70975L107 US70975L1070 06/05/2024 To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Penumbra, Inc. for the fiscal year ending December 31, 2024; and AUDIT-RELATED ISSUER 12105.000000 0 FOR 12105.000000 FOR Penumbra, Inc. 70975L107 US70975L1070 06/05/2024 To approve, on an advisory basis, the compensation of Penumbra, Inc.'s named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 12105.000000 0 FOR 12105.000000 FOR Sagimet Biosciences, Inc. 786700104 US7867001049 06/05/2024 The election of Class I directors for a three year term expiring in 2027: Paul Hoelscher DIRECTOR ELECTIONS ISSUER 21965.000000 0 FOR 21965.000000 FOR Sagimet Biosciences, Inc. 786700104 US7867001049 06/05/2024 The election of Class I directors for a three year term expiring in 2027: Timothy P. Walbert DIRECTOR ELECTIONS ISSUER 21965.000000 0 FOR 21965.000000 FOR Sagimet Biosciences, Inc. 786700104 US7867001049 06/05/2024 The ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 21965.000000 0 FOR 21965.000000 FOR Stoke Therapeutics, Inc. 86150R107 US86150R1077 06/05/2024 Election of Class II Directors to serve until the 2027 annual meeting of shareholders or until their successor has been duly elected and qualified: Jennifer C. Burstein DIRECTOR ELECTIONS ISSUER 65255.000000 0 FOR 65255.000000 FOR Stoke Therapeutics, Inc. 86150R107 US86150R1077 06/05/2024 Election of Class II Directors to serve until the 2027 annual meeting of shareholders or until their successor has been duly elected and qualified: Arthur A. Levin DIRECTOR ELECTIONS ISSUER 65255.000000 0 FOR 65255.000000 FOR Stoke Therapeutics, Inc. 86150R107 US86150R1077 06/05/2024 Election of Class II Directors to serve until the 2027 annual meeting of shareholders or until their successor has been duly elected and qualified: Ian F. Smith DIRECTOR ELECTIONS ISSUER 65255.000000 0 FOR 65255.000000 FOR Stoke Therapeutics, Inc. 86150R107 US86150R1077 06/05/2024 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 65255.000000 0 FOR 65255.000000 FOR Voyager Therapeutics, Inc. 92915B106 US92915B1061 06/05/2024 To elect each of the following directors to serve as a Class III director until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Michael Higgins DIRECTOR ELECTIONS ISSUER 32205.000000 0 FOR 32205.000000 FOR Voyager Therapeutics, Inc. 92915B106 US92915B1061 06/05/2024 To elect each of the following directors to serve as a Class III director until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Jude Onyia DIRECTOR ELECTIONS ISSUER 32205.000000 0 FOR 32205.000000 FOR Voyager Therapeutics, Inc. 92915B106 US92915B1061 06/05/2024 To elect each of the following directors to serve as a Class III director until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Nancy Vitale DIRECTOR ELECTIONS ISSUER 32205.000000 0 FOR 32205.000000 FOR Voyager Therapeutics, Inc. 92915B106 US92915B1061 06/05/2024 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 32205.000000 0 FOR 32205.000000 FOR Voyager Therapeutics, Inc. 92915B106 US92915B1061 06/05/2024 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 32205.000000 0 FOR 32205.000000 FOR Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/06/2024 Election of Directors: Brett P. Monia DIRECTOR ELECTIONS ISSUER 18725.000000 0 FOR 18725.000000 FOR Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/06/2024 Election of Directors: Michael Yang DIRECTOR ELECTIONS ISSUER 18725.000000 0 FOR 18725.000000 FOR Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/06/2024 To make an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 18725.000000 0 FOR 18725.000000 FOR Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/06/2024 To approve an amendment of the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under such plan by 3,300,000 shares to an aggregate of 38,500,000 shares and to prohibit certain share recycling on full value awards. COMPENSATION ISSUER 18725.000000 0 FOR 18725.000000 FOR Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/06/2024 To ratify the Audit Committee's selection of Ernst & Young LLP as independent auditors for the 2024 fiscal year. AUDIT-RELATED ISSUER 18725.000000 0 FOR 18725.000000 FOR Sarepta Therapeutics, Inc. 803607100 US8036071004 06/06/2024 to elect, as Class I directors to hold office until 2026 annual meeting of stockholders, or until their successors are earlier elected, the following director nominees: Douglas S. Ingram DIRECTOR ELECTIONS ISSUER 22338.000000 0 FOR 22338.000000 FOR Sarepta Therapeutics, Inc. 803607100 US8036071004 06/06/2024 to elect, as Class I directors to hold office until 2026 annual meeting of stockholders, or until their successors are earlier elected, the following director nominees: Hans Wigzell, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 22338.000000 0 FOR 22338.000000 FOR Sarepta Therapeutics, Inc. 803607100 US8036071004 06/06/2024 to elect, as Class I directors to hold office until 2026 annual meeting of stockholders, or until their successors are earlier elected, the following director nominees: Kathryn J. Boor, Ph.D. DIRECTOR ELECTIONS ISSUER 22338.000000 0 FOR 22338.000000 FOR Sarepta Therapeutics, Inc. 803607100 US8036071004 06/06/2024 to elect, as Class I directors to hold office until 2026 annual meeting of stockholders, or until their successors are earlier elected, the following director nominees: Michael Chambers DIRECTOR ELECTIONS ISSUER 22338.000000 0 FOR 22338.000000 FOR Sarepta Therapeutics, Inc. 803607100 US8036071004 06/06/2024 advisory vote to approve, on a non-binding basis, name executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 22338.000000 0 FOR 22338.000000 FOR Sarepta Therapeutics, Inc. 803607100 US8036071004 06/06/2024 ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the current year ending December 31, 2024 AUDIT-RELATED ISSUER 22338.000000 0 FOR 22338.000000 FOR Vaxcyte, Inc. 92243G108 US92243G1085 06/06/2024 Election of Class I Directors Nominees would serve until the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Annie Drapeau DIRECTOR ELECTIONS ISSUER 28905.000000 0 FOR 28905.000000 FOR Vaxcyte, Inc. 92243G108 US92243G1085 06/06/2024 Election of Class I Directors Nominees would serve until the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Teri Loxam DIRECTOR ELECTIONS ISSUER 28905.000000 0 FOR 28905.000000 FOR Vaxcyte, Inc. 92243G108 US92243G1085 06/06/2024 Election of Class I Directors Nominees would serve until the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Carlos Paya, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 28905.000000 0 FOR 28905.000000 FOR Vaxcyte, Inc. 92243G108 US92243G1085 06/06/2024 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 28905.000000 0 FOR 28905.000000 FOR Vaxcyte, Inc. 92243G108 US92243G1085 06/06/2024 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 28905.000000 0 FOR 28905.000000 FOR SAGE Therapeutics, Inc. 78667J108 US78667J1088 06/10/2024 To elect two directors, Elizabeth Barrett and Geno Germano, each to serve as a Class I director until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, subject to his or her earlier death, resignation, or removal: Elizabeth Barrett DIRECTOR ELECTIONS ISSUER 13650.000000 0 WITHHOLD 13650.000000 AGAINST SAGE Therapeutics, Inc. 78667J108 US78667J1088 06/10/2024 To elect two directors, Elizabeth Barrett and Geno Germano, each to serve as a Class I director until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, subject to his or her earlier death, resignation, or removal: Geno Germano DIRECTOR ELECTIONS ISSUER 13650.000000 0 FOR 13650.000000 FOR SAGE Therapeutics, Inc. 78667J108 US78667J1088 06/10/2024 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024 AUDIT-RELATED ISSUER 13650.000000 0 FOR 13650.000000 FOR SAGE Therapeutics, Inc. 78667J108 US78667J1088 06/10/2024 To hold a non-binding advisory vote to approve the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 13650.000000 0 FOR 13650.000000 FOR SAGE Therapeutics, Inc. 78667J108 US78667J1088 06/10/2024 To approve the Sage Therapeutics, Inc. 2024 Equity Incentive Plan. COMPENSATION ISSUER 13650.000000 0 FOR 13650.000000 FOR 10X Genomics, Inc. 88025U109 US88025U1097 06/11/2024 Election of Directors: Election of the one Class II director listed in the accompanying proxy statement, to serve a three-year term expiring at the 2027 annual meeting of stockholders or until such director's successor is duly elected and qualified or until such director's earlier death, resignation, disqualification or removal; Kimberly J. Popovits DIRECTOR ELECTIONS ISSUER 15123.000000 0 FOR 15123.000000 FOR 10X Genomics, Inc. 88025U109 US88025U1097 06/11/2024 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024; AUDIT-RELATED ISSUER 15123.000000 0 FOR 15123.000000 FOR 10X Genomics, Inc. 88025U109 US88025U1097 06/11/2024 A vote to approve an amendment to our amended and restated bylaws such that the bylaws may be amended by our board of directors without requiring stockholder approval; CORPORATE GOVERNANCE ISSUER 15123.000000 0 AGAINST 15123.000000 AGAINST 10X Genomics, Inc. 88025U109 US88025U1097 06/11/2024 A vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 15123.000000 0 AGAINST 15123.000000 AGAINST Blueprint Medicines Corporation 09627Y109 US09627Y1091 06/12/2024 Election of Directors: Daniella Beckman DIRECTOR ELECTIONS ISSUER 26672.000000 0 FOR 26672.000000 FOR Blueprint Medicines Corporation 09627Y109 US09627Y1091 06/12/2024 Election of Directors: Habib Dable DIRECTOR ELECTIONS ISSUER 26672.000000 0 FOR 26672.000000 FOR Blueprint Medicines Corporation 09627Y109 US09627Y1091 06/12/2024 Election of Directors: Lynn Seely DIRECTOR ELECTIONS ISSUER 26672.000000 0 FOR 26672.000000 FOR Blueprint Medicines Corporation 09627Y109 US09627Y1091 06/12/2024 Approval of a non-binding advisory vote on the frequency of future advisory votes on the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 26672.000000 0 ONE YEAR 26672.000000 FOR Blueprint Medicines Corporation 09627Y109 US09627Y1091 06/12/2024 Approval of a non-binding advisory vote on the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 26672.000000 0 FOR 26672.000000 FOR Blueprint Medicines Corporation 09627Y109 US09627Y1091 06/12/2024 Approval of the Blueprint Medicines Corporation 2024 Stock Incentive Plan. COMPENSATION ISSUER 26672.000000 0 FOR 26672.000000 FOR Blueprint Medicines Corporation 09627Y109 US09627Y1091 06/12/2024 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 26672.000000 0 FOR 26672.000000 FOR Guardant Health, Inc. 40131M109 US40131M1099 06/12/2024 Election of Class III Directors: Helmy Eltoukhy DIRECTOR ELECTIONS ISSUER 24415.000000 0 FOR 24415.000000 FOR Guardant Health, Inc. 40131M109 US40131M1099 06/12/2024 Election of Class III Directors: Steve Krognes DIRECTOR ELECTIONS ISSUER 24415.000000 0 WITHHOLD 24415.000000 AGAINST Guardant Health, Inc. 40131M109 US40131M1099 06/12/2024 Election of Class III Directors: AmirAli Talasaz DIRECTOR ELECTIONS ISSUER 24415.000000 0 FOR 24415.000000 FOR Guardant Health, Inc. 40131M109 US40131M1099 06/12/2024 Ratification of the appointment of Deloitte & Touche LLP as Guardant Health, Inc.'s independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 24415.000000 0 FOR 24415.000000 FOR Guardant Health, Inc. 40131M109 US40131M1099 06/12/2024 Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 24415.000000 0 FOR 24415.000000 FOR Incyte Corporation 45337C102 US45337C1027 06/12/2024 Election of Directors: Julian C. Baker DIRECTOR ELECTIONS ISSUER 15306.000000 0 FOR 15306.000000 FOR Incyte Corporation 45337C102 US45337C1027 06/12/2024 Election of Directors: Jean-Jacques Bienaime DIRECTOR ELECTIONS ISSUER 15306.000000 0 FOR 15306.000000 FOR Incyte Corporation 45337C102 US45337C1027 06/12/2024 Election of Directors: Otis W. Brawley DIRECTOR ELECTIONS ISSUER 15306.000000 0 FOR 15306.000000 FOR Incyte Corporation 45337C102 US45337C1027 06/12/2024 Election of Directors: Paul J. Clancy DIRECTOR ELECTIONS ISSUER 15306.000000 0 FOR 15306.000000 FOR Incyte Corporation 45337C102 US45337C1027 06/12/2024 Election of Directors: Jacqualyn A. Fouse DIRECTOR ELECTIONS ISSUER 15306.000000 0 FOR 15306.000000 FOR Incyte Corporation 45337C102 US45337C1027 06/12/2024 Election of Directors: Edmund P. Harrigan DIRECTOR ELECTIONS ISSUER 15306.000000 0 FOR 15306.000000 FOR Incyte Corporation 45337C102 US45337C1027 06/12/2024 Election of Directors: Katherine A. High DIRECTOR ELECTIONS ISSUER 15306.000000 0 FOR 15306.000000 FOR Incyte Corporation 45337C102 US45337C1027 06/12/2024 Election of Directors: Herve Hoppenot DIRECTOR ELECTIONS ISSUER 15306.000000 0 FOR 15306.000000 FOR Incyte Corporation 45337C102 US45337C1027 06/12/2024 Election of Directors: Susanne Schaffert DIRECTOR ELECTIONS ISSUER 15306.000000 0 FOR 15306.000000 FOR Incyte Corporation 45337C102 US45337C1027 06/12/2024 Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 15306.000000 0 FOR 15306.000000 FOR Incyte Corporation 45337C102 US45337C1027 06/12/2024 Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 15306.000000 0 FOR 15306.000000 FOR Nuvalent, Inc. 670703107 US6707031075 06/12/2024 Election of the following nominees as Class III directors: Emily Drabant Conley, Ph.D. DIRECTOR ELECTIONS ISSUER 12436.000000 0 FOR 12436.000000 FOR Nuvalent, Inc. 670703107 US6707031075 06/12/2024 Election of the following nominees as Class III directors: Sapna Srivastava, Ph.D. DIRECTOR ELECTIONS ISSUER 12436.000000 0 FOR 12436.000000 FOR Nuvalent, Inc. 670703107 US6707031075 06/12/2024 Election of the following nominees as Class III directors: Cameron Wheeler, Ph.D. DIRECTOR ELECTIONS ISSUER 12436.000000 0 FOR 12436.000000 FOR Nuvalent, Inc. 670703107 US6707031075 06/12/2024 To approve, on an advisory basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 12436.000000 0 FOR 12436.000000 FOR Nuvalent, Inc. 670703107 US6707031075 06/12/2024 To approve, on an advisory basis, the frequency of future advisory votes to approve the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 12436.000000 0 ONE YEAR 12436.000000 FOR Nuvalent, Inc. 670703107 US6707031075 06/12/2024 To ratify the appointment of KPMG LLP as Nuvalent, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 12436.000000 0 FOR 12436.000000 FOR Nyxoah SA B6S7WD106 BE0974358906 06/12/2024 Approve Financial Statements and Allocation of Income CAPITAL STRUCTURE CORPORATE GOVERNANCE ISSUER 29870.000000 0 FOR 29870.000000 FOR Nyxoah SA B6S7WD106 BE0974358906 06/12/2024 Approve Discharge of Directors CORPORATE GOVERNANCE ISSUER 29870.000000 0 FOR 29870.000000 FOR Nyxoah SA B6S7WD106 BE0974358906 06/12/2024 Approve Discharge of Auditors AUDIT-RELATED CORPORATE GOVERNANCE ISSUER 29870.000000 0 FOR 29870.000000 FOR Nyxoah SA B6S7WD106 BE0974358906 06/12/2024 Approve Remuneration Report COMPENSATION ISSUER 29870.000000 0 AGAINST 29870.000000 AGAINST Nyxoah SA B6S7WD106 BE0974358906 06/12/2024 Approve Amended Remuneration Policy COMPENSATION ISSUER 29870.000000 0 AGAINST 29870.000000 AGAINST Nyxoah SA B6S7WD106 BE0974358906 06/12/2024 Elect Robelga SRL, Permanently Represented by Robert Taub, as Director DIRECTOR ELECTIONS ISSUER 29870.000000 0 AGAINST 29870.000000 AGAINST Nyxoah SA B6S7WD106 BE0974358906 06/12/2024 Reelect Jurgen Hambrecht as Independent Director DIRECTOR ELECTIONS ISSUER 29870.000000 0 AGAINST 29870.000000 AGAINST Nyxoah SA B6S7WD106 BE0974358906 06/12/2024 Reelect Kevin Rakin as Independent Director DIRECTOR ELECTIONS ISSUER 29870.000000 0 FOR 29870.000000 FOR Nyxoah SA B6S7WD106 BE0974358906 06/12/2024 Reelect Rita Johnson-Mills as Independent Director DIRECTOR ELECTIONS ISSUER 29870.000000 0 AGAINST 29870.000000 AGAINST Nyxoah SA B6S7WD106 BE0974358906 06/12/2024 Reelect Virginia Kirby as Independent Director DIRECTOR ELECTIONS ISSUER 29870.000000 0 FOR 29870.000000 FOR Nyxoah SA B6S7WD106 BE0974358906 06/12/2024 Reelect Wildman Ventures LLC Permanently Represented by Daniel Wildman, as Independent Director DIRECTOR ELECTIONS ISSUER 29870.000000 0 AGAINST 29870.000000 AGAINST Nyxoah SA B6S7WD106 BE0974358906 06/12/2024 Reelect Pierre Gianello as Director DIRECTOR ELECTIONS ISSUER 29870.000000 0 FOR 29870.000000 FOR Nyxoah SA B6S7WD106 BE0974358906 06/12/2024 Reelect Olivier Taelman as Director DIRECTOR ELECTIONS ISSUER 29870.000000 0 FOR 29870.000000 FOR Nyxoah SA B6S7WD106 BE0974358906 06/12/2024 Renew Authorization to Increase Share Capital within the Framework of Authorized Capital and Amend Article 7 Accordingly CAPITAL STRUCTURE ISSUER 29870.000000 0 AGAINST 29870.000000 AGAINST Nyxoah SA B6S7WD106 BE0974358906 06/12/2024 Authorize Filing of Required Documents/Formalities at Trade Registry CORPORATE GOVERNANCE ISSUER 29870.000000 0 AGAINST 29870.000000 AGAINST Prime Medicine, Inc. 74168J101 US74168J1016 06/12/2024 To elect Wendy Chung, M.D., Ph.D., Kaye Foster, Keith Gottesdiener, M.D., and Jeffrey Marrazzo as Class II Directors: Wendy Chung, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 22929.000000 0 WITHHOLD 22929.000000 AGAINST Prime Medicine, Inc. 74168J101 US74168J1016 06/12/2024 To elect Wendy Chung, M.D., Ph.D., Kaye Foster, Keith Gottesdiener, M.D., and Jeffrey Marrazzo as Class II Directors: Kaye Foster DIRECTOR ELECTIONS ISSUER 22929.000000 0 FOR 22929.000000 FOR Prime Medicine, Inc. 74168J101 US74168J1016 06/12/2024 To elect Wendy Chung, M.D., Ph.D., Kaye Foster, Keith Gottesdiener, M.D., and Jeffrey Marrazzo as Class II Directors: Keith Gottesdiener, M.D. DIRECTOR ELECTIONS ISSUER 22929.000000 0 FOR 22929.000000 FOR Prime Medicine, Inc. 74168J101 US74168J1016 06/12/2024 To elect Wendy Chung, M.D., Ph.D., Kaye Foster, Keith Gottesdiener, M.D., and Jeffrey Marrazzo as Class II Directors: Jeffrey Marrazzo DIRECTOR ELECTIONS ISSUER 22929.000000 0 FOR 22929.000000 FOR Prime Medicine, Inc. 74168J101 US74168J1016 06/12/2024 To approve an amendment to our Third Amended and Restated Certificate of Incorporation to limit the liability of certain of our officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 22929.000000 0 FOR 22929.000000 FOR Prime Medicine, Inc. 74168J101 US74168J1016 06/12/2024 To ratify the appointment of PricewaterhouseCoopers LLP as our Independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 22929.000000 0 FOR 22929.000000 FOR Exact Sciences Corporation 30063P105 US30063P1057 06/13/2024 To elect three members of the Board of Directors to serve for one-year terms as Class III Directors: Michael Barber DIRECTOR ELECTIONS ISSUER 19226.000000 0 FOR 19226.000000 FOR Exact Sciences Corporation 30063P105 US30063P1057 06/13/2024 To elect three members of the Board of Directors to serve for one-year terms as Class III Directors: Paul Clancy DIRECTOR ELECTIONS ISSUER 19226.000000 0 FOR 19226.000000 FOR Exact Sciences Corporation 30063P105 US30063P1057 06/13/2024 To elect three members of the Board of Directors to serve for one-year terms as Class III Directors: Daniel Levangie DIRECTOR ELECTIONS ISSUER 19226.000000 0 FOR 19226.000000 FOR Exact Sciences Corporation 30063P105 US30063P1057 06/13/2024 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2024. AUDIT-RELATED ISSUER 19226.000000 0 FOR 19226.000000 FOR Exact Sciences Corporation 30063P105 US30063P1057 06/13/2024 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 19226.000000 0 FOR 19226.000000 FOR Nautilus Biotechnology, Inc. 63909J108 US63909J1088 06/13/2024 Election of Class III Directors: Melissa Epperly DIRECTOR ELECTIONS ISSUER 16560.000000 0 FOR 16560.000000 FOR Nautilus Biotechnology, Inc. 63909J108 US63909J1088 06/13/2024 Election of Class III Directors: Matthew L. Posard DIRECTOR ELECTIONS ISSUER 16560.000000 0 FOR 16560.000000 FOR Nautilus Biotechnology, Inc. 63909J108 US63909J1088 06/13/2024 Election of Class III Directors: Karen Akinsanya DIRECTOR ELECTIONS ISSUER 16560.000000 0 FOR 16560.000000 FOR Nautilus Biotechnology, Inc. 63909J108 US63909J1088 06/13/2024 Ratification of the appointment of PricewaterhouseCoopers, LLP as our independent registered public accounting firm for the year ended December 31, 2024. AUDIT-RELATED ISSUER 16560.000000 0 FOR 16560.000000 FOR Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Election of Directors: Elisabeth Bjork, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 18343.000000 0 FOR 18343.000000 FOR Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Election of Directors: Carsten Boess DIRECTOR ELECTIONS ISSUER 18343.000000 0 FOR 18343.000000 FOR Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Election of Directors: Pedro Granadillo DIRECTOR ELECTIONS ISSUER 18343.000000 0 FOR 18343.000000 FOR Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Election of Directors: Gotham Makker, M.D. DIRECTOR ELECTIONS ISSUER 18343.000000 0 FOR 18343.000000 FOR Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Election of Directors: Fady Malik, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 18343.000000 0 FOR 18343.000000 FOR Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Election of Directors: Gaurav Shah, M.D. DIRECTOR ELECTIONS ISSUER 18343.000000 0 FOR 18343.000000 FOR Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Election of Directors: David P. Southwell DIRECTOR ELECTIONS ISSUER 18343.000000 0 FOR 18343.000000 FOR Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Election of Directors: Roderick Wong, M.D. DIRECTOR ELECTIONS ISSUER 18343.000000 0 FOR 18343.000000 FOR Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Election of Directors: R. Keith Woods DIRECTOR ELECTIONS ISSUER 18343.000000 0 FOR 18343.000000 FOR Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Election of Directors: Naveen Yalamanchi, M.D. DIRECTOR ELECTIONS ISSUER 18343.000000 0 WITHHOLD 18343.000000 AGAINST Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Ratification of the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 18343.000000 0 FOR 18343.000000 FOR Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 18343.000000 0 FOR 18343.000000 FOR Rocket Pharmaceuticals, Inc 77313F106 US77313F1066 06/13/2024 Approval of an amendment to the Company's Seventh Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock. CAPITAL STRUCTURE ISSUER 18343.000000 0 FOR 18343.000000 FOR Neurogene, Inc. 64135M105 US64135M1053 06/14/2024 Election of Class I Directors for terms expiring in 2027: Cory Freedland DIRECTOR ELECTIONS ISSUER 19342.000000 0 FOR 19342.000000 FOR Neurogene, Inc. 64135M105 US64135M1053 06/14/2024 Election of Class I Directors for terms expiring in 2027: Rachel McMinn DIRECTOR ELECTIONS ISSUER 19342.000000 0 FOR 19342.000000 FOR Neurogene, Inc. 64135M105 US64135M1053 06/14/2024 To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 19342.000000 0 FOR 19342.000000 FOR Neurogene, Inc. 64135M105 US64135M1053 06/14/2024 To ratify on an advisory (non-binding) basis of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting rm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 19342.000000 0 FOR 19342.000000 FOR Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/14/2024 Election of Directors: N. Anthony Coles, M.D. DIRECTOR ELECTIONS ISSUER 9307.000000 0 FOR 9307.000000 FOR Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/14/2024 Election of Directors: Kathryn Guarini, Ph.D. DIRECTOR ELECTIONS ISSUER 9307.000000 0 FOR 9307.000000 FOR Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/14/2024 Election of Directors: Arthur F. Ryan DIRECTOR ELECTIONS ISSUER 9307.000000 0 FOR 9307.000000 FOR Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/14/2024 Election of Directors: David P. Schenkein, M.D. DIRECTOR ELECTIONS ISSUER 9307.000000 0 FOR 9307.000000 FOR Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/14/2024 Election of Directors: George L. Sing DIRECTOR ELECTIONS ISSUER 9307.000000 0 FOR 9307.000000 FOR Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/14/2024 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 9307.000000 0 FOR 9307.000000 FOR Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/14/2024 Proposal to approve, on an advisory basis, executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 9307.000000 0 FOR 9307.000000 FOR Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/14/2024 Adopt Simple Majority Vote SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 9307.000000 0 FOR 9307.000000 AGAINST Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/17/2024 Approve Allocation of Income, with a Final Dividend of JPY 30 CAPITAL STRUCTURE ISSUER 34800.000000 0 FOR 34800.000000 FOR Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/17/2024 Elect Director Manabe, Sunao DIRECTOR ELECTIONS ISSUER 34800.000000 0 FOR 34800.000000 FOR Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/17/2024 Elect Director Okuzawa, Hiroyuki DIRECTOR ELECTIONS ISSUER 34800.000000 0 FOR 34800.000000 FOR Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/17/2024 Elect Director Hirashima, Shoji DIRECTOR ELECTIONS ISSUER 34800.000000 0 FOR 34800.000000 FOR Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/17/2024 Elect Director Fukuoka, Takashi DIRECTOR ELECTIONS ISSUER 34800.000000 0 FOR 34800.000000 FOR Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/17/2024 Elect Director Kama, Kazuaki DIRECTOR ELECTIONS ISSUER 34800.000000 0 FOR 34800.000000 FOR Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/17/2024 Elect Director Nohara, Sawako DIRECTOR ELECTIONS ISSUER 34800.000000 0 FOR 34800.000000 FOR Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/17/2024 Elect Director Komatsu, Yasuhiro DIRECTOR ELECTIONS ISSUER 34800.000000 0 FOR 34800.000000 FOR Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/17/2024 Elect Director Nishii, Takaaki DIRECTOR ELECTIONS ISSUER 34800.000000 0 FOR 34800.000000 FOR Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/17/2024 Elect Director Matsumoto, Takashi DIRECTOR ELECTIONS ISSUER 34800.000000 0 FOR 34800.000000 FOR Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/17/2024 Elect Director Homma, Yo DIRECTOR ELECTIONS ISSUER 34800.000000 0 FOR 34800.000000 FOR PTC Therapeutics, Inc. 69366J200 US69366J2006 06/18/2024 Election of Four Class II Directors: Emma Reeve DIRECTOR ELECTIONS ISSUER 19817.000000 0 FOR 19817.000000 FOR PTC Therapeutics, Inc. 69366J200 US69366J2006 06/18/2024 Election of Four Class II Directors: Michael Schmertzler DIRECTOR ELECTIONS ISSUER 19817.000000 0 FOR 19817.000000 FOR PTC Therapeutics, Inc. 69366J200 US69366J2006 06/18/2024 Election of Four Class II Directors: Mary Smith DIRECTOR ELECTIONS ISSUER 19817.000000 0 FOR 19817.000000 FOR PTC Therapeutics, Inc. 69366J200 US69366J2006 06/18/2024 Election of Four Class II Directors: Glenn D. Steele, Jr., M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 19817.000000 0 FOR 19817.000000 FOR PTC Therapeutics, Inc. 69366J200 US69366J2006 06/18/2024 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 19817.000000 0 FOR 19817.000000 FOR PTC Therapeutics, Inc. 69366J200 US69366J2006 06/18/2024 Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 19817.000000 0 FOR 19817.000000 FOR Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 06/18/2024 Nominees: Deborah Dunsire, M.D. DIRECTOR ELECTIONS ISSUER 14268.000000 0 FOR 14268.000000 FOR Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 06/18/2024 Nominees: Michael Narachi DIRECTOR ELECTIONS ISSUER 14268.000000 0 FOR 14268.000000 FOR Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 06/18/2024 Nominees: Corsee D. Sanders, Ph.D. DIRECTOR ELECTIONS ISSUER 14268.000000 0 FOR 14268.000000 FOR Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 06/18/2024 Approval of the Amended and Restated 2023 Incentive Plan. COMPENSATION ISSUER 14268.000000 0 FOR 14268.000000 FOR Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 06/18/2024 Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 14268.000000 0 FOR 14268.000000 FOR Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 06/18/2024 Advisory (non-binding) vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 14268.000000 0 FOR 14268.000000 FOR AC Immune SA H00263105 CH0329023102 06/20/2024 Accept Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 78180.000000 0 FOR 78180.000000 FOR AC Immune SA H00263105 CH0329023102 06/20/2024 Approve Remuneration Report (Non-Binding) COMPENSATION ISSUER 78180.000000 0 AGAINST 78180.000000 AGAINST AC Immune SA H00263105 CH0329023102 06/20/2024 Approve Treatment of Net Loss CAPITAL STRUCTURE ISSUER 78180.000000 0 FOR 78180.000000 FOR AC Immune SA H00263105 CH0329023102 06/20/2024 Approve Discharge of Board and Senior Management CORPORATE GOVERNANCE ISSUER 78180.000000 0 FOR 78180.000000 FOR AC Immune SA H00263105 CH0329023102 06/20/2024 Approve Remuneration of Directors in the Amount of CHF 883,000 COMPENSATION ISSUER 78180.000000 0 FOR 78180.000000 FOR AC Immune SA H00263105 CH0329023102 06/20/2024 Approve Remuneration of Executive Committee in the Amount of CHF 7.6 Million COMPENSATION ISSUER 78180.000000 0 FOR 78180.000000 FOR AC Immune SA H00263105 CH0329023102 06/20/2024 Reelect Douglas Williams as Director and Board Chair DIRECTOR ELECTIONS ISSUER 78180.000000 0 FOR 78180.000000 FOR AC Immune SA H00263105 CH0329023102 06/20/2024 Reelect Monika Buetler as Director DIRECTOR ELECTIONS ISSUER 78180.000000 0 FOR 78180.000000 FOR AC Immune SA H00263105 CH0329023102 06/20/2024 Reelect Carl June as Director DIRECTOR ELECTIONS ISSUER 78180.000000 0 FOR 78180.000000 FOR AC Immune SA H00263105 CH0329023102 06/20/2024 Reelect Werner Lanthaler as Director DIRECTOR ELECTIONS ISSUER 78180.000000 0 FOR 78180.000000 FOR AC Immune SA H00263105 CH0329023102 06/20/2024 Reelect Andrea Pfeifer as Director DIRECTOR ELECTIONS ISSUER 78180.000000 0 FOR 78180.000000 FOR AC Immune SA H00263105 CH0329023102 06/20/2024 Reelect Monica Shaw as Director DIRECTOR ELECTIONS ISSUER 78180.000000 0 FOR 78180.000000 FOR AC Immune SA H00263105 CH0329023102 06/20/2024 Reelect Roy Twyman as Director DIRECTOR ELECTIONS ISSUER 78180.000000 0 FOR 78180.000000 FOR AC Immune SA H00263105 CH0329023102 06/20/2024 Reappoint Monika Buetler as Member of the Compensation, Nomination and Corporate Governance Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 78180.000000 0 AGAINST 78180.000000 AGAINST AC Immune SA H00263105 CH0329023102 06/20/2024 Reappoint Roy Twyman as Member of the Compensation, Nomination and Corporate Governance Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 78180.000000 0 AGAINST 78180.000000 AGAINST AC Immune SA H00263105 CH0329023102 06/20/2024 Reappoint Douglas Williams as Member of the Compensation, Nomination and Corporate Governance Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 78180.000000 0 AGAINST 78180.000000 AGAINST AC Immune SA H00263105 CH0329023102 06/20/2024 Ratify PricewaterhouseCoopers SA as Auditors AUDIT-RELATED ISSUER 78180.000000 0 FOR 78180.000000 FOR AC Immune SA H00263105 CH0329023102 06/20/2024 Designate Reymond & Associes as Independent Proxy CORPORATE GOVERNANCE ISSUER 78180.000000 0 FOR 78180.000000 FOR AC Immune SA H00263105 CH0329023102 06/20/2024 Approve Creation of Capital Band within the Upper Limit of CHF 2.9 Million and the Lower Limit of CHF 2.1 Million with or without Exclusion of Preemptive Rights CAPITAL STRUCTURE ISSUER 78180.000000 0 AGAINST 78180.000000 AGAINST AC Immune SA H00263105 CH0329023102 06/20/2024 Approve Creation of CHF 129,844 Pool of Conditional Capital for Employee Equity Plans COMPENSATION ISSUER 78180.000000 0 FOR 78180.000000 FOR AC Immune SA H00263105 CH0329023102 06/20/2024 Amend Articles Re: Shares and Share Register CORPORATE GOVERNANCE ISSUER 78180.000000 0 FOR 78180.000000 FOR AC Immune SA H00263105 CH0329023102 06/20/2024 Amend Articles of Association (Incl. Approval of Virtual-Only or Hybrid Shareholder Meetings) CORPORATE GOVERNANCE ISSUER 78180.000000 0 FOR 78180.000000 FOR AC Immune SA H00263105 CH0329023102 06/20/2024 Transact Other Business (Voting) CORPORATE GOVERNANCE ISSUER 78180.000000 0 ABSTAIN 78180.000000 AGAINST Biogen Inc. 09062X103 US09062X1037 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Caroline D. Dorsa DIRECTOR ELECTIONS ISSUER 42571.000000 0 FOR 42571.000000 FOR Biogen Inc. 09062X103 US09062X1037 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Maria C. Freire DIRECTOR ELECTIONS ISSUER 42571.000000 0 FOR 42571.000000 FOR Biogen Inc. 09062X103 US09062X1037 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: William A. Hawkins DIRECTOR ELECTIONS ISSUER 42571.000000 0 FOR 42571.000000 FOR Biogen Inc. 09062X103 US09062X1037 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. Langer DIRECTOR ELECTIONS ISSUER 42571.000000 0 FOR 42571.000000 FOR Biogen Inc. 09062X103 US09062X1037 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Jesus B. Mantas DIRECTOR ELECTIONS ISSUER 42571.000000 0 FOR 42571.000000 FOR Biogen Inc. 09062X103 US09062X1037 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Monish Patolawala DIRECTOR ELECTIONS ISSUER 42571.000000 0 FOR 42571.000000 FOR Biogen Inc. 09062X103 US09062X1037 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Eric K. Rowinsky DIRECTOR ELECTIONS ISSUER 42571.000000 0 FOR 42571.000000 FOR Biogen Inc. 09062X103 US09062X1037 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Stephen A. Sherwin DIRECTOR ELECTIONS ISSUER 42571.000000 0 FOR 42571.000000 FOR Biogen Inc. 09062X103 US09062X1037 06/20/2024 Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Christopher A. Viehbacher DIRECTOR ELECTIONS ISSUER 42571.000000 0 FOR 42571.000000 FOR Biogen Inc. 09062X103 US09062X1037 06/20/2024 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 42571.000000 0 FOR 42571.000000 FOR Biogen Inc. 09062X103 US09062X1037 06/20/2024 Say on Pay - To hold an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 42571.000000 0 FOR 42571.000000 FOR Biogen Inc. 09062X103 US09062X1037 06/20/2024 To approve an amendment to Biogen's Amended and Restated Certificate of Incorporation, as amended, to add an officer exculpation provision. CORPORATE GOVERNANCE ISSUER 42571.000000 0 FOR 42571.000000 FOR Biogen Inc. 09062X103 US09062X1037 06/20/2024 To approve the Biogen Inc. 2024 Omnibus Plan. COMPENSATION ISSUER 42571.000000 0 FOR 42571.000000 FOR Biogen Inc. 09062X103 US09062X1037 06/20/2024 To approve the Biogen Inc. 2024 Employee Stock Purchase Plan. COMPENSATION ISSUER 42571.000000 0 FOR 42571.000000 FOR Immatics N.V. N44445109 NL0015285941 06/20/2024 Adopt Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 21538.000000 0 FOR 21538.000000 FOR Immatics N.V. N44445109 NL0015285941 06/20/2024 Approve Discharge of Directors CORPORATE GOVERNANCE ISSUER 21538.000000 0 FOR 21538.000000 FOR Immatics N.V. N44445109 NL0015285941 06/20/2024 Reelect M.G. Atieh as Non-Executive Director Class I DIRECTOR ELECTIONS ISSUER 21538.000000 0 FOR 21538.000000 FOR Immatics N.V. N44445109 NL0015285941 06/20/2024 Reelect P.R. Carter as Non-Executive Director Class I DIRECTOR ELECTIONS ISSUER 21538.000000 0 AGAINST 21538.000000 AGAINST Immatics N.V. N44445109 NL0015285941 06/20/2024 Elect E.R. Forster as Non-Executive Director Class I DIRECTOR ELECTIONS ISSUER 21538.000000 0 AGAINST 21538.000000 AGAINST Immatics N.V. N44445109 NL0015285941 06/20/2024 Grant Board Authority to Issue Shares or to Grant Rights to Subscribe for Ordinary Shares CAPITAL STRUCTURE ISSUER 21538.000000 0 AGAINST 21538.000000 AGAINST Immatics N.V. N44445109 NL0015285941 06/20/2024 Authorize Board to Exclude Preemptive Rights from Share Issuances CAPITAL STRUCTURE ISSUER 21538.000000 0 AGAINST 21538.000000 AGAINST Immatics N.V. N44445109 NL0015285941 06/20/2024 Authorize Repurchase of Ordinary Shares or Depositary Receipts CAPITAL STRUCTURE ISSUER 21538.000000 0 AGAINST 21538.000000 AGAINST Immatics N.V. N44445109 NL0015285941 06/20/2024 Approve 2024 Stock Option and Incentive Plan COMPENSATION ISSUER 21538.000000 0 AGAINST 21538.000000 AGAINST Immatics N.V. N44445109 NL0015285941 06/20/2024 Ratify PricewaterhouseCoopers Accountants N.V. as Auditors AUDIT-RELATED ISSUER 21538.000000 0 FOR 21538.000000 FOR Orchestra Biomed Holdings, Inc. 68572M106 US68572M1062 06/20/2024 Election of Class I Directors: Eric A. Rose, M.D. DIRECTOR ELECTIONS ISSUER 18076.000000 0 WITHHOLD 18076.000000 AGAINST Orchestra Biomed Holdings, Inc. 68572M106 US68572M1062 06/20/2024 Election of Class I Directors: Jason Aryeh DIRECTOR ELECTIONS ISSUER 18076.000000 0 FOR 18076.000000 FOR Orchestra Biomed Holdings, Inc. 68572M106 US68572M1062 06/20/2024 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 18076.000000 0 FOR 18076.000000 FOR Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/20/2024 To elect the Class II director nominees named below to hold office until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Sarah A. O'Dowd DIRECTOR ELECTIONS ISSUER 27836.000000 0 FOR 27836.000000 FOR Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/20/2024 To elect the Class II director nominees named below to hold office until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: William D. Waddill DIRECTOR ELECTIONS ISSUER 27836.000000 0 FOR 27836.000000 FOR Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/20/2024 To elect the Class II director nominees named below to hold office until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Lewis T. "Rusty" Williams, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 27836.000000 0 FOR 27836.000000 FOR Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/20/2024 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 27836.000000 0 FOR 27836.000000 FOR Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/20/2024 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 27836.000000 0 FOR 27836.000000 FOR Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/20/2024 To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of our common stock from 90,000,000 to 180,000,000. CAPITAL STRUCTURE ISSUER 27836.000000 0 FOR 27836.000000 FOR Revolution Medicines, Inc. 76155X100 US76155X1000 06/20/2024 To elect three Class I directors to hold office until the 2027 Annual Meeting of Stockholders or until his or her successor is elected: Elizabeth McKee Anderson DIRECTOR ELECTIONS ISSUER 19714.000000 0 FOR 19714.000000 FOR Revolution Medicines, Inc. 76155X100 US76155X1000 06/20/2024 To elect three Class I directors to hold office until the 2027 Annual Meeting of Stockholders or until his or her successor is elected: Flavia Borellini, Ph.D. DIRECTOR ELECTIONS ISSUER 19714.000000 0 FOR 19714.000000 FOR Revolution Medicines, Inc. 76155X100 US76155X1000 06/20/2024 To elect three Class I directors to hold office until the 2027 Annual Meeting of Stockholders or until his or her successor is elected: Lorence Kim, M.D. DIRECTOR ELECTIONS ISSUER 19714.000000 0 FOR 19714.000000 FOR Revolution Medicines, Inc. 76155X100 US76155X1000 06/20/2024 To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024; and AUDIT-RELATED ISSUER 19714.000000 0 FOR 19714.000000 FOR Revolution Medicines, Inc. 76155X100 US76155X1000 06/20/2024 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 19714.000000 0 FOR 19714.000000 FOR BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/21/2024 To elect five (5) directors, Eric Aguiar, M.D., Jennifer E. Cook, Andrea J. Ellis, Fred Hassan and Ali J. Satvat, to serve as Class II directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2026 and until their successors are duly elected and qualified, or until such director's earlier death, resignation or removal: Eric Aguiar, M.D. DIRECTOR ELECTIONS ISSUER 16735.000000 0 FOR 16735.000000 FOR BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/21/2024 To elect five (5) directors, Eric Aguiar, M.D., Jennifer E. Cook, Andrea J. Ellis, Fred Hassan and Ali J. Satvat, to serve as Class II directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2026 and until their successors are duly elected and qualified, or until such director's earlier death, resignation or removal: Jennifer E. Cook DIRECTOR ELECTIONS ISSUER 16735.000000 0 FOR 16735.000000 FOR BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/21/2024 To elect five (5) directors, Eric Aguiar, M.D., Jennifer E. Cook, Andrea J. Ellis, Fred Hassan and Ali J. Satvat, to serve as Class II directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2026 and until their successors are duly elected and qualified, or until such director's earlier death, resignation or removal: Andrea J. Ellis DIRECTOR ELECTIONS ISSUER 16735.000000 0 FOR 16735.000000 FOR BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/21/2024 To elect five (5) directors, Eric Aguiar, M.D., Jennifer E. Cook, Andrea J. Ellis, Fred Hassan and Ali J. Satvat, to serve as Class II directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2026 and until their successors are duly elected and qualified, or until such director's earlier death, resignation or removal: Fred Hassan DIRECTOR ELECTIONS ISSUER 16735.000000 0 FOR 16735.000000 FOR BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/21/2024 To elect five (5) directors, Eric Aguiar, M.D., Jennifer E. Cook, Andrea J. Ellis, Fred Hassan and Ali J. Satvat, to serve as Class II directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2026 and until their successors are duly elected and qualified, or until such director's earlier death, resignation or removal: Ali J. Satvat DIRECTOR ELECTIONS ISSUER 16735.000000 0 WITHHOLD 16735.000000 AGAINST BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/21/2024 To cast a non-binding, advisory vote to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 16735.000000 0 FOR 16735.000000 FOR BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/21/2024 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 16735.000000 0 FOR 16735.000000 FOR BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/21/2024 To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to, among other things, increase the number of shares of common stock reserved for issuance thereunder by 6,500,000 shares. COMPENSATION ISSUER 16735.000000 0 FOR 16735.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Adopt Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Approve Remuneration Report COMPENSATION ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Approve Discharge of Management Board CORPORATE GOVERNANCE ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Approve Discharge of Supervisory Board CORPORATE GOVERNANCE ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Reelect Metin Colpan to Supervisory Board DIRECTOR ELECTIONS ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Reelect Toralf Haag to Supervisory Board DIRECTOR ELECTIONS ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Reelect Ross L. Levine to Supervisory Board DIRECTOR ELECTIONS ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Reelect Elaine Mardis to Supervisory Board DIRECTOR ELECTIONS ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Reelect Eva Pisa to Supervisory Board DIRECTOR ELECTIONS ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Reelect Lawrence A. Rosen to Supervisory Board DIRECTOR ELECTIONS ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Reelect Stephen H. Rusckowski to Supervisory Board DIRECTOR ELECTIONS ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Reelect Elizabeth E. Tallett to Supervisory Board DIRECTOR ELECTIONS ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Reelect Bert van Meurs to Supervisory Board DIRECTOR ELECTIONS ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Reelect Eva van Pelt to Supervisory Board DIRECTOR ELECTIONS ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Reelect Thierry Bernard to Management Board CORPORATE GOVERNANCE ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Reelect Roland Sackers to Management Board CORPORATE GOVERNANCE ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Approve Remuneration Policy for the Supervisory Board COMPENSATION ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Approve Remuneration of Supervisory Board COMPENSATION ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Reappoint KPMG Accountants N.V. as Auditors for the Financial Year Ending December 31, 2024 AUDIT-RELATED ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Ratify Ernst & Young Accountants LLP as Auditors for the Financial Year Ending December 31, 2025 AUDIT-RELATED ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Grant Supervisory Board Authority to Issue Shares CAPITAL STRUCTURE ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Authorize Supervisory Board to Exclude Preemptive Rights from Share Issuances CAPITAL STRUCTURE ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Authorize Repurchase of Up to 10 Percent of Issued Share Capital CAPITAL STRUCTURE ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Approve Discretionary Rights for the Managing Board to Implement Capital Repayment by Means of Synthetic Share Repurchase CAPITAL STRUCTURE ISSUER 35078.000000 0 FOR 35078.000000 FOR QIAGEN NV N72482149 NL0015001WM6 06/21/2024 Approve Cancellation of Shares CAPITAL STRUCTURE ISSUER 35078.000000 0 FOR 35078.000000 FOR CureVac NV N2451R105 NL0015436031 06/24/2024 Adopt Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 17910.000000 11940.000000 FOR 17910.000000 FOR CureVac NV N2451R105 NL0015436031 06/24/2024 Approve Discharge of Management Board CORPORATE GOVERNANCE ISSUER 17910.000000 11940.000000 FOR 17910.000000 FOR CureVac NV N2451R105 NL0015436031 06/24/2024 Approve Discharge of Supervisory Board CORPORATE GOVERNANCE ISSUER 17910.000000 11940.000000 FOR 17910.000000 FOR CureVac NV N2451R105 NL0015436031 06/24/2024 Elect Thaminda Ramanayake to Management Board CORPORATE GOVERNANCE ISSUER 17910.000000 11940.000000 FOR 17910.000000 FOR CureVac NV N2451R105 NL0015436031 06/24/2024 Reelect Malte Greune to Management Board CORPORATE GOVERNANCE ISSUER 17910.000000 11940.000000 FOR 17910.000000 FOR CureVac NV N2451R105 NL0015436031 06/24/2024 Reelect Jean Stephenne to Supervisory Board DIRECTOR ELECTIONS ISSUER 17910.000000 11940.000000 AGAINST 17910.000000 AGAINST CureVac NV N2451R105 NL0015436031 06/24/2024 Reelect Mathias Hothum to Supervisory Board DIRECTOR ELECTIONS ISSUER 17910.000000 11940.000000 AGAINST 17910.000000 AGAINST CureVac NV N2451R105 NL0015436031 06/24/2024 Elect Birgit Hofmann to Supervisory Board DIRECTOR ELECTIONS ISSUER 17910.000000 11940.000000 FOR 17910.000000 FOR CureVac NV N2451R105 NL0015436031 06/24/2024 Ratify KPMG N.V. as Auditors AUDIT-RELATED ISSUER 17910.000000 11940.000000 FOR 17910.000000 FOR Structure Therapeutics Inc. 86366E106 US86366E1064 06/25/2024 Election of the nominee for Class I director named below to serve until the 2027 annual general meeting of shareholders and until her successor is duly elected and qualified, or until her earlier death, resignation or removal: Sharon Tetlow DIRECTOR ELECTIONS ISSUER 16214.000000 10700.000000 FOR 16214.000000 FOR Structure Therapeutics Inc. 86366E106 US86366E1064 06/25/2024 To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 16214.000000 10700.000000 FOR 16214.000000 FOR Autolus Therapeutics Plc 05280R100 US05280R1005 06/28/2024 Accept Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 64258.000000 0 FOR 64258.000000 FOR Autolus Therapeutics Plc 05280R100 US05280R1005 06/28/2024 Approve Remuneration Report COMPENSATION ISSUER 64258.000000 0 FOR 64258.000000 FOR Autolus Therapeutics Plc 05280R100 US05280R1005 06/28/2024 Reappoint Ernst & Young LLP as Auditors and Authorise Their Remuneration AUDIT-RELATED ISSUER 64258.000000 0 FOR 64258.000000 FOR Autolus Therapeutics Plc 05280R100 US05280R1005 06/28/2024 Elect Director Linda Bain DIRECTOR ELECTIONS ISSUER 64258.000000 0 FOR 64258.000000 FOR Autolus Therapeutics Plc 05280R100 US05280R1005 06/28/2024 Elect Director Cynthia Butitta DIRECTOR ELECTIONS ISSUER 64258.000000 0 FOR 64258.000000 FOR Autolus Therapeutics Plc 05280R100 US05280R1005 06/28/2024 Elect Director Christian Itin DIRECTOR ELECTIONS ISSUER 64258.000000 0 FOR 64258.000000 FOR Autolus Therapeutics Plc 05280R100 US05280R1005 06/28/2024 Elect Director William Young DIRECTOR ELECTIONS ISSUER 64258.000000 0 FOR 64258.000000 FOR Autolus Therapeutics Plc 05280R100 US05280R1005 06/28/2024 Authorise Issue of Equity CAPITAL STRUCTURE ISSUER 64258.000000 0 FOR 64258.000000 FOR Autolus Therapeutics Plc 05280R100 US05280R1005 06/28/2024 Authorise Issue of Equity without Pre-emptive Rights CAPITAL STRUCTURE ISSUER 64258.000000 0 FOR 64258.000000 FOR